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INTRODUCTION
Nanotechnology, applications of nanoparticles and potential risks 
Nanotechnology is a relatively new field of science and technology, in which, amongst 
others, the development of nanomaterials (NMs) is increasing very rapidly. In this thesis 
the focus lies on the use of nanoparticles (NPs), which are NMs with sizes between ~1 and 
100 nm in three dimensions. Because of their small size, resulting in a relatively large surface 
area compared to volume, NPs show unique physical and chemical properties that are not 
found in bulk counterparts of the same material, not even at the same mass (Chaudhry 
et al. 2008; Auffan et al. 2009; Allahverdiyev et al. 2011). Due to the high surface area to 
volume ratio NPs obtain higher reactivity. Because of these unique properties, NPs find 
many applications, including health care, pharmaceutical and food industries. While there 
are many benefits of using NP-containing products, the unique properties of NPs also give 
rise to safety concerns like adverse health effects upon exposure to and potential intake of 
NPs, intentional and unintentional (Oberdorster et al. 2005; Drake and Hazelwood 2005; 
Navarro et al. 2008; Sung et al. 2009).
There are many NP-containing products already on the market, and their number is 
expected to further increase in the near future (Duran and Marcato 2013). NPs are currently 
being used in consumer products, like electronics, clothing, textiles, wound dressings and 
cosmetics (e.g. sunscreens, lipsticks, skin creams, and toothpaste). In medicine, NPs are 
used for drug delivery, bio-imaging, regenerative medicine, and therapeutics. In food 
industry, they are used for processing and packaging (e.g. edible thin film packaging), but 
also as storage life sensors, food additives, and juice clarifiers (Bouwmeester et al. 2014). 
NPs can enter the gastrointestinal tract intentionally or unintentionally, mainly through 
food or cosmetics. 
In food and food-related products a great variety of NPs are used. Silver, silica and 
titanium dioxide are the NPs that are used most commonly in the food sector, as a part of 
materials coming in contact with food during its processing and packaging, as well as a part 
of food itself. 
1. Silver metal has been used by mankind for centuries, e.g. as coins, for utensils or  in 
antimicrobial applications and as NPs in ancient glass, etc. (Wijnhoven et al. 2009). 
Since the introduction of engineered silver NPs (AgNPs) on the market, they gain a lot 
of attention for their properties resulting from nano-size, which are higher reactivity 
and ease of releasing Ag+ ions. AgNPs are increasingly being used in many industrial 
sectors for antimicrobial properties, e.g. in odor-resistant textiles and odor-killing and 
wound-dressing cosmetics (Nanoparticle Products Inventory, PEN; Wijnhoven et al. 
2009). AgNPs constitute the majority of the NPs used in the food sector (Nanoparticle 
Products Inventory, PEN). They are used for their antimicrobial properties mainly in 
processing and packaging of food (e.g., kitchenware coated with AgNPs, or foils and 
containers with incorporated AgNPs), but they are also used in food products itself, 
for example, as health supplements and food additives (E174) (Nanoparticle Products 
Inventory, PEN; Chaudhry et al. 2008; Bouwmeester et al. 2009). Health supplements 
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in the form of aqueous dispersions of AgNPs for oral consumption are claimed to act 
as an antimicrobial and to augment the body’s immune system. These suspensions 
are easily accessible from numerous sources (Nanoparticle Products Inventory, PEN). 
Therefore, the likelihood of oral human exposure to AgNPs is high. What makes AgNPs 
so attractive for industries is their dissociation of ions (Kittler et al. 2010; Liu and Hurt 
2010; Maurer-Jones et al. 2013) and the release of Ag+ ions from AgNPs can reach up 
to 90% of their total mass, depending on the environmental conditions like pH and 
chemical composition of the medium and the temperature (Kittler et al. 2010; Maurer 
et al. 2014). Therefore, Ag+ ions are an inseparable element accompanying AgNPs in 
aqueous solutions and the behaviour of Ag+ ions should be considered in any biological 
study using AgNPs.
2. Another type of NP commonly used in the food industry is synthetic amorphous silica 
(SAS). In the EU it is registered as a food additive (E551), used as an anticaking agent 
and carrier of flavours (Dekkers et al. 2011). The highest concentrations of nano-sized 
silica are found in coffee creamers, instant soups, seasoning mixes and rubs (Dekkers 
et al. 2011).
3. Other types of NPs often used in the food industry include: titanium dioxide, zinc 
oxide, magnesium oxide, gold and platinum, alumina, copper, cerium oxide, calcium, 
selenium, iron oxides, cadmium telluride (Bouwmeester et al. 2009; Bouwmeester et 
al. 2014; Chaudhry et al. 2008; Frohlich and Roblegg 2012). Titanium dioxide is an 
authorized to be used as additive in food (E171) as a food colorant. The food-grade 
titanium dioxide has been shown to contain approximately 36% of the particles in size 
smaller than 100 nm (Weir et al. 2012). The highest content of titanium dioxide can be 
found in sweets, candies, and chewing gums (Weir et al. 2012; Peters et al. 2014).  
Given the use of NPs in food and consumer products, consumers are very likely orally 
exposed to NPs. Presently, risk assessment of NPs relies mainly on in vivo studies (EFSA 
and Committee 2011). Given the enormous diversity of NPs, a high number of animals 
would be required to test all of them in vivo. For both scientific and societal reasons this 
is undesirable. Meanwhile, there is a strong societal demand to reduce animal studies for 
testing of chemicals (so also NPs). Reduction of animal studies could also potentially reduce 
costs and time needed for NP safety testing. In order to reduce in vivo testing, efficient 
alternative in vitro methods for prediction of toxicity and bioavailability of NPs would be of 
great value. The role of alternative in vitro methods is to reduce, refine and replace animal 
studies, three principles known as the “3Rs”. The search for alternative methods for testing 
chemicals is rapidly increasing due to special organisations and networks validating in vitro 
techniques to replace animal studies, like ECVAM, OECD and EUNETVAL. An approach 
for testing oral exposure to NPs was proposed by EFSA (European Food Safety Authority) 
in a guidance document on risk assessment of NPs in the food and feed chain (EFSA and 
Committee 2011). According to this document, testing NP behaviour and bioavailability 
upon oral ingestion should be a tiered approach, so it should encompass several steps. 
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These steps, relevant for the topic of the present thesis, are discussed in more detail in the 
next section.  
In vitro models to assess NP behaviour upon oral ingestion and oral bioavailability 
As advised by EFSA, NPs should be tested in a series of in vitro assays, reflecting all 
steps that specifically occur after oral administration. The first step is the gastrointestinal 
digestion of NPs. The second step is the intestinal translocation of NPs across the intestinal 
barrier, resulting in systemic circulation of the NPs and thus their bioavailability. The 
currently existing in vitro models for human gastrointestinal digestion and for intestinal 
translocation are discussed below. 
In vitro human gastrointestinal digestion model
The first crucial step in studying the behaviour of NPs upon oral exposure would be 
testing their response to the dynamic conditions in the human gastrointestinal tract. 
Gastrointestinal digestion might influence the physicochemical properties of NPs due to 
multiple factors, such as an elevated temperature, variable pH, and variable concentrations 
of salts and proteins along the digestive tract. These parameters are known to affect the 
properties of NPs including their surface chemistry and agglomeration state (Chaudhry et 
al. 2008; Fabrega et al. 2009; El Badawy et al. 2010; Liu and Hurt 2010; Bihari et al. 2008; 
Greulich et al. 2009; Rogers et al. 2012), their interaction with biomolecules (Cedervall et 
al. 2007; Lundqvist et al. 2008; Lynch and Dawson 2008) and their dissolution rate, in case 
of dissolving NPs like zinc oxide and silver NPs (Liu and Hurt 2010). 
Several in vitro digestion models are described in the literature that could be used to 
evaluate the behaviour of NPs during gastrointestinal digestion. The available models range 
in complexity and adequacy to recapitulate the whole human gastrointestinal digestion. 
Some simplified models simulate only gastric digestion, in which compounds are incubated 
in a salt buffer at low pH (Mahler et al. 2009; Mwilu et al. 2013). The Dynamic Gastric Model 
mimics changes in pH, enzyme addition, shearing, mixing and retention time of an adult 
human stomach (Vardakou et al. 2011). The Human Gastric Simulator in addition includes 
the continuous peristaltic movements of the stomach wall and dynamic gastric secretion, 
emptying systems and temperature control (Kong and Singh 2010). A model simulating 
the small intestinal conditions only is the pH-stat method, a simple in vitro lipolysis model 
which is used to characterize lipid digestion (Li and McClements 2010). 
More complex models incorporate both the gastric and intestinal compartments. A static 
model that encompasses the majority of conditions relevant for oral exposure (i.e. the oral, 
gastric, and small intestinal conditions) was developed by Versantvoort et al. (Versantvoort 
et al. 2005) and was subsequently used in studies determining the bioaccessibility of 
orally ingested compounds like heavy metals (Oomen et al. 2003) and other contaminants 
(Versantvoort et al. 2005). This model mimics the human in vivo conditions, regarding pH 
values, salt and enzyme concentrations and incubation times. Other static digestion models 
are: the modified PBET method (Physiologically Based Extraction Test) operated by the BGS 
(United Kingdom), the German E DIN 19738, applied by the Ruhr-Universität Bochum 
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(Germany) and the SHIME (Simulator of the Human Intestinal Microbial Ecosystem) 
procedure used by LabMET (Ghent University, Belgium) (Van de Wiele et al. 2007). All these 
models differ slightly between one another, regarding composition and pH of digestive juices 
and incubation times. Furthermore, several dynamic digestion models have been developed, 
which are more sophisticated and computerized. They allow the simulation of the dynamics 
of digestion, with regulation of transit times, transport of the sample between digestive 
compartments and time-dependent regulation of pH values and enzyme concentrations. 
One of these models is the multi-compartmental digestion model, called TNO Intestinal 
Model 1 (TIM1), which simulates the physiological conditions of the human stomach and 
small intestine, including peristaltic mixing and transit and removal of the products of 
digestion (Minekus et al. 1999; Reis et al 2008; Helbig et al. 2013). Other examples of dynamic 
digestion models are the models of the English Institute of Food Research (Wickham et al. 
2009; Wickham et al. 2012) and of the French INRA (Menard et al. 2014). 
Even though dynamic models are more sophisticated and closer to a realistic digestion 
process, static models are used as well since they are simpler and suitable for more high 
throughput studies. In addition, static models provide the advantage that samples can be 
collected at each step of the digestion, gastric and intestinal, separately.  
At the start of this project no studies were available using the digestion models for NPs. 
In vitro human intestinal epithelium model 
After passing through the mouth and stomach, NPs reach the small intestine, which is 
the most prominent compartment for uptake of NPs into blood. The bioavailability of 
NPs, therefore, depends on the translocation efficiency of NPs through the small intestine 
influences their bioavailability. Following the already mentioned tiered approach, the 
intestinal translocation of NPs should be carefully evaluated to assess their bioavailability. 
In vitro translocation models, mimicking the small intestinal wall, are therefore the next 
step in line for the prediction of NP bioavailability after oral exposure in vivo. Mainly 
Caco-2 cells (human epithelial colorectal adenocarcinoma cells) have been used as an 
intestinal epithelial cell model, grown as a cell layer on semi-permeable membrane inserts 
which separate an apical from a basolateral chamber. In vitro intestinal cell models based 
on Caco-2 cells have a long history of use in the uptake screening of conventional chemicals 
(Hilgers et al. 1990; Prieto et al. 2010). 
Caco-2 cells may be used as a mono-culture, which is the most commonly used 
intestinal barrier model (des Rieux et al. 2005; Mahler et al. 2009; Bhattacharjee et al. 2013a; 
Nkabinde et al. 2012; Natoli et al., 2012). Caco-2 cells lack mucus production, responsible 
for covering the cell layer with mucus, which has been shown to play an important 
role in affecting the permeability and resistance of the intestinal cell layer to hazardous 
compounds (Norris and Sinko 1997; Crater and Carrier 2010). Mucus presents a barrier to 
the absorption of NPs through the intestinal wall because of its thickness, high molecular 
weight and negative charge. It can entrap NPs or act repulsive (depending on the charge 
of NPs) (Crater and Carrier 2010) or simply pose a physical barrier due to density and 
thickness (Cone 2009). Mucus can also cause agglomeration of NPs (Ensign et al. 2012). 
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Therefore, Caco-2 cells are often used in co-culture with mucus producing HT29-MTX 
cells (human colon adenocarcinoma mucus secreting cells) (Mahler et al. 2009; Behrens et 
al. 2002; Scaldaferri et al. 2012). Another cell type present in human intestinal epithelium 
is the human intestine microfold (M) cell. M cells are localized in the intestinal Peyer’s 
patches, of which adult humans have about 30 and M cells in total compose less than 1 
percent of the small intestine epithelial cell layer. M cells are responsible for the uptake 
and translocation of relatively larger particles (Kerneis et al. 1997; des Rieux et al. 2005; 
des Rieux et al. 2007; Bouwmeester et al. 2011b; Martinez-Argudo et al. 2007). Co-cultures 
of Caco-2 and M cells have been used for testing NP translocation (des Rieux et al. 2007; 
Bouwmeester et al. 2011b). The most complex model, employing all three cell types present 
in the human small intestinal epithelium, has been used (Bazes et al. 2011; Antunes et al. 
2013), also for assessing translocation of polystyrene (PS)-NPs and demonstrated a role of 
M cells in translocation of larger (200 nm) NPs (Mahler et al. 2012).
A limited number of studies have used these in vitro models to test the translocation 
of NPs. These studies often use easily detectable NPs like fluorescently labelled PS-NPs as 
model NPs due to their stability and due to the availability of these NPs in various sizes and 
with different surface modifications resulting in different surface charges, steric hindrance, 
hydrophobicity properties, and fluorescent properties. All these properties make these NPs 
easy to use, reliable and suitable for testing biological effects in response to the surface 
characteristics (des Rieux et al. 2005; Lundqvist et al. 2008; Mahler et al. 2012). Using 
fluorescently labelled NPs facilitates detection in biological systems, enabling tracing and 
quantification. Taken together, PS-NPs are very suitable model NPs to apply in studies 
aiming to develop alternative in vitro models for NP testing. Table 1 gives an overview of 
the various human intestinal epithelium in vitro models for testing the translocation of 
different types of PS-NPs. For the study of translocation of NPs models with increasing 
complexity are used: mono-cultures, co- and tri- cultures, with and without a mucus layer. 
This overview demonstrates that the different intestinal cell models have been successfully 
used for studies on NP translocation. It is difficult, though, to draw any firm conclusion 
from these results, as the reported translocation values are highly variable between different 
studies. At the start of this PhD project, a systematic study comparing different cell models 
with use of different types of PS-NPs was still lacking.   
At the start of this PhD project, a combination of in vitro digestion models with in vitro 
intestinal translocation models had never been used before to assess the fate and uptake of 
NPs. Such a combination had been applied only to test the bioavailability of conventional 
chemicals like iron from different foods (Mahler et al. 2009) or phenolic compounds from 
strawberries (Kosinska-Cagnazzo et al., 2014). 
In vivo oral studies with PS-NPs 
Several in vivo oral studies have been performed before with differently sized and coated 
PS-NPs in rats. These studies have demonstrated the oral bioavailability of PS-NPs of 23% 
for 500 nm PS-NPs (Hussain et al. 1997) and ranging from 0.8 to 6.6% for PS-NPs in size 
of 1 µm to 50 nm (Jani et al. 1990). The results from these studies highlight the dependence 
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Table 1. Summary of human intestinal epithelium in vitro models used for testing the translocation 
of different types of PS-NPs.
NP type Size Concentration
Exposure 
time Cells Translocation Reference
PS-NPs, 
plain
460 nm 7.7x108  
NPs/ml
4 h Caco-2 1% (Martinez-
Argudo et al. 
2007)Caco-2 + M cells 11%
PS-NPs
-carboxylated
200 nm 4.5x109  
NPs/ml
1.5 h Caco-2 cells 0% (des Rieux et 
al. 2005)Caco-2 + M cells ~0.0007%
-aminated Caco-2 cells ~0%
Caco-2 + M cells ~0.002%
-carboxylated 500 nm Caco-2 cells ~0%
Caco-2 + M cells ~0%
PS-NPs,
carboxylated
200 nm 4.5x109  
NPs/ml
1 h Caco-2 cells 2x10-5 % (des Rieux et 
al. 2007)Caco-2 + M cells 8x10-4 % 
PS-NPs,
carboxylated
50 nm 2x1011  
NPs/ml
45 min Caco-2 + 
HT29-MTX 
~2.3% * (Mahler et al. 
2012)
Caco-2 + 
HT29-MTX + 
M cells
~3% *
200 nm 1.25x1010 
NPs/ml
Caco-2 + 
HT29-MTX 
~0.1% * 
Caco-2 + 
HT29-MTX + 
M cells
0.8% *
PS-NPs
- aminated
50 nm 1 µg/ml 24 h Caco-2 ~35% (Bhattacharjee 
et al. 2013c)
- carboxylated ~10%
Latex NPs, 
plain
2 µm 5.68x106 NPs 1.5 h Caco-2 ~0.006% * (Moyes et al. 
2007)
PS-NPs,
plain
50 nm 100 µg/ml 2 h Caco-2 5% (Kulkarni and 
Feng 2013)100 nm 10%
*Calculated from the numbers given in the manuscript
of absorption and accumulation of PS-NPs on several factors, including the size, surface 
charge and type of coating material (Jani et al. 1989; Hillery et al. 1994; Hussain et al. 1997; 
Hussain and Florence 1998). In general, smaller PS-NPs were taken up to a higher extent 
than the larger ones (Jani et al. 1990) and the non-ionized more than the carboxylated ones 
(Jani et al. 1989). The intestinal wall has been shown to be the main accumulation site for 
PS-NPs (Hussain et al. 1997). This could be related with the uptake of PS-NPs in lymphoid 
tissue associated with these organs, as shown in other studies (Seifert et al. 1996; Hillery 
et al. 1994; Florence et al. 1995). PS-NPs were distributed also to liver, spleen and kidney 
(Hussain et al. 1997; Jani et al. 1990). 
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Despite the results of the in vivo exposures, no data are available from studies that used 
the same PS-NPs in vitro and in vivo.  
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(pH=6.8)                                    
(incubation time: 5 min) 
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(pH=2.5)                                      
(incubation time: 2 h) 
+ intestinal juice               
(pH=6.5)                                   
(incubation time: 2 h) 
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Figure 1. Schematic overview of the steps taken in the present thesis to develop an integrated in vitro 
model for the prediction of oral bioavailability of nanoparticles.
Figure 2. Schematic representation of the integrated in vitro model developed in the present thesis. 
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Physicochemical characterization of NPs
In discussions NPs are often considered as homogenous materials. This is reflected in 
assumptions that all NPs are alike and trigger similar biological responses. In practise this 
is by far not true, one might regard the group of NPs as diverse as chemicals (ranging from 
metals to complex organic compounds). Perhaps the most simple illustration is that a batch 
of a given NP contains NPs with different sizes (i.e., a size distribution, with a different 
number of particles per size), that in an ideal case follows a normal distribution. In attempts 
to describe this huge variability in NPs and to adequately characterize NPs, long lists of 
physicochemical parameters have been compiled by expert committees. No single metric 
is known that fully describes the relation between physicochemical properties and the 
biological effects, but the most important parameters that influence the properties of NPs 
are size, chemical composition, surface charge, chemical composition of the core, surface 
functionalization, dissolution into ions and shape (Oberdorster et al. 2005; Bouwmeester et 
al. 2009; Bouwmeester et al. 2011a). These factors influence NP kinetics at the cellular level 
and at the level of the whole body (uptake, distribution, and excretion), thereby affecting 
their possible toxicity (Oberdorster et al. 2005; Sager and Castranova 2009; Park et al. 2011; 
Bhattacharjee et al. 2013b). An additional degree of complexity in describing NPs arises 
from their high reactivity in different biological environments. Upon contact with any 
media, the size and surface charge of NPs can be modified, and the NPs might become 
coated with molecules present in the media. The resulting changes in physicochemical 
characteristics will in turn affect the biological effects exerted by NPs. 
To understand the observed biological effects, a sound characterization of the NPs in 
the testing environment is required. Different analytical chemical methods are being used 
for this characterization. The size of NPs can be measured with several techniques. NPs can 
be visualized by electron microscopy techniques, like transmission electron microscopy 
(TEM) or scanning electron microscopy (SEM), enabling measurement of the diameter. 
Other techniques are dynamic light scattering (DLS) and nanoparticle tracking analysis 
(NTA), which measure the hydrodynamic diameters of NPs. DLS analyses the velocity 
distribution of particle movement by measuring dynamic fluctuations of light scattering 
intensity caused by the Brownian motion of the particle. The hydrodynamic diameter given 
by DLS is the diameter of the core of NPs together with a hydration layer surrounding 
the particle. Therefore, the size measured with DLS is slightly larger than the one given 
by electron microscopy techniques, which only measure the core NP without a hydration 
layer. Another technique for measuring the size of NPs is (single particle-) inductively 
coupled plasma-mass spectroscopy (SP-ICPMS). With this technique the masses of NPs are 
measured, which are further mathematically converted into sizes, using the assumption that 
all NPs have spherical shape. SP-ICPMS enables detection of AgNPs in relatively complex 
matrices and at very low concentrations.
The next important physicochemical parameter to measure is the chemical composition. 
The composition of the NP core is crucial for the function, but the whole range of 
physicochemical properties of NPs are further exerted by the functional groups present 
on the surface of NPs. At this level, the physicochemical properties are shaped by the type 
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and density of the chemical groups, their structure, steric hindrance, and hydrophobicity. 
The surface charge, induced by the functional groups, can be measured by measuring zeta 
potential. The chemical composition of the surface can be estimated based on matrix-
assisted laser desorption ionization – time of flight (MALDI-TOF) measurements. This 
technique is based on a desorption of a sample with laser and its subsequent ionization. 
Other techniques available for the measurement of chemical composition of the surface of 
NPs are: energy-dispersive X-ray spectroscopy (EDX), x-ray photoelectron spectroscopy 
(XPS), Raman spectroscopy and infrared spectroscopy. 
Upon introduction in any biological media, NPs are immediately coated with biological 
molecules resulting in a protein corona, a layer of proteins adsorbed tightly (hard corona) 
and loosely (soft corona) on the surface of NPs. The protein corona is known to affect 
the interactions of NPs with biological systems and it has been suggested to be the main 
parameter that mediates any interaction of NPs (Walczyk et al. 2010; Lesniak et al. 2012; 
Monopoli et al. 2012). Both the amount of adsorbed proteins and their composition 
have been shown to affect the cellular uptake of NPs, as well as their translocation and 
interaction with receptors and cellular components (Tedja et al. 2012; Lesniak et al. 2010; 
Lundqvist 2013; Ehrenberg et al. 2009). The thickness and composition of the protein 
corona can be analysed with techniques like sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), 2-dimensional gel electrophoresis (2DE), proteomics, and 
liquid chromatography–mass spectrometry (LC-MS/MS). While SDS-PAGE indicates the 
approximate molecular mass of the proteins, LC-MS/MS gives an accurate indication of the 
molecular mass and allow identification of exact proteins. Additionally, with some types 
of dissolving NPs like silver, zinc oxide or silica NPs, it is important to measure their ion 
release in media. This is crucial because ions, e.g. in case of silver, exert biological functions 
and it is necessary to know their concentration in exposure media to distinguish the effects 
attributed to AgNPs from the ones of Ag+ ions. The concentration of ions in solutions can 
be measured with several techniques, like a silver ion/sulphide selective electrode, or- after 
separation from AgNPs- with atomic absorption spectroscopy (AAS) or ICP-MS, which 
measure the total content of elemental silver. Ultraviolet-Visible spectroscopy (UV-Vis) 
gives a semi-quantitative indication of silver ions content.  
AIM AND OUTLINE OF THE THESIS 
The aim of the present thesis was to develop an integrated in vitro approach to evaluate the 
uptake of NPs following ingestion for the prediction of their oral bioavailability in the human 
body. To achieve this, an in vitro gastrointestinal digestion model was used, to test the fate 
of NPs upon digestion in the human digestion tract. Further, in vitro intestinal epithelial 
models were used to evaluate the potential translocation of NPs across the intestinal barrier 
to predict their potential systemic absorption. Next, the in vitro gastrointestinal model 
was combined with the intestinal model and the translocation of digested NPs was tested 
across the intestinal model. Lastly, an in vivo experiment was performed to pre-validate the 
integrated in vitro model.
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Chapter 1, the present chapter of this thesis, gives an introduction to the topic of 
nanotoxicology, highlights the importance of careful characterization of NPs tested in the 
various assays and presents existing in vitro models of gastrointestinal digestion and human 
intestinal epithelium used for toxicity testing of NPs. Some of these in vitro models were 
selected and evaluated for testing NPs in the next (experimental) chapters. The aim and 
contents of the present thesis are also presented. 
In chapter 2, the influence of a gastrointestinal digestion on the behaviour and properties 
of highly characterized AgNPs is described. AgNPs were selected for this study due to their 
common application in food and food-related products. To this end, an in vitro model of 
human gastrointestinal digestion was used and NPs were carefully characterized with an 
array of techniques after each phase of the digestion. 
In chapter 3, the translocation of PS-NPs across in vitro intestinal models is described. 
In this study three in vitro intestinal epithelial cell models of increasing complexity were 
used to assess the translocation of differently sized (50 and 100 nm) and charged (neutral, 
positive and negative charge) PS-NPs. PS-NPs were selected for this study as they are 
commercially available with a wide variety of physicochemical properties like charge 
and fluorescent labelling, which makes them excellent model NPs, suitable for model 
development studies. A mono-culture of Caco-2 cells, a co-culture with additional mucus 
secreting HT29-MTX cells, and a tri-culture with additional both HT29-MTX cells and M 
cells were used. 
In chapter 4, the effect of in vitro gastrointestinal digestion on the protein corona of 
NPs and their subsequent translocation across an in vitro intestinal barrier is investigated. 
PS-NPs were used with different charges (neutral, positive and negative), but also with 
different surface modifications (i.e. two types of negatively charged PS-NPs from two 
different suppliers) for comparison. 
In chapter 5, an in vivo study is described which was performed to validate the in vitro 
integrated model described in Chapter 4. In this study the uptake and biodistribution of 
orally administered PS-NPs (i.e. the same PS-NPs as used in Chapter 4) were evaluated and 
results were compared with outcomes of the in vitro model. 
Finally, chapter 6 discusses the results described in the present thesis and provides 
suggestions for future research.    
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ABSTRACT
Oral ingestion is an important exposure route for silver nanoparticles (AgNPs), but 
their fate during gastrointestinal digestion is unknown. This was studied for 60 nm 
AgNPs and silver ions (AgNO3) using in vitro human digestion model. Samples 
after saliva, gastric and intestinal digestion were analysed with SP-ICPMS, DLS and 
SEM-EDX. In presence of proteins, after gastric digestion the number of particles 
dropped significantly, to rise back to original values after the intestinal digestion. 
SEM-EDX revealed that reduction in number of particles was caused by their 
clustering. These clusters were composed of AgNPs and chlorine. During intestinal 
digestion, these clusters disintegrated back into single 60 nm AgNPs. The authors 
conclude that these AgNPs under physiological conditions can reach the intestinal 
wall in their initial size and composition. Importantly, intestinal digestion of AgNO3 
in presence of proteins resulted in particle formation. These nanoparticles (of 
20-30 nm) were composed of silver, sulphur and chlorine. 
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INTRODUCTION
Nanotechnology develops rapidly and use of consumer products containing manufactured 
nanoparticles (NPs) is expected to further increase in the near future (Chaudhry et al. 
2008). Particularly silver nanoparticles (AgNPs) are used in a wide range of applications 
(e.g.,  textiles and wound dressings), mostly because of their antimicrobial properties 
(Chaudhry et al. 2008; Tien et al. 2008; Rai et al. 2009). Also in food industry, AgNPs are 
applied for this reason not only in materials used for processing and packaging of food 
(e.g., kitchenware coated with AgNPs, or foils and containers with incorporated AgNPs), but 
also in food itself, for example, as health supplements (Chaudhry et al. 2008; Bouwmeester 
et al. 2009). Aqueous dispersions of AgNPs for oral consumption are easily accessible from 
numerous sources (Nanoparticle Products Inventory, PEN). Therefore, consumers are very 
likely exposed orally to AgNPs, either intentionally or accidentally. 
The interest in NPs in general is caused by their size resulting in unique physical and 
chemical properties that differ from their bulk counterparts, even at the same mass dose 
(Chaudhry et al. 2008; Allahverdiyev et al. 2011). On the other hand, the unique properties 
of particles at nanoscale also give rise to possible safety concerns (Oberdorster et al. 2005; 
Drake and Hazelwood 2005; Navarro et al. 2008; Sung et al. 2009). However, the relations 
between observed biological effects of NPs and their physicochemical properties remain to 
be elucidated. For this, a set of nanomaterial properties has been proposed that should be 
determined at the minimum in any biological study (Bouwmeester et al. 2009; Oberdorster 
et al. 2005). A specific feature of AgNPs is their dissociation of ions (Kittler et al. 2010), 
which distinguishes AgNPs from inert gold or titanium dioxide NPs and which makes Ag+ 
ions an inseparable element accompanying AgNPs in aqueous solutions. Depending on the 
conditions, release of Ag+ ions from AgNPs can reach 90% of their total mass (Kittler et 
al. 2010). Clearly in any biological study using AgNPs, also the fate and behaviour of Ag+ 
ions should be considered, as well as the possibility of Ag salt complex formation in the 
nanosized range.
At the moment, risk assessment of chemicals and NPs heavily relies on in vivo studies. 
There is a high societal and scientific demand to develop alternative testing strategies 
to reduce or refine animal studies. The recent EFSA (European Food Safety Authority) 
guidance on risk assessment of NPs in the food and feed chain (EFSA and Committee 
2011) proposes a tiered approach for testing, in which all steps occurring after oral 
administration are assessed by a series of in vitro assays. The first step is to understand the 
impact of human digestion, which in turn will help defining in vitro exposure conditions. 
It has been shown that AgNPs are very responsive to environmental conditions and 
frequently agglomerate readily when suspended in various solvents, including water (Bihari 
et al. 2008; Murdock et al. 2008). Gastrointestinal digestion consists of multiple factors 
that might influence the dynamic nature of AgNPs, such as elevated temperature, variable 
pH and variable concentrations of salts and enzymes along the digestive tract. All these 
parameters individually are known to affect the properties of AgNPs including their surface 
chemistry and agglomeration state (Chaudhry et al. 2008; Fabrega et al. 2009; El Badawy 
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et al. 2010; Liu and Hurt 2010; Bihari et al. 2008; Greulich et al. 2009; Rogers et al. 2012), 
their interaction with biomolecules (Cedervall et al. 2007; Lundqvist et al. 2008; Lynch and 
Dawson 2008) and their dissolution rate (Liu and Hurt 2010). However, the impact of the 
full digestion on AgNPs has not been studied in vitro yet. 
The aim of the present study was to test the behaviour of well-characterized 60 nm 
AgNPs and Ag+ ions derived from AgNO3 in an in vitro model of human gastrointestinal 
digestion. For this, the authors adapted the fed digestion model described by Versantvoort 
et al. (2005) that allowed us to monitor changes of AgNPs after incubation in artificial saliva, 
gastric and intestinal juice. This model simulates the human digestion in the oral, gastric 
and intestinal compartments with salt and protein composition, pH differences and transit 
times alike the in vivo digestion (Brandon et al. 2006). The model has been used so far for 
determining the bioaccessibility of orally ingested compounds like heavy metals (Oomen et 
al. 2003) or other contaminants (Versantvoort et al. 2005), and silica nanoparticles (Peters 
et al. 2012). Samples of AgNPs and AgNO3 were tested with dynamic light scattering (DLS) 
and single particle-inductively coupled plasma mass spectrometry (SP-ICPMS) at each step 
of the digestion process, so after saliva, gastric and intestinal incubation. Scanning electron 
microscopy with energy dispersive X-ray analysis (SEM-EDX) was used to characterize 
morphology and elemental composition of particles. 
The digestion process turns out to have a critical impact on AgNPs and Ag+ ions. The 
results indicate that under physiological conditions (in the presence of proteins) AgNPs 
reach the intestine most likely in their original, unchanged form. Ag+ ions reach the intestine 
as silver-containing NPs. These findings have important implications for the design of in 
vitro exposure and translocation studies conducted to evaluate the health impact of orally 
administered AgNPs.
MATERIALS AND METHODS
Materials including nanoparticles
The 60 nm AgNPs dispersed in 2 mM citrate buffer (pH=5.1) were purchased from 
NanoComposix, Inc. (San Diego, CA, USA). The silver mass concentration of the stock 
solution was 1 mg/ml. Transmission electron microscopy (TEM) size of the NPs, as provided 
by the manufacturer, was 58 ± 5 nm, and the hydrodynamic size was 68 nm. For the Ag+ 
ionic experiments, the authors used AgNO3 from Sigma (Steinbach, Germany). 
LC-MS (liquid chromatography-mass spectrometry) grade water for the characterisation 
studies was obtained from Biosolve (Valkenswaard, The Netherlands). For the preparation 
of artificial digestive juices for in vitro digestion (fed model variant), all the chemicals 
were obtained from Merck (Darmstadt, Germany), except for NaCl, which was obtained 
from VWR (Leuven, Belgium), uric acid from Alfa Aesar (Karlsruhe, Germany), 
glucosaminehydrochloride from Calbiochem (Darmstadt, Germany), mucin from Roth 
(Karlsruhe, Germany) and lipase, bile, MgCl2∙6H2O, glucuronic acid and amylase from Sigma.
The constituents and concentrations of the digestive juices were as described by 
Versantvoort et al. (2005) and are listed in Table 1.  
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Sample characterisation  
AgNPs and AgNO3 samples in water and saliva were characterised with three techniques: 
TEM, DLS and SP-ICPMS. Samples collected from the in vitro digestion were measured 
with SP-ICPMS, and selected samples also with DLS and SEM-EDX.  
TEM analysis to determine morphological properties of AgNPs was performed on a 
JEOL JEM 1011 microscope (JEOL, Nieuw Vennep, The Netherlands), delivering beam 
current at 0.45 A and fitted with a Keenview 1k-1k camera. 
DLS measurements to determine the hydrodynamic sizes of AgNPs were performed 
on an ALV, Laser Goniometer, Model ALV/SP-125 #011, Type: Diode Pumped Solid State 
(DPSS). DLS measurements were conducted at a scattering angle of 90°. Each correlation 
function was accumulated for 30 s, which was repeated 10 times for each sample. DLS 
analyses the velocity distribution of particle movement by measuring dynamic fluctuations 
of light scattering intensity caused by the Brownian motion of the particle. The data 
from these measurements are then calculated via the Stokes-Einstein equation to give 
the hydrodynamic radius of the particles. Hydrodynamic diameters were obtained using 
AfterALV software. Data cut-off was applied, so that samples with intensity lower or equal 
to the blank (pure solvent) were assumed as not containing any particles. 
SP-ICPMS was used to determine the size and particle number concentration of 
AgNPs. SP-ICPMS enables detection of AgNPs in relatively complex matrices. The ICP-MS 
machine used in this study was a Thermo Scientific X series 2 equipped with a Babington 
type nebulizer and a quartz impact bead spray chamber. The ICP-MS machine was operated 
Table 1. Composition of juices of the “fed” in vitro digestion model (amounts based on 1000 ml juice) 
(Versantvoort et al. 2005).
Saliva
(pH 6.8±0.1)
Gastric juice
(pH 1.3±0.1)
Duodenal juice
(pH 8.1±0.1)
Bile juice
(pH 8.2±0.1)
896 mg KCl
200 mg KSCN
1021 mg NaH2PO4.H2O
570 mg Na2SO4
298 mg NaCl
1694 mg NaHCO3
200 mg urea
290 mg amylase*
15 mg uric acid
25 mg mucin*
Milli-Q water
2752 mg NaCl
306 mg NaH2PO4.H2O
824 mg KCl
302 mg CaCl2
306 mg NH4Cl
6.5 ml 37% HCl
650 mg glucose
20 mg glucuronic acid
85 mg urea
330 mg glucosaminehy-
drochloride
1 g BSA*
2.5 g pepsin*
3 g mucin*
Milli-Q water
7012 mg NaCl
3388 mg NaHCO3
80 mg KH2PO4
564 mg KCl
50 mg MgCl2.6H2O
180 μl HCl (37%)
100 mg urea
151 mg CaCl2
1 g BSA*
9 g pancreatin*
1.5 g lipase*
Milli-Q water
5259 mg NaCl
5785 mg NaHCO3
376 mg KCl
150 μl HCl (37%)
250 mg urea
167.5 mg CaCl2
1.8 g BSA*
30 g bile*
Milli-Q water
Sodium carbonate 
solution
84.7 g NaHCO3
Milli-Q water
*Protein components included in the “digestion with proteins” but not included in the “digestion without 
proteins”.  
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at a forward power of 1400 W and the gas flows were at the following settings: plasma 
13 l/min, nebulizer 1.1 l/min and auxiliary 0.7 l/min. The sample flow rate to the nebulizer 
was set at 1.5 ml/min using the integrated peristaltic pump. Data acquisition was done 
using the Thermo Plasmalab software in the time resolved analysis (TRA) mode. Typical 
acquisition times were 60 s per measurement. Silver was measured at m/z 107. Data were 
transferred to a CSV (comma-separated values) file, which was processed in Microsoft 
Excel for calculation of particle sizes, particle size distributions and particle concentrations. 
Data cut-off was applied, so that samples were treated as a background when they contained 
a number of particles lower than or the same as in blank samples. The lower size detection 
limit of SP-ICPMS for AgNPs is 18-20 nm (Laborda et al. 2011), and the silver lower 
concentration limit is 5 ng/ml.  
SEM-EDX was used to determine the morphology and elemental composition of 
particles in samples after the digestion. The high resolution field emission gun scanning 
electron microscope (FEG-SEM) used in this study was a Tescan MIRA-LMH FEG-SEM 
(Tescan, Brno, Czech Republic). The microscope was operated at an accelerating voltage of 
15 kV, working distance (WD) of 10 mm and spot size of 5 nm. The EDX spectrometer used 
was a Bruker AXS spectrometer with a Quantax 800 workstation and a XFlash 4010 detector 
with an active area of 10 mm2 and super light element window (SLEW), which allows X-ray 
detection of elements higher than borium (Z>5). The spectral resolution of the detector 
was 123 eV (Mn (10 kcps) ave FWHM (full width at half maximum)). Three different 
magnifications were used: 10,000 x, 25,000 x and 50,000 x, so that both agglomerates and 
single particles could be detected. After recognising the particles in a field of view, an X-ray 
spectrum from each detected particle was acquired.
The lower size detection limit of SEM-EDX for AgNPs is 15-20 nm.  
Characterisation of AgNPs and AgNO
3
 in media 
AgNPs and AgNO3 were characterised in water and in artificial saliva (pH = 6.8 ± 0.1). 
First, freshly prepared samples of AgNPs and AgNO3 were characterised with TEM, DLS 
and SP-ICPMS. For the TEM measurements, a stock solution of AgNPs was suspended at 
100 µg/ml in each solvent and vortexed for 10 s to provide a homogenous suspension. A 5 µl 
drop of AgNP suspension was deposited onto a copper formvar-coated TEM carbon grid. 
Samples were left to dry completely prior to analysis. All samples were analysed in triplicate. 
For the DLS measurements, a stock solution of AgNPs was diluted to 10 µg/ml in 
each solvent, vortexed for 10 s and measured within 2 min (t=0 h).  The concentration of 
10 µg/ml was selected based on average reported concentrations in commercially available 
NP colloidal silver suspensions (see PEN).  A stock of 10 µg/ml AgNO3, to be used as a source 
of Ag+ ions, was prepared in water and further diluted to 1 µg/ml in each solvent, vortexed 
for 10 s and measured within 2 min (t=0 h). Samples were measured with DLS in six inde-
pendent repetitions, and for each repetition 10 measurements were collected. The total DLS 
measurement procedure took about 5 min. For the SP-ICPMS measurements, a stock of 
AgNPs was suspended at 10 µg/ml in each solvent, vortexed for 10 s and within 2 min further 
diluted with adequate solvent to 25 and 250 ng/l. A stock solution of AgNO3 was prepared at 
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10 µg/ml in water, vortexed for 10 s and within 2 min further diluted with adequate solvent 
to two sub-samples of 500 ng/l. The final concentrations of samples were chosen as most 
optimal, based on previous measurements (Peters et al. 2012). All samples were analysed 
with SP-ICPMS within 5-15 min (t=0 h). SP-ICPMS measurements were performed in trip-
licate and each sample of the triplicate was analysed in two analytical dilutions.  
Second, the effect of ageing of NPs in the solvents was tested. To this end, DLS and 
SP-ICPMS measurements were repeated after incubating the AgNPs and AgNO3 for 
24 hours (t=24 h) in the dark, at room temperature. The samples were analysed as described 
above for t=0 h. 
Characterisation of AgNPs and AgNO
3
 during in vitro digestion 
In this study, the authors used 60 nm AgNPs and AgNO3 solution as a source of Ag+ ions, to 
check the behaviour of AgNPs and Ag+ ions in the in vitro model of human digestion. Water, 
not containing any forms of silver, was used as a blank sample. The in vitro digestion model 
used was adapted from Versantvoort et al. (2005), and is described there in detail (the fed 
model variant). Briefly, all digestive juices were prepared according to Table 1 and heated 
to 37°C. The digestion started by adding 1 ml of water, 10 µg/ml 60 nm AgNPs (i.e., 1661 
± 154 particles/ml) or 1 µg/ml AgNO3 to 6 ml of saliva (pH = 6.8 ± 0.1). The mixture was 
incubated for 5 min at 37 ± 2°C, rotating head-over-heels at 55 rpm, simulating peristaltic 
movements. Subsequently, 12 ml of gastric juice (pH=1.3) was added to the mixture and the 
pH of the sample was checked and, if necessary, adjusted to 2.5 ± 0.5 with NaOH (1M) or 
HCl (37%). The sample was further incubated rotating at 37°C for 2 h. Subsequently, 12 ml 
of duodenal juice (pH=8.1), 6 ml of bile (pH=8.2) and 2 ml of sodium bicarbonate solution 
were added. The pH of this mixture was set at 6.5 ± 0.5 with NaOH (1M) or HCl (37%) and 
it was rotated head-over-heels for another 2 h. 
The impact of digestion was evaluated under two conditions: without proteins and 
with proteins. Samples without proteins were measured with SP-ICPMS and DLS. Samples 
with proteins could only be measured with SP-ICPMS, because DLS measurements were 
disturbed by the proteins present in the gastric and intestinal juices.
During the digestion procedure, samples of 0.5 ml were collected at three successive 
steps: after incubation in saliva, gastric and intestinal juice. Prior to SP-ICPMS analysis, 
samples with AgNPs were diluted with water to two sub-samples of 25 and 250 ng/l, and the 
samples with AgNO3 were diluted to two sub-samples of 500 ng/l. Blank (water) samples 
were incubated in the digestion model and diluted in exactly the same way as the samples 
containing AgNPs. All samples (with AgNPs, with AgNO3 and blanks) were incubated in 
triplicate, and each sample of the triplicate was analysed in two analytical dilutions.  
For DLS analysis, the starting concentrations of AgNPs and AgNO3 were increased to 50 
and 5 µg/ml, respectively, in order to obtain minimum measurable concentration of 1 µg/ml 
in the final intestinal samples. Sub-samples of 1 ml were collected during digestion and they 
were measured directly with DLS.  
SEM-EDX was used to characterise morphology and elemental composition of particles 
during digestion with proteins. Samples of AgNPs were measured after gastric and intestinal 
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digestion, and the samples of AgNO3 were measured after intestinal incubation. Exclusively 
for these measurements, the concentrations of digested AgNPs and AgNO3 were increased 
to 50 and 100 µg/ml, respectively, to increase the chances of particle detection. Aliquots 
of 2-5 ml of the juices were filtered over a nickel-coated polycarbonate filter with pore 
size 50 nm using a vacuum pump. While mounted in aluminium holders connected to the 
pump, the filters were rinsed with 5 ml of Milli-Q water. Subsequently, the moist filters were 
quickly dried and mounted on aluminium specimen holders with double-sided adhesive 
carbon tape. The filters were analysed immediately afterwards.  
Statistics
All results are presented as an average ± standard error. One-way analysis of variance 
(ANOVA) was applied to determine statistical significance for the sizes of AgNPs in media 
and the numbers of particles detected during the digestion experiment. Tukey post hoc 
test was used to determine the identity of the groups in which the significant difference 
was observed.  
Groups were considered significantly different, when p<0.05. 
RESULTS
Characterisation of AgNPs and AgNO
3
 in media
The authors characterised the behaviour of AgNPs and AgNO3 in two solvents. Water 
was used as a basic simple solvent to assess the initial size of AgNPs, and artificial saliva 
with proteins as the first step of the digestion model to assess the size of AgNPs entering 
the digestion model. Three techniques were used to measure AgNPs in these media: TEM 
provided the diameters of the particles, DLS provided hydrodynamic diameters of particles 
and SP-ICPMS provided masses of the particles that were mathematically converted into 
sizes. TEM analysis of AgNPs in water confirmed that the size provided by the manufacturer 
(58 ± 5 nm) was appropriate. A representative picture of these spherical particles is shown in 
Figure 1. Throughout the paper, the authors used the size from TEM analysis as indicated by 
the manufacturer (60 nm) to describe the AgNPs. As indicated by DLS, AgNPs suspended in 
both media had monodisperse size distributions, as shown in Figure 2. Consequently, the data 
obtained from these measurements can be summarised by presenting the means ± standard 
error of the diameters. The hydrodynamic size of AgNPs measured with DLS at t=0 was 67 ± 
1 nm in water and 92 ± 3 nm in saliva. The size of AgNPs measured with SP-ICPMS at t=0 h 
was 59 ± 2 nm in water and 49 ± 1 nm in saliva. Sizes  in water and saliva measured by DLS 
were approximately 15% and 88% larger than those indicated by both TEM and SP-ICPMS. 
Subsequently, the effect of incubation of AgNPs and AgNO3 in water and saliva for 24 h 
in the dark, at room temperature was studied. The sizes of AgNPs were determined with 
DLS and with SP-ICPMS. As measured with DLS (Figure 2), AgNPs had a hydrodynamic 
diameter of 70 ± 2 nm in water and 105 ± 4 nm in saliva. As measured with SP-ICPMS, 
AgNP sizes after 24 h incubation in both media did not differ compared with AgNPs 
analysed at t=0 h: 58 ± 4 and 52 ± 9 nm in water and saliva respectively.
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Solutions of AgNO3 in the media did not contain any particles apart from some 
incidental particles of 815 ± 135 nm detected with DLS at t=24 h in saliva. 
Characterisation of AgNPs and AgNO
3
 during the in vitro digestion
In the next experiment, the authors tested the behaviour of 60 nm AgNPs and Ag+ ions 
derived from AgNO3 in the in vitro model of human digestion. 
Sizes of the particles in samples were quantified with SP-ICPMS and DLS at each step 
of the digestion process, that is, after saliva, gastric and intestinal incubation. The impact 
of digestion was evaluated under two conditions: with proteins normally present during 
human digestion, included in the digestion juices (with SP-ICPMS) and without these 
proteins (with SP-ICPMS and DLS). 
duodenal juice (pH = 8.1), 6 ml of bile (pH = 8.2) and 2 ml of
sodium bicarbonate solution were added. The pH of this
mixture was set at 6.5 ± 0.5 with NaOH (1M) or HCl (37%)
and it was rotated head-over-heels for another 2 h.
The impact of digestion was evaluated under two condi-
tions: without proteins and with proteins. Samples without
proteins were measured with SP-ICPMS and DLS. Samples
with proteins could only be measured with SP-ICPMS,
because DLS measurements were disturbed by the proteins
present in the gastric and intestinal juices.
During the digestion procedure, samples of 0.5 ml were
collected at three successive steps: after incubation in saliva,
gastric and intestinal juice. Prior to SP-ICPMS analysis,
samples with AgNPs were diluted with water to two sub-
samples of 25 and 250 ng/l, and the samples with AgNO3
were diluted to two sub-samples of 500 ng/l. Blank (water)
samples were incubated in the digestion model and diluted
in exactly the same way as the samples containing AgNPs. All
samples (with AgNPs, with AgNO3 and blanks) were incu-
bated in triplicate, and each sample of the triplicate was
analysed in two analytical dilutions.
For DLS analysis, the starting concentrations of AgNPs
and AgNO3 were increased to 50 and 5 mg/ml, respectively,
in order to obtain minimum measurable concentration of
1 mg/ml in the ﬁnal intestinal samples. Sub-samples of 1 ml
were collected during digestion and they were measured
directly with DLS.
SEM-EDX was used to characterise morphology and
elemental composition of particles during digestion with
proteins. Samples of AgNPs were measured after gastric and
intestinal digestion, and the samples of AgNO3weremeasured
after intestinal incubation. Exclusively for these measure-
ments, the concentrations of digested AgNPs and AgNO3
were increased to 50 and 100 mg/ml, respectively, to increase
thechancesofparticledetection.Aliquotsof2–5mlof the juices
were ﬁltered over a nickel-coated polycarbonate ﬁlter with
pore size 50 nm using a vacuum pump. While mounted in
aluminium holders connected to the pump, the ﬁlters were
rinsed with 5 ml of Milli-Q water. Subsequently, the moist
ﬁlters were quickly dried and mounted on aluminium
specimen holders with double-sided adhesive carbon tape.
The ﬁlters were analysed immediately afterwards.
Statistics
All results are presented as an average ± standard error.
One-way analysis of variance (ANOVA) was applied to deter-
mine statistical signiﬁcance for the sizes of AgNPs in media
and the number of particles detected during the digestion
experiment. Tukey post hoc test was used to determine the
identity of the groups in which the signiﬁcant difference was
observed.
Groups were considered signiﬁcantly different, when
p < 0.05.
Results
Characterisation of AgNPs and AgNO3 in media
Theauthors characterised thebehaviour ofAgNPsandAgNO3
in two solvents. Water was used as a basic simple solvent to
assess the initial size of AgNPs, and artiﬁcial saliva with
proteins as the ﬁrst step of the digestion model to assess
the size of AgNPs entering the digestion model. Three tech-
niques were used to measure AgNPs in these media: TEM
provided the diameters of the particles, DLS provided hydro-
dynamic diameters of particles and SP-ICPMS provided
masses of the particles that were mathematically converted
into sizes. TEM analysis of AgNPs in water conﬁrmed that the
size provided by the manufacturer (58 ± 5 nm) was appro-
priate. A representative picture of these spherical particles is
showninFigure1.Throughout thepaper, theauthorsused the
size from TEM analysis as indicated by the manufacturer
(60 nm) to describe the AgNPs. As indicated by DLS, AgNPs
suspended in both media had monodisperse size distribu-
tions, as shown in Figure 2. Consequently, the data obtained
from these measurements can be summarised by presenting
the means ± standard error of the diameters. The hydrody-
namic size of AgNPsmeasuredwithDLS at t = 0was 67± 1 nm
in water and 92 ± 3 nm in saliva. The size of AgNPsmeasured
with SP-ICPMS at t = 0 hwas 59 ± 2 nm inwater and 49 ± 1 nm
in saliva. Sizes in water and saliva measured by DLS were
approximately 15% and 88% larger than those indicated by
both TEM and SP-ICPMS.
Subsequently, the effect of incubation of AgNPs and
AgNO3 in water and saliva for 24 h in the dark, at room
temperature was studied. The sizes of AgNPs were deter-
mined with DLS and with SP-ICPMS. As measured with DLS
(Figure 2), AgNPs had a hydrodynamic diameter of 70 ± 2 nm
in water and 105 ± 4 nm in saliva. As measured with
SP-ICPMS, AgNP sizes after 24 h incubation in both media
did not differ compared with AgNPs analysed at t = 0 h: 58 ± 4
and 52 ± 9 nm in water and saliva, respectively.
Solutions of AgNO3 in the media did not contain any
particles apart from some incidental particles of 815 ±
135 nm detected with DLS at t = 24 h in saliva.
Characterisation of AgNPs and AgNO3 during
the in vitro digestion
In the next experiment, the authors tested the behaviour
of 60 nm AgNPs and Ag+ ions derived from AgNO3 in the
in vitro model of human digestion.
Figure 1. TEMphotoof60nmAgNPs inwater.Thebar indicates100nm.
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Figure 1. TEM photo of 60 nm AgNPs in water. The bar indicates 100 nm.
Sizes of the particles in samples were quantiﬁed with
SP-ICPMS and DLS at each step of the digestion process, that
is, after saliva, gastric and intestinal incubation. The impact
of digestion was evaluated under two conditions: with
proteins normally present during human digestion, included
in the digestion juices (with SP-ICPMS) and without these
proteins (with SP-ICPMS and DLS).
Digestion without proteins
As shown in Figure 3, AgNPs detected with SP-ICPMS after
the incubation for 5 min in saliva were present nearly as
numerously (1418 ± 137/ml) as in water (1747 ± 77/ml) with
the same size distribution, with ost of the particles in the
size range of around 60 nm. After incubation in the gastric
juice, the number of particles decreased signiﬁcantly
(p < 0.05) by 90% (to 125 ± 85/ml) and stayed on this level
(149 ± 75/ml) during the intestinal incubation. At the same
time, the sizes of the remaining particles in these gastric and
intestinal samples decreased to 20–30 nm. As the lower
size detection limit of SP-ICPMS for AgNPs is 18–20 nm
(Peters et al. 2012; Laborda et al. 2011), it is possible that
also smaller particles were present in the intestinal phase,
assuming a normal size distribution.
The numbers of particles per ml determined after diges-
tion of the AgNO3 sample (14 ± 7 in saliva, 6 ± 9 i g stric
juice and 12 ± 16 in intestinal juice) were comparable with
that of AgNO3 solutions in water (6 ± 6), and therefore
considered to be the background.
10
-20
30
-40
50
-60
70
-80
90
-10
0
10
-20
30
-40
50
-60
70
-80
90
-10
0
20
-30
20
-30
0
200
400
600
800
size [nm]
n
u
m
be
r o
f p
ar
tic
le
s 
/ m
l
Water Saliva Gastricjuice
Intestinal
juice
* *
Figure 3. Size distributions of particles detected after digestion of 60 nm AgNPs, measured with SP-ICPMS. The digestion was carried out without
proteins. Sizes of AgNPs are shown in water, saliva, gastric and intestinal juice. On the left axis: numbers of particles per ml detected in the samples
(average ± SEM). The total numbers of particles per ml in AgNP samples were: 1747 ± 77 in water control, 1418 ± 137 in saliva, 125 ± 85 in the gastric
juice and 149 ± 75 in the intestinal juice. *Number of particles signiﬁcantly different (p < 0.05) compared with saliva sample.
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Figure 2. Hydrodynamic sizes of AgNPs in water and saliva, measured at t = 0 h and t = 24 h with DLS. DLSmeasurements were generally performed
in triplicate, on two separate days (n = 6). The results presented are an average of all measurements for each sample.
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Figure 2. Hydrodynamic sizes of AgNPs in water and saliva, measured at t=0 h and t=24 h with DLS. 
DLS measurements were generally performed in triplicate, on two separate days (n=6). The results 
presented are an average of all measuremen s for each sample. 
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Digestion without proteins
As shown in Figure 3, AgNPs detected with SP-ICPMS after the incubation for 5 minutes 
in saliva were present nearly as numerously (1418 ± 137 /ml) as in water (1747 ± 77 /ml) 
with the same size distribution, with most of the particles in the size range of around 60 nm. 
After incubation in the gastric juice, the number of particles decreased significantly (p<0.05) 
by 90% (to 125 ± 85 /ml) and stayed on this level (149 ± 75 /ml) during the intestinal 
incubation. At the same time, the sizes of the remaining particles in these gastric and 
intestinal samples decreased to 20-30 nm. As the lower size detection limit of SP-ICPMS for 
AgNPs is 18-20 nm (Peters et al. 2012; Laborda et al. 2011), it is possible that also smaller 
particles were present in the intestinal phase, assuming a normal size distribution. 
The numbers of particles per ml determined after digestion of the AgNO3 sample (14 ± 
7 in saliva, 6 ± 9 in gastric juice and 12 ± 16 in intestinal juice) were comparable with that 
of AgNO3 solutions in water (6 ± 6), and therefore considered to be the background.
Samples digested without proteins were measured also with DLS. After incubation of 
AgNPs in saliva, numerous particles were detected with the average hydrodynamic size 
of around 100 nm and with a wide size distribution (60-300 nm). After incubation in the 
gastric and intestinal juice no particles were detected by DLS.
Sizes of the particles in samples were quantiﬁed with
SP-ICPMS and DLS at each step of the digestion process, that
is, after saliva, gastric and intestinal incubation. The impact
of digestion was evaluated under two conditions: with
proteins normally present during human digestion, included
in the digestion juices (with SP-ICPMS) and without these
proteins (with SP-ICPMS and DLS).
Digestion without proteins
As shown in Figure 3, AgNPs detected with SP-ICPMS after
the incubation for 5 min in saliva were present nearly as
numerously (1418 ± 137/ml) as in water (1747 ± 77/ml) with
the same size distribut on, with most of the particles in the
size range of around 60 nm. After incubation in the gastric
juice, the number of particles decreased signiﬁcantly
(p < 0.05) by 90% (to 125 ± 85/ml) and stayed n this level
(149 ± 75/ml) during the intestinal incubation. At the same
time, the sizes of the remaining particles in these gastric and
intestinal samples decreased to 20–30 nm. As the lower
size detection limit of SP-ICPMS for AgNPs is 18–20 nm
(Peters et al. 2012; Laborda et al. 2011), it is possible that
also smaller particles were present in the intestinal phase,
assuming a normal size distribution.
The numbers of particles per ml determined after diges-
tion of the AgNO3 sample (14 ± 7 in saliva, 6 ± 9 in gastric
juice and 12 ± 16 in intestinal juice) were comparable with
that of AgNO3 solutions in water (6 ± 6), and therefore
considered to be the background.
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Figure 3. Size distributions of particles detected after digestion of 60 nm AgNPs, measured with SP-ICPMS. The digestion was carried out without
proteins. Sizes of AgNPs are shown in water, saliva, gastric and intestinal juice. On the left axis: numbers of particles per ml detected in the samples
(average ± SEM). The total numbers of particles per ml in AgNP samples were: 1747 ± 77 in water control, 1418 ± 137 in saliva, 125 ± 85 in the gastric
juice and 149 ± 75 in the intestinal juice. *Number of particles signiﬁcantly different (p < 0.05) compared with saliva sample.
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Figure 2. Hydrodynamic sizes of AgNPs in water and aliva, measured at t = 0 h and t = 24 h with DLS. DLSmeasurements were generally performed
in triplicate, on two separate days (n = 6). The results presented are an average of all measurements for each sample.
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Figure 3. Size distributions of particles detected after digestion of 60 nm AgNPs, measured with 
SP-ICPMS. The digestion was carried out without proteins. Sizes of AgNPs are shown in w ter, saliva, 
gastric and intestinal juice. On the left axis: numbers of particles per ml detected in the samples 
(average ± SEM). The total numbers of particles per ml in AgNP samples were: 1747 ± 77 in water 
control, 1418 ± 137 in saliva, 125 ± 85 in the gastric juice and 149 ± 75 in the intestinal juice. *Number 
of particles significantly different (p<0.05) compared with saliva sample. 
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AgNO3 samples only rarely contained NPs after saliva digestion and these had a 
hydrodynamic diameter of approximately 300 nm. No particles were detected after gastric 
and intestinal digestion (data not shown).  
Digestion with proteins
SP-ICPMS analysis showed that during the whole digestion with proteins AgNPs kept 
similar size (around 60 nm) and size distribution (Figure 4A). The number of particles 
determined by SP-ICPMS in saliva (1627 ± 22 /ml) was in accordance with the number of 
particles detected in the control AgNP samples in water (1460 ± 51 /ml). In the gastric stage 
the number of particles dropped significantly (p<0.05) to 374 ± 33 /ml, to rise back to 1577 
± 72 /ml after the intestinal incubation.  
In AgNO3 samples (Figure 4B), there were hardly any particles detected after saliva 
(12 ± 10 /ml) and gastric (13 ± 7 /ml) digestion, which was only a few more than in the 
water control (7 ± 4 /ml). After the intestinal incubation, however, the particles became 
more abundant and their numbers were highly variable between triplicates (860 ± 811 /ml). 
The same high variability was seen in size distributions of these particles. These outcomes 
suggest that formation of particles from Ag+ had a chaotic course. The particles formed 
from Ag+ during the intestinal incubation were much smaller (20-40 nm) than the particles 
in the corresponding AgNP group after intestinal incubation (around 60 nm).
Because SP-ICPMS revealed a drop in the number of AgNPs after gastric digestion 
with proteins and an increase in the number of AgNPs after intestinal digestion, but the 
size distribution was constant, further study with SEM-EDX was applied to determine 
appearance and composition of particles. In all cases, the detected particles contained silver. 
AgNPs after gastric digestion were present in two forms: as big clusters of approximately 
200-500 nm and as single, well-dispersed particles (Figure 5A). The big clusters clearly 
consisted of grouped single AgNPs. EDX analysis of the clusters revealed the presence of 
chlorine, in addition to the strong silver signal (Figure 5B). Figure 6 shows the clear co-
localisation of Ag and Cl in one of such clusters. Following subsequent intestinal digestion, 
SEM-EDX revealed the presence of single, well-dispersed silver particles with an average 
diameter of 48 ± 8 nm (Figure 7A). EDX analysis showed that these particles were composed 
of silver only (Figure 7B). 
As SP-ICPMS revealed the presence of silver particles after the intestinal stage of AgNO3 
with proteins, this was also studied further with SEM-EDX. Particles were found with a 
size of approximately 20-30 nm (Figure 8A). EDX analysis showed that these particles were 
composed of silver, sulphur and chlorine (Figure 8B).
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Samples digested without proteins were measured also
with DLS. After incubation of AgNPs in saliva, numerous
particles were detected with the average hydrodynamic
size of around 100 nm and with a wide size distribution
(60–300 nm). After incubation in the gastric and intestinal
juice no particles were detected by DLS.
AgNO3 samples only rarely contained NPs after saliva
digestion and these had a hydrodynamic diameter of
approximately 300 nm. No particles were detected after
gastric and intestinal digestion (data not shown).
Digestion with proteins
SP-ICPMS analysis showed that during the whole digestion
with proteins AgNPs kept similar size (around 60 nm) and
size distribution (Figure 4A). The number of particles
determined by SP-ICPMS in saliva (1627 ± 22/ml) was in
accordance with the number of particles detected in the
control AgNP samples in water (1460 ± 51/ml). In the gastric
stage the number of particles dropped signiﬁcantly (p < 0.05)
to 374 ± 33/ml, to rise back to 1577 ± 72/ml after the
intestinal incubation.
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Figure 4. Size distributions of particles detected after digestion of (A) 60 nm AgNPs and (B) AgNO3, measured with SP-ICPMS. The digestion was
carried out in the presence of proteins normally present during human digestion. Sizes of AgNPs are shown in water, saliva, gastric and intestinal
juice. On the left axis: numbers of particles per ml detected in the samples (average ± SEM). The total numbers of particles per ml in AgNP samples
(A) were: 1460 ± 51 in water control, 1627 ± 22 in saliva, 374 ± 33 in the gastric juice and 1577 ± 72 in the intestinal juice. The total numbers of
particles per ml detected in AgNO3 samples (B) were: 7 ± 4 in water control, 12 ± 10 in saliva, 13 ± 7 in the gastric juice and 860 ± 811 in the intestinal
juice. *Number of particles signiﬁcantly different (p < 0.05) compared with saliva sample.
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Figu  4. Size distributions of particles detected after digestion of (A) 60 nm AgNPs and (B) AgNO3, 
measured with SP-ICPMS. The digestion was carried out in the presence of proteins normally present 
during human digestion. Sizes of AgNPs are shown in water, saliva, gastric and intestinal juice. On the 
left axis: numbers of particl s per ml detected in the samples (average ± SEM). The total numbers of 
particles per ml in AgNP samples (A) were: 1460 ± 51 in water control, 1627 ± 22 in saliva, 374 ± 33 
in the gastric juice and 1577 ± 72 in the intestinal juice. The total numbers of particles per ml detected 
in AgNO3 samples (B) were: 7 ± 4 in water control, 12 ± 10 in saliva, 13 ± 7 in the gastric juice and 
860 ± 811 in the intestinal juice. *Number of particles significantly different (p<0.05) compared with 
saliva sample. 
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In AgNO3 samples (Figure 4B), there were hardly any
particles detected after saliva (12 ± 10/ml) and gastric (13 ±
7/ml) digestion, which was only a fewmore than in the water
control (7 ± 4/ml). After the intestinal incubation, however,
the particles became more abundant and their numbers
were highly variable between triplicates (860 ± 811/ml).
The same high variability was seen in size distributions of
these particles. These outcomes suggest that formation of
particles from Ag+ had a chaotic course. The particles formed
from Ag+ during the intestinal incubation were much smaller
(20–40 nm) than the particles in the corresponding AgNP
group after intestinal incubation (around 60 nm).
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Figure 5. A) Representative cluster of AgNPs found in gastric sample of AgNP digestion in the presence of proteins. There are also single AgNPs
found in the sample (indicated with arrows). B) X-ray spectrum obtained from the cluster, indicating the presence of silver and chlorine.
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Figure 5. (A) Representative cluster of AgNPs found in gastric sample of AgNP digestion in the 
presence of proteins. There are also single AgNPs found in the sample (indicated with arrows). (B) 
X-ray spectru  obtained from the cluster, indicating t e presence of silver and chlorine.   
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Because SP-ICPMS revealed a drop in the number of
AgNPs after gastric digestion with proteins and an increase in
the number of AgNPs after intestinal digestion, but the size
distribution was constant, further study with SEM-EDX was
applied to determine appearance and composition of
particles. In all cases, the detected particles contained silver.
AgNPs after gastric digestion were present in two forms: as
big clusters of approximately 200–500 nm and as single, well-
dispersed particles (Figure 5A). The big clusters clearly
consisted of grouped single AgNPs. EDX analysis of the
Cl
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Figure 6. X-ray element mapping of the cluster of AgNPs found in gastric sample in the presence of proteins (Figure 5A). Mapping was done for (B)
silver and (C) chlorine. Co-localisation of Ag and Cl in the cluster is clear (A).
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Figure 6. X-ray element mapping of the cluster of AgNPs found in gastric sample in the presence of 
proteins (Figure 5A). Mapping was done for (B) silver and (C) chlorine. Co-localisation of Ag and Cl 
in the cluster is clear (A). 
38
2BEH
A
V
IO
U
R O
F SILV
ER N
A
N
O
PA
RTIC
LES A
N
D
 SILV
ER IO
N
S...
clusters revealed the presence of chlorine, in addition to the
strong silver signal (Figure 5B). Figure 6 shows the clear
co-localisation of Ag and Cl in one of such clusters. Following
subsequent intestinal digestion, SEM-EDX revealed the pres-
ence of single, well-dispersed silver particles with an average
diameter of 48 ± 8 nm (Figure 7A). EDX analysis showed that
these particles were composed of silver only (Figure 7B).
As SP-ICPMS revealed the presence of silver particles after
the intestinal stage of AgNO3 with proteins, this was also
studied further with SEM-EDX. Particles were found with a
size of approximately 20–30 nm (Figure 8A). EDX analysis
showed that these particles were composed of silver, sulphur
and chlorine (Figure 8B).
Discussion
The aim of the present study was to test the behaviour of well-
characterised 60 nmAgNPs and Ag+ ions derived from AgNO3
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Figure 7. (A) Single particles (indicated with arrows) found in intestinal sample of AgNP digestion in the presence of proteins. (B) X-ray spectrum
obtained from the particles, indicating the presence of only silver.
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Figure 7. (A) Single particl s (indicated with arrows) found in intestinal sample of AgNP digestion 
in the presence of proteins. (B) X-ray spectrum obtained from the particles, indicating the presence 
of only silver.   
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in the in vitromodel of human digestion. First, the behaviour
of AgNPs and Ag+ ions derived from AgNO3 in water and
saliva was tested with three different techniques. AgNPs were
conﬁrmed to be approximately 60 nm in water. In general,
sizes measured with DLS were somewhat larger (by approx-
imately 15–88%) than those indicated by both TEM and SP-
ICPMS. With TEM and SP-ICPMS only the silver content of
AgNPs was measured. Therefore, sizes obtained from TEM
and SP-ICPMS can differ from sizes obtained from DLS,
which measures the hydrodynamic sizes of particles (Nath
& Chilkoti 2004). Comparing results from DLS and TEM/SP-
ICPMS allows to differentiate indirectly the silver core of NP
from its non-silver coating. The DLS sizes of AgNPs in saliva
were slightly larger than in water (by approximately 37%)
and larger than SP-ICPMS sizes in saliva (by approximately
88%). Likely these differences can be explained by the
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500 nm
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Figure 8. (A) Particle (indicated with arrow) found in intestinal sample of AgNO3 digestion in the presence of proteins. (B) X-ray spectrum obtained
from the particle, indicating the presence of silver, sulphur and chlorine.
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Figure 8. (A) Particle (indicated with arrow) found in intestinal sample of AgNO3 digestion in the 
presence of proteins. (B) X-ray spectrum obtained from the particle, indicating the presence of silver, 
sulphur and chlorine.   
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DISCUSSION
The aim of the present study was to test the behaviour of well-characterised 60 nm AgNPs 
and Ag+ ions derived from AgNO3 in the in vitro model of human digestion. First, the 
behaviour of AgNPs and Ag+ ions derived from AgNO3 in water and saliva was tested with 
three different techniques. AgNPs were confirmed to be approximately 60 nm in water. In 
general, sizes measured with DLS were somewhat larger (by approximately 15- 88%) than 
those indicated by both TEM and SP-ICPMS. With TEM and SP-ICPMS only the silver 
content of AgNPs is measured. Therefore, sizes obtained from TEM and SP-ICPMS can 
differ from sizes obtained from DLS, which measures the hydrodynamic sizes of particles 
(Nath and Chilkoti 2004). Comparing results from DLS and TEM/SP-ICPMS allows to 
differentiate indirectly the silver core of NP from its non-silver coating. The DLS sizes of 
AgNPs in saliva were slightly larger than in water (by approximately 37%) and larger than 
SP-ICPMS sizes in saliva (by approximately 88%). Likely these differences can be explained 
by the hydrodynamic size measured by DLS or by the formation of a protein corona around 
the particles (Walczyk et al. 2010), which is not detected with SP-ICPMS. The sizes of 
AgNPs were stable during the 24 h of incubation in saliva. It has been reported before that 
media containing proteins stabilize the particles (Greulich et al. 2009; Murdock et al. 2008). 
The stability of AgNPs in media and the retention of their size during the time frame of the 
experiments are necessary for reliability and reproducibility of the results. 
In this study, the authors used the well-established model for gastrointestinal digestion 
described previously (Versantvoort et al. 2005; Peters et al. 2012), consisting of subsequent 
incubation in oral, gastric and intestinal conditions. The main outcome of this study is that 
60 nm AgNPs ingested in the concentration of 10 µg/ml (i.e., 1661 ± 153 particles/ml) in 
the presence of proteins, survive the extreme conditions of gastrointestinal digestion and 
reach the intestine. It can be concluded that the human intestinal epithelium is very likely 
exposed to 60 nm AgNPs as ingested, with minimal changes in size. At the same time, 
ingestion of Ag+ ions at 1 µg/ml also results in intestinal exposure to particles, but these are 
most likely complexes of silver, sulphur and chlorine (Table 2). 
The results indicate that in the absence of proteins during digestion the behaviour of 
both AgNPs and AgNO3 is completely different compared with the digestion in the presence 
of proteins. In the absence of proteins, after both gastric and intestinal digestion, only a 
small fraction of initial AgNP concentration was detected with SP-ICPMS, and the sizes of 
particles were smaller (20-30 nm). With DLS no particles were detected in these samples. 
This suggests that without the “protection” of proteins, particles dissolve in the low gastric 
pH, as proposed before (Chen and Schluesener 2008; Loeschner et al. 2011). It is known that 
high temperature, low pH and high ionic strength can facilitate the dissolution of AgNPs 
(Zelyanskii et al. 2001; Kittler et al. 2010; Liu and Hurt 2010; Huynh and Chen 2011).
After the gastric digestion with proteins, the number of AgNPs measured by SP-ICPMS 
decreased, but SEM analysis indicated clusters of AgNPs. It was shown by SEM that most of 
the AgNPs were present in the form of big clusters (200-500 nm diameter), each containing 
easily distinguishable single NPs. AgNPs are known to agglomerate in media of high ionic 
41
2BEH
A
V
IO
U
R O
F SILV
ER N
A
N
O
PA
RTIC
LES A
N
D
 SILV
ER IO
N
S...
strength (Bihari et al. 2008; Greulich et al. 2009; Foldbjerg et al. 2009; El Badawy et al. 2010) 
and this could be the reason underlying their agglomeration in the gastric juice. High ionic 
strength enhances AgNP dissolution (Huynh and Chen 2011), which in turn facilitates the 
agglomeration process (Li et al. 2010). Subsequent EDX analysis showed the co-localisation 
of silver and chlorine. It suggests that chlorine was involved in connecting separate AgNPs 
inside clusters with chlorine interparticle “bridges”. Formation of such chlorine bridges 
is reported in solutions where AgNPs come in contact with chlorine ions (Li et al. 2010; 
Huynh and Chen 2011). Formation of agglomerates with incorporation of chlorine has 
been recently reported after digestion of 40 nm AgNPs at a concentration of 25 µg/ml in 
a simple in vitro model of the human stomach (Rogers et al. 2012). Both in their and this 
model, AgNP agglomeration was observed after gastric digestion. Apparently, neither 
the difference in size (40 vs. 60 nm) nor in concentration (25 vs. 10 µg/ml) influences the 
occurrence of agglomeration of AgNPs during gastric digestion. However, in this model 
after gastric digestion some fraction of AgNPs remained in well-dispersed, single form of 
unchanged size. This is in line with the results obtained from SP-ICPMS that revealed the 
presence of AgNPs with sizes distributed around 60 nm. Strikingly, no clusters of AgNPs 
were detected with SP-ICPMS. Theoretically, SP-ICPMS should be able to measure AgNPs 
up to µm sizes (Pace et al. 2011). Possibly, the clusters did not reach the detector of the 
ICPMS, probably because the clusters sedimented before analysis.
Importantly, after the intestinal digestion in the presence of proteins, well-dispersed, 
single AgNPs were detected with SP-ICPMS with size distribution around 60 nm. Additional 
Table 2. Summary of the results of in vitro digestion of 60 nm AgNPs and AgNO3.
Type of 
material
Digestive  
conditions
Digestive stage
(number of particles/ml and mean size of NPs 
as determined by SP-ICPMS)
Saliva Gastric Intestinal
AgNPs Without proteins 1418 ± 137 125 ± 85* 149 ± 75*
60 nm 20-30 nm# 20-30 nm#
With proteins 1627 ± 22 374 ± 33* 1577 ± 72
60 nm 60 nm 
and large clusters of 
200-500 nm shown 
by SEM-EDX
60 nm
Ag ions Without proteins ND ND ND
With proteins ND ND 860 ± 811 nm
20-40 nm
#The lower size detection limit of SP-ICPMS is 18-20 nm; *Number of particles significantly different 
(p< 0.05) compared with saliva sample; ND, number of nanoparticles/ml in the respective digestive juices 
was comparable with the number of nanoparticles/ml in water; AgNPs, silver nanoparticles; SEM-EDX, 
scanning electron microscopy with energy dispersive X-ray analysis; SP-ICPMS, single particle-inductively 
coupled plasma mass spectrometry.
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EDX analysis showed that these were pure silver NPs, without co-localisation of any other 
element. Apparently, the increase of pH from gastric to intestinal stage, even though in 
combination with high ionic strength, induced the process of cluster disintegration resulting 
in reappearance of single particles. Similar intestinal disintegration of particles clustered 
previously in the stomach has recently been shown for silica nanoparticles (Peters et al. 
2012). Reversible clustering and disassembling of NPs due to changes in pH was shown to 
be caused by changes in the protein coating of the NPs (Meziani and Sun 2003). 
Interestingly, after intestinal digestion of AgNO3 in the presence of proteins, silver-
containing particles were found by SP-ICPMS, while no particles were detected at the 
earlier digestion stages. The particles were small, with diameter of 20-30 nm. Because 
this size is close to the lower size detection limit of SP-ICPMS, it is possible that there 
were a number of smaller particles in the sample, assuming a normal size distribution. 
Since the lower size detection limit for SEM is around 15-20 nm, a 10 times higher AgNO3 
concentration was used for the SEM experiment. Particles containing Ag were detected, 
and EDX analysis showed that these particles were composed of silver, chlorine and 
sulphur. Silver is known to have a very high affinity with both chlorine and sulphur. 
AgCl and Ag2S are formed readily in solutions containing Ag+ ions and Cl- or S2- (Li and 
Zhu 2006; Cheng et al. 2004; Loeschner et al. 2011; Levard et al. 2011; Danscher and 
Stoltenberg 2006; Choi et al. 2009). 
Data from in vivo studies indicate that upon oral administration of AgNPs and Ag+ 
ions, particles accumulate in tissues and these particles were shown to consist of silver 
and sulphur (Danscher and Stoltenberg 2006; Jonas et al. 2007; Loeschner et al. 2011). 
Additionally, oral exposure to Ag+ ions has been recently shown to result in formation of 
sulphur containing silver granules in the intestinal epithelium (Loeschner et al. 2011). The 
authors suggested that these complexes were formed in lysosomes, but our results indicate 
that these complexes might already be formed in the intestinal lumen during digestion.
The fact that during intestinal digestion Ag+ ions give rise to particle formation, most 
probably Ag2S and/or AgCl salt particles, might influence their potential uptake and toxicity. 
The toxic effects of silver ions should be reduced by the formation of insoluble silver salts 
(Loeschner et al. 2011). On the other hand, the effects of silver salts (Ag2S) on the intestine 
are unknown and, given the results of the present study, need to be investigated.  
CONCLUSION
From this study, the authors conclude that gastrointestinal digestion impacts AgNPs and 
Ag+ ions so that they change during gastrointestinal digestion. AgNPs agglomerate to a 
high extent during gastric passage, a process facilitated by chlorine interparticle bridges. 
Nevertheless, these agglomerates break down when changing into intestinal conditions, 
releasing the original AgNPs retaining their original size in the intestinal juice. Thus, it 
is concluded that orally ingested 60 nm AgNPs, digested under physiologically relevant 
conditions (i.e., in the presence of proteins), ultimately can reach the intestinal wall in their 
size and dispersion. The results of the present study also revealed that ingestion of Ag+ ions 
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results in formation of NPs containing silver, sulphur and chlorine. Therefore, ingestion 
of both AgNPs and Ag+ ions ultimately leads to intestinal exposure to NPs, albeit with a 
different chemical composition. The outcomes of this study should be used for designing 
future in vitro and in vivo experiments, to serve future risk assessments of orally ingested 
silver nanoparticles and ions.
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ABSTRACT
Intestinal translocation is a key factor for determining bioavailability of nanoparticles 
(NPs) after oral uptake. Therefore, we evaluated three in vitro intestinal cell models 
of increasing complexity which might affect the translocation of NPs: a mono-culture 
(Caco-2 cells), a co-culture with mucus secreting HT29-MTX cells and a tri-culture 
with M-cells. Cell models were exposed to well characterized differently sized (50 and 
100 nm) and charged (neutral, positively and negatively) polystyrene NPs. In addition, 
two types of negatively charged NPs with different surface chemistries were used. Size 
strongly affected the translocation of NPs, ranging up to 7.8% for the 50 nm NPs and 
0.8% for the 100 nm NPs. Surface charge of NPs affected the translocation, however, 
surface chemistry seems more important, as the two types of negatively charged 
50 nm NPs had an over 30-fold difference in translocation. Compared to the Caco-2 
mono-culture, presence of mucus significantly reduced the translocation of neutral 
50 nm NPs, but significantly increased the translocation of one type of negatively 
charged NPs. Incorporation of M-cells shifted the translocation rates for both NPs 
closer to those in the mono-culture model. The relative pattern of NP translocation 
in all three models was similar, but the absolute amounts of translocated NPs differed 
per model. We conclude that for comparing the relative translocation of different 
NPs, using one intestinal model is sufficient. To choose the most representative model 
for risk assessment, in vivo experiments are now needed to determine the in vivo 
translocation rates of the used NPs.
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INTRODUCTION
Nanotechnology in the food industry develops quickly and the large number of products 
containing nanoparticles (NPs) on the market is expected to further increase (Chaudhry 
et al. 2008) resulting in consumer exposure to NPs. Classically, human safety assessment of 
chemicals and NPs relies heavily on in vivo studies (EFSA and Committee 2011). Given the 
enormous diversity of NPs, these cannot all be evaluated using animal studies. In addition, 
there is a strong societal demand to develop alternative testing approaches (3Rs: replacement, 
reduction and refinement) to reduce animal studies. An in vitro screening method should be 
developed for linking the physicochemical properties of NPs with their translocation across 
cells for prioritizing NPs for further animal testing. Therefore, the aim of this study was to 
evaluate three in vitro intestinal epithelial cell models of increasing complexity to compare 
their barrier properties for differently sized and charged polystyrene (PS)-NPs. 
Physicochemical properties of NPs play a crucial role in the interactions between NPs 
and cells (Shang et al. 2014). No single metric is postulated to govern translocation, but 
size and surface modifications certainly play a role (Oomen et al. 2014; Zhao et al. 2011). 
Therefore, these parameters are targeted for boosting the physicochemical properties of 
NPs to increase their commercial, including medical, applications (Pozzi et al. 2014; Prijic 
et al. 2012; Sharma et al. 2013; Yang et al. 2014). Smaller NPs generally translocate more 
efficiently through cell layers than larger particles (Elbakry et al. 2012; Mahler et al. 2012; 
Oh et al. 2011; Schubbe et al. 2012; Varela et al. 2012). The exact contribution of the surface 
charge on translocation has not yet been elucidated. A positive surface charge of NPs is 
often associated with a higher translocation efficiency, as shown for PS-NPs in MDCK-II 
cells (Fazlollahi et al. 2011) and in an intestinal co-culture model of Caco-2 and M cells (des 
Rieux et al. 2005). 
Size, surface chemistry and charge have been shown to significantly affect the coating 
of NPs by proteins present in cell culture media, resulting in a protein corona (Lundqvist 
et al. 2008; Meder et al. 2012). The composition and amount of proteins adsorbed onto 
NPs influence their biological interactions ( Lesniak et al. 2010; Lundqvist 2013; Tedja et 
al. 2012). For instance, the amount of adsorbed proteins onto NPs has been suggested to 
positively correlate with the NP cellular uptake (Ehrenberg et al. 2009). 
To study NP translocation across the human intestinal epithelium in vitro, in previous 
studies cells were grown on a semi-permeable membrane, separating apical and basolateral 
chambers. Presently, models with different degrees of complexity are being employed, 
starting with the simplest and most commonly used mono-culture of Caco-2 cells 
(Nkabinde et al. 2012). These mono-cultures, however, lack a mucus layer which, especially 
for charged NPs, might be a very important barrier because of electrostatic repulsion (for 
negatively charged NPs) and mucus entrapment (for positively charged NPs) (Hussain et 
al. 2001; Lai et al. 2007; Norris et al. 1998; Szentkuti 1997). Therefore, co-culture models 
that include mucus producing goblet cells have been proposed (i.e. the combination 
of Caco-2 and HT29-MTX cells) (Chen et al. 2010; Hilgendorf et al. 2000; Walter et al. 
1996). Finally, in vitro models incorporating human intestine microfold (M) cells have also 
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been developed. M-cells, localized in the intestinal Peyer’s patches, are responsible for the 
uptake and translocation and immune presentation of relatively larger particles and they 
have been accommodated in co- and tri-culture models. In these models, Caco-2 cells are 
differentiated into M-cells by a temporary co-culture with Raji cells (des Rieux et al. 2005). 
All these models have been used for testing the translocation of NPs (Bouwmeester et al. 
2011; des Rieux et al. 2005; Mahler et al. 2012), but have never been compared with each 
other in one study to evaluate their applicability for NP testing. 
In this study, we compared three in vitro intestinal epithelial cell models of increasing 
complexity to assess the translocation of differently sized and charged PS-NPs. We used a 
mono-culture of Caco-2 cells, a co-culture with additional mucus secreting HT29-MTX 
cells and a tri-culture with additional both HT29-MTX cells and M-cells. These three 
models were exposed to fluorescently labelled 50 and 100 nm PS-NPs with neutral, negative, 
or positive charge, resulting from different surface modifications. 
MATERIALS AND METHODS
NPs
Neutral, amine- and carboxyl-modified PS-NPs, 50 and 100 nm (referred to as 50 (0), 50 
(+), 50 (-M), 100 (0), 100 (+) and 100 (-)) with a red fluorophore core (Ex/Em: 530/590 
nm) were purchased from Magsphere (Pasadena, CA, USA). Carboxyl-modified PS-NPs, 
50 nm (referred to as 50 (-P)) with a yellow-green fluorophore core (Ex/Em: 485/530 nm) 
were purchased from Polysciences (Warrington, PA, USA). The mass concentration of all 
stock solutions was 2.5 %. 
NP characterization
PS-NP morphology, size and surface charge were characterized with scanning electron 
microscopy (SEM), dynamic light scattering (DLS) and zeta-potential measurements. In 
addition, a chemical analysis of NPs was performed by matrix-assisted laser desorption/
ionization-time-of-flight mass spectrometry (MALDI-TOF) and the adsorbed protein 
corona was analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) following its desorption from the NPs, performed as described hereafter.
SEM analysis was performed using a high resolution field emission gun (FEG) SEM 
(Tescan MIRA-LMH FEG-SEM; Tescan, Brno, Czech Republic). Samples were prepared by 
depositing 20 μl of a 20 µg/ml NP suspension in water onto a nickel-coated polycarbonate 
filter which was left to dry completely and then coated with a 5 nm layer of chromium. Size 
distributions were determined using Scandium SIS image analysis software (Olympus Soft 
Imaging Solutions GmbH, Germany). The mean diameter ± SD of 80-600 particles is given.
DLS measurements were performed as previously described (Walczak et al. 2013). 
The zeta-potential was measured using a Malvern Zetasizer 2000 (Malvern Instruments, 
Malvern, UK). Each sample was measured in 5 runs, 1.5 min each. For DLS and zeta-
potential measurements, 100 µg/ml NP suspensions in water or cell culture medium were 
used. All samples were analysed in triplicate and the results are presented as the mean ± SD.
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For MALDI-TOF analyses suspensions of NPs at 2 mg/ml were prepared in 5 mM 
sodium acetate and mixed with MALDI-TOF matrix solution at a 1:1 (v:v) ratio, from which 
1 μl was spotted on a Bruker 384 ground steel target plate and air-dried. MALDI-TOF 
matrix solution contained 2,5-dihydrobenzoic acid (20 mg/ml) in 50% aqueous acetonitril. 
MALDI-TOF analyses were performed in positive mode on a Bruker Ultraflextreme II mass 
spectrometer (Bruker Daltonics, Bremen, Germany). For each MALDI-TOF MS spectrum 
3 x 500 shots were recorded.
The absence of detectable leakage of the fluorescent dye from the used NPs was confirmed 
by centrifugation of NPs after 24 h incubation in cell culture medium at 37°C, using filter 
tubes (Amicon Ultra-4 3kDa Ultracel-PL memb 24/Pk; Millipore BV, the Netherlands).
Assessment of the protein corona of NPs
The 50 nm PS-NPs at a concentration of 1.66 mg/ml and the 100 nm PS-NPs at an equal 
total surface area were incubated in cell culture medium for 24 h at 37°C (Lundqvist et 
al. 2008). Subsequently, to remove non-firmly bound proteins, the samples were washed 
three times by centrifugation (18 000 rcf, 15°C, 40 min), re-suspension of the pellet in 1 ml 
PBS (Gibco; Bleiswijk, the Netherlands) and transferring to a new tube. The final pellet 
was re-suspended in a loading buffer (Laemmli Sample Buffer, BIO-RAD; Veenendaal, the 
Netherlands) containing β-mercaptoethanol (Sigma; Steinbach, Germany). The samples 
were boiled for 5 min and the centrifugation step was repeated once more to separate the 
NPs from proteins desorbed from their surface. Protein containing supernatant was then 
loaded onto a SDS-PAGE gel. Each lane contained the amount of protein corresponding to 
equal NP surface areas, protein samples obtained from the 100 nm NPs were 1.5 x diluted. 
Intensity of each whole lane in the gel was digitally analysed and the amount of protein per 
lane was estimated. Based on this, a second gel was prepared with each lane containing an 
equal amount of protein.  
One-dimensional polyacrylamide gel electrophoresis was performed at 90 V for about 
80 min on 12% polyacrylamide gels of 1 mm thickness (Mini-PROTEAN TGX Gels, 
BIO-RAD). A protein ladder of 10-250 kDa was included in each gel (Precision Plus 
Protein Dual Color Standards, BIO-RAD). The gels were washed in 40% methanol in 
water containing 10% acetic acid for 15 min and were subsequently stained with Bio-Safe 
Coomassie Stain G-250 (BIO-RAD) for 1.5 hrs. Afterwards, the gels were destained by 
extensive washing in distilled water.
The experiments were repeated three times with comparable results. The gels were 
scanned (Odyssey, Li-Cor ISO 9001, Bad Homburg, Germany) and gel densitometry was 
performed using the Odyssey software (Odyssey Biosciences, Bad Homburg, Germany).   
Cell models
Caco-2 and Raji B cell lines were obtained from the American Type Culture Collection and 
were used in experiments at passage numbers 29-38 and 8-24, respectively. A human colon 
adenocarcinoma mucus secreting cell line (HT29-MTX) was obtained from the European 
Collection of Cell Cultures and was used at passages 20-29. Caco-2 and HT29-MTX cells 
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were cultured with Dulbecco’s Modified Eagle Medium (DMEM) (Lonza, Verviers, Belgium) 
without phenol red, supplemented with 10% heat-inactivated fetal bovine serum (FBS) 
(Gibco), 1% penicillin-streptomycin (Sigma), 1% MEM non-essential amino acids (Gibco) 
and 1% GlutaMAX (Gibco). The complete medium is further referred to as DMEM+. 
The medium was changed every 2-3 days and cells were subcultured upon reaching 80% 
confluence. Raji cells were cultured in RPMI 1640 medium (Gibco), supplemented with 
10% heat- inactivated FBS and 1% penicillin-streptomycin. The medium was changed every 
3-4 days by centrifugation of the cells at 1200 rpm (Heraeus Labofuge 400R) for 7 min and 
resuspending the cells in fresh medium.
For translocation experiments cells were seeded at a density of 40 000 cells/cm2 in 
transwell polyester inserts (3 µm pore size, 1.12 cm2 surface area, Corning, the Netherlands). 
All cell models were used for experiments on day 21. For the mono-culture, Caco-2 cells 
were used. For the co- and tri-cultures, Caco-2 and HT29-MTX cells were seeded at a ratio 
of 3:1. For the tri-cultures, an inverted model (des Rieux et al. 2007) was used as follows: 
on day 6 of Caco-2/HT29-MTX culture the inserts were inverted and further cultured as 
described before (Bouwmeester et al. 2011), and on day 16, 40 000 Raji cells were added 
into the basolateral chamber of the insert. On day 21, Raji cells were removed and the 
inserts were placed in plates in their original orientation to be used in experiments.
Cell model characterization: assessment of cell barrier integrity
The integrity of the cell barrier in all cell models was assessed before and after NP exposure 
by measuring the transepithelial electrical resistance (TEER) with a STX01 electrode 
connected to a Millicell ERS-2 Epithelial Volt-Ohm Meter (Millipore, Bedford, MA). After 
each cell culture medium refreshment, cells were allowed to equilibrate for 30 min at 37°C 
before TEER measurements. Only inserts with TEER values above 200 Ω x cm2 were used 
in experiments. 
Cell layer integrity was also evaluated using Lucifer Yellow (Sigma) and two FITC-
dextrans (low- and high-molecular weight of 4 and 10 kDa, respectively; Sigma), in the 
presence and absence of EGTA (Sigma), which opens tight junctions. Lucifer Yellow and 
dextran solutions at a concentration of 1 mg/ml in DMEM+ were added apically to the 
cells (500 µl/insert). Controls were incubated with 2.5 mM EGTA in DMEM+ (apically 
and basolaterally) for 1 h at 37°C. Afterwards, cells were allowed to equilibrate in DMEM+ 
for 30 min and the TEER was measured. Then, EGTA/DMEM+ was added again in the 
basolateral chamber, while the integrity marker solutions were added apically. After 1 h 
incubation at 37°C, the basolateral medium was collected and analysed for fluorescence at 
485/530 nm.
Cell model characterization: histological evaluation
For histological evaluation, after 21 days in culture, cells in the insert were fixed with 4% 
paraformaldehyde (pH 7.4), followed by washing with PBS and addition of 0.5 ml filtered 
10 mg/ml Alcian blue solution (8GX; Sigma) in 3% acetic acid (pH 2.5). After 20 min of 
incubation at room temperature, the cells were extensively washed with PBS. The insert 
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membrane with cells was cut out of the plastic insert holder, mounted onto a glass slide 
using a drop of PBS, and visualized by microscopy. 
NP in vitro translocation experiments
After 21 days in culture, cells were exposed apically to 500 µl/insert of NPs at 250 µg/ml. 
After 24 h exposure, the basolateral medium was collected and fluorescence was measured 
with a Synergy HT Multi-Detection Microplate Reader at excitation/emission wavelengths 
of 530/590 and 485/530 nm, for red and yellow-green NPs, respectively. The obtained values 
were converted into NP concentrations, based on a concentration standard calibration 
curve included in every experiment. 
All experiments were conducted in triplicate for each treatment and repeated twice. 
The reported percentages of translocation are the NP amounts in basolateral samples 
divided by the NP amounts to which cells were exposed in the apical chamber. The results 
of translocation are presented as an average ± standard error of the mean (SEM).
Statistics
Data were analysed with Prism software (v5.02; GraphPad Software, Inc., La Jolla, CA, 
USA). A one-way analysis of variance test and post hoc Tukey test were used to determine 
significant differences between the groups. Groups were considered significantly different 
when p <0.05. 
RESULTS
NP characterization
We characterized the PS-NPs in water using SEM. The spherical shape of the NPs was 
confirmed (Figure 1 and Table 1). All types of 50 nm NPs had similar size distributions 
except for the 50 nm (+) NPs, which had a larger average size of 50.6 nm, compared with 
the other 50 nm NPs (Figure 1, Table 1 and Supplementary Figure S1). The 100 nm (0) and 
100 nm (+) had similar size distributions, while the 100 nm (-) NPs had a fraction of 34.6% 
of smaller (15-35 nm) NPs causing a smaller average projected area diameter (54.2 nm) as 
compared with the other 100 nm NPs. 
With DLS we measured the hydrodynamic diameters of all NPs in water and DMEM+. 
In water, the size ranged from 52.4 to 56.2 nm and from 96.3 to 121.4 nm, for the 50 and 
100 nm NPs, respectively (Table 2). In DMEM+ at t=0 h hydrodynamic diameters were 
in all cases, except for the 100 (+) NPs, significantly larger than in water, ranging from 
114.9 to 187.6 nm for 50 nm NPs and from 138.5 to 255.3 nm for 100 nm NPs. Only the 
hydrodynamic sizes of the 100 (0) and 100 (+) NPs were significantly different from each 
other in DMEM+ at t=0 h. Incubation of the NPs for 24 h in DMEM+ did not significantly 
affect the hydrodynamic sizes compared with t=0 h (Table 2).
The zeta-potential measurements of the (+) and (-) NPs in water confirmed their 
positive and negative charges (Table 3). The neutral NPs had a negative charge of -26.0 mV 
and -59.1 mV for the 50 and 100 nm NPs, respectively. The two types of negatively charged 
55
3TR
A
N
SLO
C
A
TIO
N
 O
F D
IFFEREN
TLY
 SIZED
 A
N
D
 C
H
A
RG
ED
 PO
LY
ST
Y
REN
E N
A
N
O
PA
RTIC
LES...
washing and centrifugation steps (Lundqvist et al., 2011;
Monopoli et al., 2011). A control DMEM+ sample without
NPs, treated the same as the NP samples did not show any protein
bands on the gel (data not shown), confirming that the proteins
shown on the gels are only the proteins of the NP protein corona.
Figure 3(A) shows the gel loaded with samples normalized on the
NP surface area and it clearly demonstrates differences in the total
protein content, visible in the band intensity profiles of the NPs.
The highest protein content was found on 100 nm (�) and 100 nm
(0) NPs with intensities of whole lanes of 809 and 773,
respectively. However, in the 100 nm (+) sample hardly any
protein was detected (39). Also, 50 nm (+) NPs had a relatively
low protein content (132), while the other 50 nm NPs had much
more protein adsorbed on the surface: the highest in (�P) (528),
followed by (�M) and (0) with similar contents (375 and 330,
respectively). Remarkably, there was a 1.5-fold difference in the
amount of adsorbed protein between the two negatively charged
50 nm NPs.
Figure 3(B) shows the samples normalized on the total protein
content and it reveals relatively minor differences in the types of
adsorbed proteins between NPs, which can be derived from the
band intensity profiles. A difference in band pattern between the
50 nm (�M) and (�P) NPs shows that (�M) NPs had more
adsorbed proteins4250 kDa, and (�P) NPs had more proteins of
Figure 1. Scanning electron micrographs of 50 and 100 nm PS-NPs in water: (A) 50 nm (0), (B) 50 nm (+), (C) 50 nm (�M), (D) 50 nm (�P),
(E) 100 nm (0), (F) 100 nm (+), (G) 100 nm (�). Magnification 100 000�. The bar indicates 500 nm.
Table 2. Hydrodynamic diameters (nm) of PS-NPs in water and
DMEM+.
NPs In water (nm)
In DMEM+
(t¼ 0 h) (nm)
In DMEM+
(t¼ 24 h) (nm)
50 nm (0) 52.5± 0.5 187.6± 7.7a 143.0± 11.1
50 nm (+) 56.2± 0.7 144.4± 2.5a 161.0± 47.6
50 nm (�M) 52.4± 0.2 114.9± 5.0a 88.7± 1.6
50 nm (�P) 52.4± 0.9 183.7± 22.7a 166.3± 48.4
100 nm (0) 114.0± 2.4b 255.3± 67.8a,b 227.5± 72.6
100 nm (+) 121.4± 2.1b 138.5± 1.2b 144.3± 3.7
100 nm (�) 96.3± 2.6b 198.5± 27.8a 205.7± 31.2
The measurements in water were done at t¼ 0 h, and the measurements in
DMEM+ were done at t¼ 0 h and 24 h. (0), Neutral NPs; (+), positively
charged NPs; (�), negatively charged NPs.
aSignificant difference between sizes in water and DMEM+. n¼ 3.
bSignificant difference between NP types.
Table 1. Projected area diameters (Dpa) (nm) of PS-NPs in water at
t¼ 0 h, as determined by SEM.
NPs n Sphericity Dpa (nm) Size range (nm)
50 nm (0) 170 0.70 31.2± 12.7 �15–70
50 nm (+) 80 0.78 50.6± 9.3 20–80
50 nm (�M) 100 0.66 35.0± 15.3 �15–70
50 nm (�P) 290 0.70 31.6± 13.6 �15–70
100 nm (0) 350 0.89 108.1± 18.0 40–140
100 nm (+) 80 0.88 100.2± 10.7 60–140
100 nm (�) 600 0.79 54.2± 28.0 �15–130
n, Number of measured NPs; (0), neutral NPs; (+), positively charged
NPs; (�), negatively charged NPs.
4 A. P. Walczak et al. Nanotoxicology, Early Online: 1–9
N
an
ot
ox
ic
ol
og
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
W
ag
en
in
ge
n 
U
R 
on
 1
0/
19
/1
4
Fo
r p
er
so
na
l u
se
 o
nl
y.
Figure 1. Scanning electron micrographs of 50 and 100 nm PS-NPs in water: (A) 50nm (0), (B) 50nm 
(+), (C) 50nm (-M), (D) 50nm (-P), (E) 100nm (0), (F) 100nm (+), (G) 100nm (-). Magnification 
100 000 x. The bar indicates 500 nm. 
Table 1. Proje ed area diameters (Dpa) ( m) of PS-NPs in water at t=0 h, as determined by SEM. 
NPs n Sphericity Dpa (nm) Size range (nm)
50 nm (0) 170 0.70 31.2 ± 12.7 ≤15 - 70
50 nm (+) 0.78 50.6 ± 9.3 20 - 80
50 nm (-M) 100 0.66 35.0 ± 15.3 ≤15 - 70
50 nm (-P) 290 0.70 31.6 ± 13.6 ≤15 - 70
100 nm (0) 350 0.89 108.1 ± 18.0 40 - 140
100 nm (+) 80 0.88 100.2 ± 10.7 60 - 140
100 nm (-) 600 0.79 54.2 ± 28.0 ≤15 - 130
n, Number of measured NPs; (0), neu ral NPs; (+), positively charged NPs; (-), negatively charged NPs.
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50 nm NPs had the same zeta-potential. The initially different charges of NPs in water all 
converted into rather equal negative charges after suspension in DMEM+ (ranging from 
-9.4 mV to -19.5  mV) and did not significantly change after 24 h (Table 3).
The two types of negatively charged 50 nm NPs were compared by MALDI-TOF 
analysis (Figure 2). According to the manufacturers, both NPs contain carboxylic groups 
on their surface, but the MALDI-TOF spectrum of the (-M) NPs showed several peaks (at 
m/z-values of 411.3, 463.3 and 565.3) that were not detected in the spectrum of the (-P) NPs 
and vice versa at m/z-values of 351.2, 371.2, 547.2, 719.4 and 756.6. These analyses show 
that (-M) and (-P) NPs were different in their chemical composition.
Table 2.  Hydrodynamic diameters (nm) of PS-NPs in water and DMEM+. 
NPs In water (nm)
In DMEM+
(t=0 h) (nm)
In DMEM+
(t=24 h) (nm)
50 nm (0) 52.5 ± 0.5 187.6 ± 7.7a 143.0 ± 11.1
50 nm (+) 56.2 ± 0.7 144.4 ± 2.5a 161.0 ± 47.6  
50 nm (-M) 52.4 ± 0.2 114.9 ± 5.0a   88.7 ± 1.6
50 nm (-P) 52.4 ± 0.9 183.7 ± 22.7a 166.3 ± 48.4 
100 nm (0) 114.0 ± 2.4b 255.3 ± 67.8a,b 227.5 ± 72.6  
100 nm (+) 121.4 ± 2.1b 138.5 ± 1.2b 144.3 ± 3.7
100 nm (-) 96.3 ± 2.6b 198.5 ± 27.8a 205.7 ± 31.2
The measurements in water were done at t=0 h, and the measurements in DMEM+ were done at t=0 h 
and 24 h. (0), Neutral NPs; (+), positively charged NPs; (-), negatively charged NPs. aSignificant difference 
between sizes in water and DMEM+. n=3. bSignificant difference between NP types.
Table 3. Zeta-potential (mV) of PS-NPs in water and DMEM+. 
NPs In water (mV)
In DMEM+ 
(t=0 h) (mV)
In DMEM+ 
(t=24 h) (mV)
50 nm (0) -26.0 ± 16.2 -13.3 ± 1.5a   -11.9 ± 0.9  
50 nm (+)  26.6 ± 13.9 -9.4 ± 1.5a -12.2 ± 0.8 
50 nm (-M) -27.7 ± 19.3 -10.2 ± 0.8a -10.2 ± 1.1 
50 nm (-P) -27.8 ± 17.4 -12.7 ± 1.3 -12.4 ± 0.9 
100 nm (0) -59.1 ± 5.4 -19.5 ± 20.5a -12.3 ± 1.4 
100 nm (+)  64.9 ± 1.6 -10.1 ± 1.3a -10.1 ± 1.7 
100 nm (-) -51.78 ± 4.9 -12.4 ± 2.0a -12.5 ± 1.2 
The measurements in water were done at t=0 h, and the measurements in DMEM+ were done at t=0 h 
and 24 h. (0), Neutral NPs; (+), positively charged NPs; (-), negatively charged NPs. aSignificant difference 
between zeta-potential in water and DMEM+. n=2.
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�67 kDa. The gels show that the protein coronas contained mostly
proteins present at high abundancy in DMEM+, in different
ratios. However, protein coronas contained also other proteins, not
visible in DMEM+ lane, with a molecular weights of: �10, 12,
26, 43 and4250 kDa. This indicates that NPs enriched some of
the medium proteins in pellet by preferential binding.
Cell model characterization: assessment of cell barrier
integrity
In this study, we compared three types of intestinal cell barrier
models in a two chamber design. TEER values were measured in
cell cultures during culturing to monitor confluency and cell layer
integrity. TEER values increased over the first days after seeding
and then remained constant (4200V� cm2) until day 21, as
reported previously (Hilgendorf et al., 2000). On day 21, cell
barrier integrity was additionally assessed by translocation studies
using Lucifer Yellow and dextrans as translocation markers. As
shown in Figure 4, all three models allowed only a limited marker
translocation, similar to that reported before (Nollevaux et al.,
2006), which was not significantly different between the models.
Upon opening of the tight junctions with EGTA as used before
(Bouwmeester et al., 2011; Rothen-Rutishauser et al., 2002),
permeability increased significantly. Exposure to NPs at
250mg/ml for 24 h did not affect the TEER values of the cell
layers (data not shown).
Cell model characterization: presence of mucus on
co-culture
To visualize the mucus on top of the co-culture cell surface, the
cell layer was stained with Alcian blue. Figure 5 shows the
presence of mucus in blue (Figure 5B), in a pattern typical for
mucus on the co-culture cell layer, but not on the mono-culture
(Figure 5A).
NP in vitro translocation experiments
Mono-, co- and tri-culture models were exposed to six types of
PS-NPs. In each model, the translocation of each type of 50 nm
NPs was significantly different (p50.05) from that of the other
NPs. In the Caco-2 mono-culture, the 50 nm (0) NPs translocated
to the highest extent (7.8% of the apically applied amount),
followed by 50 nm (�P) NPs (4.0%), 50 nm (+) NPs (0.6%) and
finally 50 nm (�M) NPs (0%). As shown in Figure 6, this order of
translocation percentage (i.e. 50 nm (0)450 nm (�P)450 nm
(+)450 nm (�M)) was similar in the tri-culture model. In the
co-culture model, the presence of mucus significantly reduced
the translocation of 50 nm (0) NPs, but significantly increased the
translocation of 50 nm (�P) compared with the mono-culture
model. Incorporation of M-cells in the model shifted the
translocation rates for both NPs closer (but still significantly
different) to those in the Caco-2 mono-culture. Strikingly, the two
types of negatively charged 50 nm NPs had significantly different
translocation properties in all cell models, where 50 nm (�P) NPs
translocated 210.5� more than (�M) NPs in mono-culture, 78.3�
in co-culture and 30� in tri-culture. Size affected the transloca-
tion as well, as the translocation of neutral and positively charged
100 nm NPs (0.51%, 0.46% and 0.76% for (0) NPs and 0.21%,
0.46% and 0.51% for (+) NPs in the mono-, co- and tri-culture
models, respectively) was much lower than that of their equivalent
50 nm NPs. Negatively charged 100 nm NPs translocated to a
Figure 2. MALDI-TOF analyses of chemical groups on the surface of two types of negatively charged 50 nm PS-NPs: (�M) NPs and (�P) NPs.
Underlined with red are the numbers of peaks different between the two NPs.
Table 3. Zeta-potential (mV) of PS-NPs in water and DMEM+.
NPs In water (mV)
In DMEM+
(t¼ 0 h) (mV)
In DMEM+
(t¼ 24 h) (mV)
50 nm (0) �26.0± 16.2 �13.3± 1.5a �11.9± 0.9
50 nm (+) 26.6± 13.9 �9.4± 1.5a �12.2± 0.8
50 nm (�M) �27.7± 19.3 �10.2± 0.8a �10.2± 1.1
50 nm (�P) �27.8± 17.4 �12.7± 1.3 �12.4± 0.9
100 nm (0) �59.1± 5.4 �19.5± 20.5a �12.3± 1.4
100 nm (+) 64.9± 1.6 �10.1± 1.3a �10.1± 1.7
100 nm (�) �51.78± 4.9 �12.4± 2.0a �12.5± 1.2
The measurements in water were done at t¼ 0 h, and the measurements in
DMEM+ were done at t¼ 0 h and 24 h. (0), Neutral NPs; (+); positively
charged NPs; (�), negatively charged NPs.
aSignificant difference between zeta-potential in water and DMEM+.
n¼ 2.
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Assessment of the protein corona of NPs
To assess the proteins adsorbed onto the NPs that were used for exposure, we extracted 
the protein corona after incubation in DMEM+ for 24 h at 37°C. Only protein corona 
of NPs was analyzed, which was ensured by applying three washing and centrifugation 
steps (Lundqvist et al. 2011; Monopoli et al. 2011). A control DMEM+ sample without 
NPs, treated the same as the NP samples, did not show any protein bands on the gel (data 
not shown), confirming that the proteins shown on the gels are only the proteins of the 
NP protein corona. Figure 3(A) shows the gel loaded with samples normalized on the NP 
surface area and it clearly demonstrates differences in the total protein content, visible in 
the band intensity profiles of the NPs. The highest protein content was found on 100 nm (-) 
and 100 nm (0) NPs with intensities of whole lanes of 809 and 773, respectively. However, 
in the 100 nm (+) sample hardly any protein was detected (39). Also, 50 nm (+) NPs had 
a relatively low protein content (132), while the other 50 nm NPs had much more protein 
adsorbed on the surface: the highest in (-P) (528), followed by (-M) and (0) with similar 
contents (375 and 330, respectively). Remarkably, there was a 1.5-fold difference in the 
amount of adsorbed protein between the two negatively charged 50 nm NPs. 
Figure 3(B) shows the samples normalized on the total protein content and it reveals 
relatively minor differences in the types of adsorbed proteins between NPs, which can be 
derived from the band intensity profiles. A difference in band pattern between the 50 nm 
(-M) and (-P) NPs shows that (-M) NPs had more adsorbed proteins >250 kDa, and (-P) 
NPs had more proteins of ~ 67 kDa. The gels show that the protein coronas contained 
Figure 2. MALDI-TOF analyses of chemical groups on the surface of two types of negatively charged 
50 nm PS-NPs: (-M) NPs and (-P) NPs. Underlined with red are the numbers of peaks different 
between the two NPs. 
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Figure 3. SDS-PAGE showing the protein corona of PS-NPs after 24 h incubation in DMEM+: (A) 
samples normalized on the NP surface area; the protein samples obtained from the 100 nm NPs were 
1.5 x  diluted compared with 50 nm NP samples to avoid overloading the gel. The molecular weights 
of the proteins in the standard ladder are given on the left side. The sample order is indicated above 
the lanes. DMEM+: medium control. On the right: profile of band intensities of 50 nm NPs: (0): red, 
(+): green, (-M): blue, (-P): yellow. (B) Samples normalized on the total protein content. Lane 50 nm 
(+) contains less protein than the other lanes and lane 100 nm (+) is absent, both due to the lack of 
sufficient amounts of protein. On the right: profile of band intensities as described in A. 
similar extent as their 50 nm (M) counterparts (0.07%, 0.19%
and 0.15% versus 0.02%, 0.08% and 0.17%, respectively). The
relative order of translocation percentage of the 100 nm NPs was
similar to that of their corresponding 50 nm NPs (from
Magsphere).
Discussion
We investigated the influence of size and surface modifications of
PS-NPs on their translocation properties in the three cell models.
Clearly, translocation was strongly affected by the size, with
100 nm NPs reaching up to 0.8% translocation and 50 nm
NPs reaching up to 7.8%. Translocation was also strongly
affected by the surface chemistry, most clearly seen in the
results for the 50 nm NPs, which all translocated signifi-
cantly differently, varying from 0% to 7.8%. In all three cell
models, the 50 nm (0) and 50 nm (P) NPs translocated to the
highest extent.
It is striking that we observed such large differences between
the translocation of two types of negatively charged 50 nm NPs,
Figure 3. SDS-PAGE showing the protein corona of PS-NPs after 24 h incubation in DMEM+: (A) samples normalized on the NP surface area; the
protein samples obtained from the 100 nm NPs were 1.5 diluted compared with 50 nm NP samples to avoid overloading the gel. The molecular
weights of the proteins in the standard ladder are given on the left side. The sample order is indicate ab ve the lanes. DMEM+: medium control.
On the right: profile of band intensities of 50 nm NPs: (0): red, (+): green, (M): blue, (P): yellow. (B) Samples normalized on the total protein
content. Lane 50 nm (+) contains less protein than the other lanes and lane 100 nm (+) is absent, both due to the lack of sufficient amounts of protein.
On the right: profile of band intensities as describe in A.
6 A. P. Walczak et al. Nanotoxicology, Early Online: 1–9
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even though their size, surface charge (both in water and
DMEM+) and relative protein composition of their coronas
were similar. However, the corona of the (�P) NPs contained 1.5
times more protein than the (�M) NPs, therefore the total amount
of protein in corona in this case may be a factor governing
the translocation potential. We looked further into the
surface chemical composition of these NPs. For this we used
MALDI-TOF, which allows the characterization of surface
properties of NPs. MALDI-TOF spectrum showed that the
composition of the surface chemical groups is different. It has
already been shown that steric shielding of the charge and steric
interaction of chemical groups on the surface of NPs, as well as
molecular weight and density of the coating (Gref et al., 2000) can
affect their biological responses (Bhattacharjee et al., 2013;
Yoncheva et al., 2005) and protein corona (Gessner et al., 2003;
Jedlovszky-Hajdu et al., 2012). Likely, the difference in the
surface chemistry of these NPs caused differences in protein
binding capacity. The differences in surface chemistry or in
protein binding resulted in different behaviour in biological test
systems.
All three NPs of 100 nm with different surface modifications
also translocated differently. SEM analysis showed that 100 nm
(�) NPs had a fraction of 34.6% of smaller (15–35 nm) NPs and
also their hydrodynamic size in water was smaller as compared
with the other 100 nm NPs. However, they translocated to the
lowest extent. The 100 nm (0) NPs translocated to the highest
extent, even though they had the largest hydrodynamic size in
DMEM+. Additionally, their charge in water was in fact strongly
negative. This suggests the influence of surface chemistry rather
than charge on translocation.
The size and zeta-potential of all NPs were determined
in water and in DMEM+, as used in the translocation studies.
As expected, NPs in DMEM+ had larger hydrodynamic sizes than
in water, which did not change significantly upon 24 h incubation.
While in water charges of the NPs were different, they all obtained
a rather equal negative charge in DMEM+. This shift, shown
before (Cho et al., 2014; Ehrenberg et al., 2009; Fleischer &
Payne, 2012; Mahler et al., 2012; Meder et al., 2012), probably
results from the protein adsorption on the NPs or from measuring
protein aggregates of medium rather than NPs. A mucus layer as
used in the co- and tri-culture model is an important barrier
especially for charged NPs (Hussain et al., 2001; Lai et al., 2007;
Norris et al., 1998; Szentkuti, 1997). We indeed confirmed this
for the translocation of the 50 nm (0) NPs that had a negative zeta-
potential in water, but not for the 50 nm (�P) NPs that also had a
negative zeta-potential in water. Incorporation of M-cells shifted
the translocation rates for both NPs closer to those in the mono-
culture model.
Translocation of NPs is a complex process dependent on many
factors, one of them being the protein corona, which influences
the interactions of NPs with cell membranes and cellular uptake
(Lesniak et al., 2010; Lundqvist, 2013; Tedja et al., 2012). In this
study, we show that NPs with different surface modifications
adsorbed different amounts of proteins. It has been shown that the
protein adsorptive capacity of NPs, rather than the identity of
bound proteins, could predict their cellular interactions and
cellular uptake (Ehrenberg et al., 2009). In our study, the 50 nm
NPs with largest amount of adsorbed protein, (0) and (�P),
translocated to the highest extent. The difference in the amount of
adsorbed protein could also explain the difference in translocation
between 50 nm (�M) and (�P) NPs. However, the 50 nm (+) and
100 nm (+) NPs had much less adsorbed proteins and translocated
to a higher extent than 50 nm (�M) and 100 nm (�) NPs. This
indicates that the amount of protein in the corona is not the only
Figure 4. Translocation of membrane integrity markers in mono- (A), co- (B) and tri-culture (C) as used for the NP translocation studies. LY: Lucifer
Yellow, LM: low-molecular-weight dextran, HM: high-molecular-weight dextran. *: significant difference between the translocation without and with
EDTA. n¼ 3.
Figure 5. Mucus staining with Alcian blue:
(A) mono-culture (Caco-2 cells) and
(B) co-culture (Caco-2+HT29-MTX cells).
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mostly proteins present at high abundancy in DMEM+, in different ratios. However, protein 
coronas contained also other proteins, not visible in DMEM+ lane, with molecular weights 
of: ~10, 12, 26, 43 and >250 kDa. This indicates that NPs enriched some of the medium 
proteins in pellet by preferential binding.
Cell model characterization: assessment of cell barrier integrity
In this study, we compared three types of intestinal cell barrier models in a two chamber 
design. TEER values were measured in cell cultures during culturing to monitor confluency 
and cell layer integrity. TEER values i creased over th  first days after s ng and then 
remained constant (>200 Ω x cm2) until day 21, as reported previously (Hilgendorf et al. 
2000). On day 21, cell barrier integrity was additionally assessed by translocation studies 
using Lucifer Yellow and dextrans as translocation markers. As shown in Figure 4, all 
three models allowed only a limited marker translocation, similar to that reported before 
(Nollevaux et al. 2006), which was not significantly different b tween the models. Upon 
opening of the tight junctions with EGTA as used before (Bouwmeester et al. 2011; Rothen-
Rutishauser et al. 2002), permeability increased significantly. Exposur  to NPs  250 µg/ml 
for 24 h did not affect the TEER values of the cell layers (data not shown).
Cell model characterization: presence of mucus n co-culture
To visualize the mucus on top of the co-culture cell surface, the cell layer was stained with 
Alcian blue. Figure 5 shows the presence of mucus in blue (Figure 5B), in a pattern typical 
for mucus on the co-culture cell layer, but ot on the m no-culture (Figure 5A).
NP in vitro translocation experiments
Mono-, co- and tri-culture models were exposed to six types of PS-NPs. In each model, the 
translocation of each type of 50 nm NPs was significantly different (p<0.05) from that of 
the other NPs. In the Caco-2 mono-culture, the 50 nm (0) NPs translocated to the highest 
Figure 4. Translocation of membrane integrity markers in mono- (A), co- (B) and tri- culture (C) as 
used for the NP translocation studies. LY: Lucifer Yellow, LM: low-molecular-weight dextran, HM: 
high-molecular-weight dextran. *: significant difference between the translocation without and with 
EDTA. n=3.
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even though their size, surface charge (both in water and
DMEM+) and relative protein composition of their coronas
were similar. However, the corona of the (�P) NPs contained 1.5
times more protein than the (�M) NPs, therefore the total amount
of protein in corona in this case may be a factor governing
the translocation potential. We looked further into the
surface chemical composition of these NPs. For this we used
MALDI-TOF, which allows the characterization of surface
properties of NPs. MALDI-TOF spectrum showed that the
composition of the surface chemical groups is different. It has
already been shown that steric shielding of the charge and steric
interaction of chemical groups on the surface of NPs, as well as
molecular weight and density of the coating (Gref et al., 2000) can
affect their biological responses (Bhattacharjee et al., 2013;
Yoncheva et al., 2005) and protein corona (Gessner et al., 2003;
Jedlovszky-Hajdu et al., 2012). Likely, the difference in the
surface chemistry of these NPs caused differences in protein
binding capacity. The differences in surface chemistry or in
protein binding resulted in different behaviour in biological test
systems.
All three NPs of 100 nm with different surface modifications
also translocated differently. SEM analysis showed that 100 nm
(�) NPs had a fraction of 34.6% of smaller (15–35 nm) NPs and
also their hydrodynamic size in water was smaller as compared
with the other 100 nm NPs. However, they translocated to the
lowest extent. The 100 nm (0) NPs translocated to the highest
extent, even though they had the largest hydrodynamic size in
DMEM+. Additionally, their charge in water was in fact strongly
negative. This suggests the influence of surface chemistry rather
than charge on translocation.
The size and zeta-potential of all NPs were determined
in water and in DMEM+, as used in the translocation studies.
As expected, NPs in DMEM+ had larger hydrodynamic sizes than
in water, which did not change significantly upon 24 h incubation.
While in water charges of the NPs were different, they all obtained
a rather equal negative charge in DMEM+. This shift, shown
before (Cho et al., 2014; Ehrenberg et al., 2009; Fleischer &
Payne, 2012; Mahler et al., 2012; Meder et al., 2012), probably
results from the protein adsorption on the NPs or from measuring
protein aggregates of medium rather than NPs. A mucus layer as
used in the co- and tri-culture model is an important barrier
especially for charged NPs (Hussain et al., 2001; Lai et al., 2007;
Norris et al., 1998; Szentkuti, 1997). We indeed confirmed this
for the translocation of the 50 nm (0) NPs that had a negative zeta-
potential in water, but not for the 50 nm (�P) NPs that also had a
negative zeta-potential in water. Incorporation of M-cells shifted
the translocation rates for both NPs closer to those in the mono-
culture model.
Translocation of NPs is a complex process dependent on many
factors, one of them being the protein corona, which influences
the interactions of NPs with cell membranes and cellular uptake
(Lesniak et al., 2010; Lundqvist, 2013; Tedja et al., 2012). In this
study, we show that NPs with different surface modifications
adsorbed different amounts of proteins. It has been shown that the
protein adsorptive capacity of NPs, rather than the identity of
bound proteins, could predict their cellular interactions and
cellular uptake (Ehrenberg et al., 2009). In our study, the 50 nm
NPs with largest amount of adsorbed protein, (0) and (�P),
translocated to the highest extent. The difference in the amount of
adsorbed protein could also explain the difference in translocation
between 50 nm (�M) and (�P) NPs. However, the 50 nm (+) and
100 nm (+) NPs had much less adsorbed proteins and translocated
to a higher extent than 50 nm (�M) and 100 nm (�) NPs. This
indicates that the amount of protein in the corona is not the only
Figure 4. Translocation of membrane integrity markers in mono- (A), co- (B) and tri-culture (C) as used for the NP translocation studies. LY: Lucifer
Yellow, LM: low-molecular-weight dextran, HM: high-molecular-weight dextran. *: significant difference between the translocation without and with
EDTA. n¼ 3.
Figure 5. Mucus staining with Alcian blue:
(A) mono-culture (Caco-2 cells) and
(B) co-culture (Caco-2+HT29-MTX cells).
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Figure 5. Mucus staining with Alcian blue: (A) mono-culture (Caco-2 cells) and (B) co-culture 
(Caco-2 + HT29-MTX cells). 
extent (7.8% of the apically applied amount), followed by 50 nm (-P) NPs (4.0%), 50 nm 
(+) NPs (0.6%) and finally 50 nm (-M) NPs (0%). As shown in Figure 6  this order of 
translocation percentage (i.e. 50 nm (0) > 50 nm (-P) > 50 nm (+) > 50 nm (-M)) was 
similar in the tri-culture model. In the co-culture model, the presence of mucus significantly 
reduced the translocation of 50 nm (0) NPs, but ignifica tly increased the translocation 
of 50 nm (-P) compared with the mono-culture model. Incorporation of M-cells in the 
model shifted the translocation rates for both NPs closer (but still significantly different) 
to those in the Caco-2 mono-culture. Striki gly, the two types f negatively charged 50 nm 
NPs had significantly different translocation properties in all cell models, where 50 nm (-P) 
NPs translocated 210.5 x more than (-M) NPs in mono-culture, 78.3 x in co-culture and 
30 x in tri-culture. Size affected the translocatio  as well, as the translocation of neutral 
and positively charged 100 nm NPs (0.51 %, 0.46 %, 0.76 % for (0) NPs and 0.21 %, 0.46 %, 
0.51 % for (+) NPs in the mono-, co- and tri-culture models, r spectively) was much lower 
than that of their equivalent 50 nm NPs. Negatively charged 100 nm NPs translocated to a 
similar extent as their 50 nm (-M) counterparts (0.07 %, 0.19 %, 0.15 % vs 0.02 %, 0.08 %, 
0.17 %, respectively). The relative order of translocation percentage of the 100 nm NPs was 
similar to that of their corresponding 50 nm NPs (from Magsphere).
DISCUSSION
We investigated the influence of size and surface modifications of PS-NPs on their 
translocation properties in the three cell models.  Clearly, translocation was strongly 
affected by the size, with 100 nm NPs reaching up to 0.8% translocation and 50 nm NPs 
reaching up to 7.8%. Translocation was also strongly affected by the surface chemistry, most 
clearly seen in the results for the 50 nm NPs, which all translocated significantly differently, 
varying from 0 % to 7.8%. In all three cell models, the 50 nm (0) and 50 nm (-P) NPs 
translocated to the highest extent. 
It is striking that we observed such large differences between the translocation of two 
types of negatively charged 50 nm NPs, even though their size, surface charge (both in water 
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parameter influencing translocation of the NPs across the
intestinal barrier.
The types of proteins adsorbed onto all NPs were highly
comparable, while their ratios were different for different NPs,
which are illustrated by their protein band patterns. Similar
protein composition with only different protein ratios have been
shown previously in the coronas of NPs, regardless of their
surface modification (Cho et al., 2014; Jedlovszky-Hajdu et al.,
2012). The major components of the corona of tested NPs were
proteins most abundantly present in the medium as shown by
comparison of the proteins in the NP corona and those in the
DMEM+ control lane. The most prominent band on our gels had
a mass of 50–70 kDa and this was likely a combination of albumin
(72 kDa) and fibrinogen chains: gamma (50 kDa), beta
(60 kDa) and alpha (72 kDa) (Monopoli et al., 2011). The band
of 150 kDa was likely IgG (Lee et al., 2012). Albumin, IgG and
fibrinogen are the most abundant proteins in plasma (Anderson &
Anderson, 2002) and they are the main serum proteins identified
in the protein corona of NPs (Aggarwal et al., 2009; Cho et al.,
2014). Fibrinogen is known to adsorb more abundantly onto
negatively charged surfaces (Bernabeu & Caprani, 1990) and in
our gel the band 50–70 kDa was thickest in negatively charged NP
samples. Additionally, there were bands of: 90 kDa (most likely
complement factors/components or/and transferrin), 26 kDa
(most likely apolipoprotein A-1) and 12 kDa (most likely Ig
kappa chain C region) (Monopoli et al., 2011).
Conclusion
In the current study, three different intestinal in vitro cell models
were used with increasing complexity to study the translocation
properties of differently sized and charged PS-NPs. We show that
the relative pattern of NP translocation in all three used intestinal
models was similar, but the absolute amounts of translocated NPs
differed per model, significantly for 50 nm (0) and (M) NPs.
There was no coherence that one specific model had more
efficient translocation than others, because it depended on NP
type. Therefore, we conclude that for comparing the relative
translocation of different NPs, using one intestinal model would
be sufficient. However, for screening studies in a tiered risk
assessment approach, when absolute translocation values are
needed, it should be kept in mind that depending on the chosen
model, the outcomes will differ. To choose the most representa-
tive model for risk assessment, in vivo experiments are now
needed in order to assess which of the three models is most
closely reflecting the in vivo translocation.
Our results point out that size is an important metric governing
translocation. Surface charge expressed as zeta-potential could be
used, but only if determined in water. Clearly, the chemical
composition at the surface seems more important than the zeta-
potential as illustrated by the two negatively charged PS-NPs that
had comparable zeta-potential in water but different surface
chemistries. More efforts should now be devoted to relate the
chemical surface properties of NPs with the same surface charge
but different surface modification to their different biological
behaviours. Our findings suggest that ingested PS-NPs, depending
on their size and physicochemical properties, could potentially
translocate across intestinal barrier.
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and DMEM+) and relative protein composition of their coronas were similar. However, the 
corona of the (-P) NPs co tained 1.5 imes more pr tein than the (-M) NPs, therefore the 
total amount of protein in corona in this case may be a factor governing the translocation 
potential. We looked further into the surface chemical composition of these NPs. For this 
we used MALDI-TOF, which allows the characterization of surface properties of NPs. 
MALDI-TOF spectrum showed that the composition of the surface chemical groups is 
different. It has already been shown at steric shielding of the charge and st ric interaction 
of chemical groups on the surface of NPs, as well as molecular weight and density of the 
coating (Gref et al. 2000) can affect their biological responses (Bhattacharjee et al. 2013; 
Yoncheva et al. 2005) and protein corona (Gessner et al. 2003; Jedlovszky-Hajdu et al. 
Figure 6. Translocation of 50 nm (A) and 100 nm (B) PS-NPs in three cell models: mono-, co- a d 
tri-culture. (0): neutral NPs, (+): positively charged NPs, (-): negatively charged NPs; *: significantly 
different translocation within models, #: significantly different translocation between models.
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2012). Likely, the difference in the surface chemistry of these NPs caused differences in 
protein binding capacity. The differences in surface chemistry or in protein binding resulted 
in different behaviour in biological test systems.
All three NPs of 100 nm with different surface modifications also translocated 
differently. SEM analysis showed that 100 nm (-) NPs had a fraction of 34.6% of smaller 
(15-35 nm) NPs and also their hydrodynamic size in water was smaller as compared with 
the other 100 nm NPs. However, they translocated to the lowest extent. The 100 nm (0) NPs 
translocated to the highest extent, even though they had the largest hydrodynamic size in 
DMEM+. Additionally, their charge in water was in fact strongly negative. This suggests the 
influence of surface chemistry rather than charge on translocation.
The size and zeta-potential of all NPs were determined in water and in DMEM+, as used in 
the translocation studies. As expected, NPs in DMEM+ had larger hydrodynamic sizes than 
in water, which did not change significantly upon 24 h incubation. While in water charges 
of the NPs were different, they all obtained a rather equal negative charge in DMEM+. This 
shift, shown before (Cho et al. 2014; Ehrenberg et al. 2009; Fleischer and Payne 2012; Mahler 
et al. 2012; Meder et al. 2012), probably results from the protein adsorption on the NPs or 
from measuring protein aggregates of medium rather than NPs. A mucus layer as used in 
the co-and tri-culture model is an important barrier especially for charged NPs (Hussain et 
al. 2001; Lai et al. 2007; Norris et al. 1998; Szentkuti 1997). We indeed confirmed this for the 
translocation of the 50 nm (0) NPs that had a negative zeta-potential in water, but not for 
the 50 nm (-P) NPs that also had a negative zeta-potential in water. Incorporation of M-cells 
shifted the translocation rates for both NPs closer to those in the mono-culture model.
Translocation of NPs is a complex process dependent on many factors, one of them 
being the protein corona, which influences the interactions of NPs with cell membranes 
and cellular uptake (Lesniak et al. 2010; Lundqvist 2013; Tedja et al. 2012). In this study, we 
show that NPs with different surface modifications adsorbed different amounts of proteins. 
It has been shown that the protein adsorptive capacity of NPs, rather than the identity of 
bound proteins, could predict their cellular interactions and cellular uptake (Ehrenberg et 
al. 2009). In our study, the 50 nm NPs with largest amount of adsorbed protein, (0) and (-P), 
translocated to the highest extent. The difference in the amount of adsorbed protein could 
also explain the difference in translocation between 50 nm (-M) and (-P) NPs. However, 
the 50 nm (+) and 100 nm (+) NPs had much less adsorbed proteins and translocated to 
a higher extent than 50 nm (-M) and 100 nm (-) NPs. This indicates that the amount of 
protein in the corona is not the only parameter influencing translocation of the NPs across 
the intestinal barrier.
The types of proteins adsorbed onto all NPs were highly comparable, while their ratios 
were different for different NPs, which are illustrated by their protein band patterns. Similar 
protein composition with only different protein ratios have been shown previously in the 
coronas of NPs, regardless of their surface modification (Cho et al. 2014; Jedlovszky-
Hajdu et al. 2012). The major components of the corona of tested NPs were proteins most 
abundantly present in the medium as shown by comparison of the proteins in the NP 
corona and those in the DMEM+ control lane. The most prominent band on our gels had 
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a mass of 50-70 kDa and this was likely a combination of albumin (72 kDa) and fibrinogen 
chains: gamma (50 kDa), beta (60 kDa) and alpha (72 kDa) (Monopoli et al. 2011). The 
band of ~150 kDa was likely IgG (Lee et al. 2012). Albumin, IgG and fibrinogen are the 
most abundant proteins in plasma (Anderson and Anderson 2002) and they are the main 
serum proteins identified in the protein corona of NPs (Aggarwal et al. 2009; Cho et al. 
2014). Fibrinogen is known to adsorb more abundantly onto negatively charged surfaces 
(Bernabeu and Caprani 1990) and in our gel the band 50-70 kDa was thickest in negatively 
charged NP samples. Additionally, there were bands of: ~90 kDa (most likely complement 
factors/components or/and transferrin), ~26 kDa (most likely apolipoprotein A-1) and 
~12 kDa (most likely Ig kappa chain C region) (Monopoli et al. 2011).
CONCLUSION
In the current study, three different intestinal in vitro cell models were used with increasing 
complexity to study the translocation properties of differently sized and charged PS-NPs. 
We show that the relative pattern of NP translocation in all three used intestinal models 
was similar, but the absolute amounts of translocated NPs differed per model, significantly 
for 50 nm (0) and (-M) NPs. There was no coherence that one specific model had more 
efficient translocation than others, because it depended on NP type. Therefore, we conclude 
that for comparing the relative translocation of different NPs, using one intestinal model 
would be sufficient. However, for screening studies in a tiered risk assessment approach, 
when absolute translocation values are needed, it should be kept in mind that depending 
on the chosen model, the outcomes will differ. To choose the most representative model for 
risk assessment, in vivo experiments are now needed in order to assess which of the three 
models is most closely reflecting the in vivo translocation. 
Our results point out that size is an important metric governing translocation. Surface 
charge expressed as zeta-potential could be used, but only if determined in water. Clearly, 
the chemical composition at the surface seems more important than the zeta-potential 
as illustrated by the two negatively charged PS-NPs that had comparable zeta-potential 
in water but different surface chemistries. More efforts should now be devoted to relate 
the chemical surface properties of NPs with the same surface charge but different surface 
modification to their different biological behaviours. Our findings suggest that ingested 
PS-NPs, depending on their size and physicochemical properties, could potentially 
translocate across intestinal barrier. 
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Figure S1. Size distributions [nm] of PS-NPs in water at t=0 h, as determined by SEM. (0): 
neutral NPs, (+): positively charged NPs, (-): negatively charged NPs.   
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ABSTRACT
The conditions of the gastrointestinal tract may change the physicochemical 
properties of nanoparticles (NPs) and therewith the bioavailability of orally taken 
NPs. Therefore, we assessed the impact of in vitro gastrointestinal digestion on the 
protein corona of polystyrene NPs (PS-NPs) and their subsequent translocation across 
an in vitro intestinal barrier. A co-culture of intestinal Caco-2 and HT29-MTX cells 
was exposed to 50 nm PS-NPs of different charges (“neutral”, positive and negative) 
in two forms: pristine and digested in an in vitro gastrointestinal digestion model. In 
vitro digestion significantly increased the translocation of all, except the “neutral”, 
PS-NPs. Upon in vitro digestion, translocation was 4-fold higher for positively 
charged NPs and 80- and 1.7-fold higher for two types of negatively charged NPs. 
Digestion significantly reduced the amount of protein in the corona of three out of 
four types of  NPs. This reduction of proteins was 4.8-fold for “neutral”, 3.5-fold for 
positively charged and 1.8-fold for one type of negatively charged PS-NPs. In vitro 
digestion also affected the composition of the protein corona of PS-NPs by decreasing 
the presence of higher molecular weight proteins and shifting the protein content of 
the corona to low molecular weight proteins. These findings are the first to report 
that in vitro gastrointestinal digestion significantly affects the protein corona and 
significantly increases the in vitro translocation of differently charged PS-NPs. These 
findings stress the importance of including the in vitro digestion in future in vitro 
intestinal translocation screening studies for risk assessment of orally taken NPs.    
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INTRODUCTION
Nanotechnology develops rapidly and the number of consumer products containing 
nanoparticles (NPs) is constantly growing. Consumer oral exposure to NPs through some 
of these products (e.g. lipsticks, toothpaste, food packaging materials, food additives, juice 
clarifiers, health supplements) is likely [1, 2]. Currently, the safety evaluation of NPs still 
relies mainly on animal studies and there is a high societal demand to develop alternative 
in vitro methods to reduce animal studies. A combination of alternative in vitro methods 
should lead to development of a tiered safety assessment approach [3]. For this, in vitro 
models of intestinal epithelium have been evaluated using model NPs like polystyrene 
NPs (PS-NPs). Several in vitro studies report translocation of PS-NPs across the intestinal 
barrier [4-7]. However, so far these studies did not consider the effects of the different 
physicochemical environments in the digestive tract on NP behaviour. Critical factors 
in the gastrointestinal tract include dynamics of pH and ionic strength. These factors are 
known to affect the physicochemical characteristics of NPs [8, 9] and this has also been 
observed during in vitro gastrointestinal digestion of NPs [10-13]. 
The ultimate metrics that drive NP translocation have not been established yet, but 
important characteristics that determine the translocation are size, charge and surface 
modifications [7, 14-17]. Upon contact with biological fluids, NPs immediately get coated 
with biomolecules like proteins forming a protein corona [18-21], of which the amount 
and composition determine the translocation [22, 23]. A direct  correlation between 
different surface modifications of NPs and the amount and type of proteins in the corona 
has also been shown [7, 24, 25]. While it is unlikely that the digestive enzymes present 
in the in vitro digestion model affect the NPs themselves, it can be expected that these 
enzymes do affect the protein corona of the NPs. However, the effect of gastrointestinal 
digestion on the protein corona composition of NPs and the consequences of this 
digestion on their subsequent translocation across the epithelial intestinal barrier have 
not been studied so far. 
In this study, we aimed to assess the effect of in vitro gastrointestinal digestion on the 
protein corona of NPs and their subsequent translocation across an in vitro intestinal 
barrier. PS-NPs were selected for this study because of their stability and availability in a 
wide range of surface modifications. Different charges (“neutral”, positive and negative), but 
also different surface modifications (i.e. two types of negatively charged PS-NPs from two 
different suppliers) were used for comparison. The combination of in vitro gastrointestinal 
digestion with in vitro intestinal translocation should give a more complete in vitro model 
for prediction of bioavailability of orally administered NPs. 
MATERIALS AND METHODS
NPs and chemicals 
“Neutral”, amine- and carboxyl-modified 50 nm PS-NPs (referred to as 50 nm (“0”), 
50 nm (+), 50 nm (-M)) with a red fluorophore core (Ex/Em: 530/590) were purchased 
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from Magsphere (Pasadena, CA, USA). Carboxyl-modified 50 nm PS-NPs (referred to 
as 50 nm (-P)) with a yellow-green fluorophore core (Ex/Em: 485/530) were purchased 
from Polysciences (Warrington, Pennsylvania, USA). The mass concentration of all stock 
solutions was 2.5 %. Throughout the paper we have chosen to use the manufacturer 
indication to identify the different types of nanoparticles in the text.
For the preparation of artificial digestive juices for in vitro digestion (fed model variant) 
[26] all chemicals were obtained from Merck (Darmstadt, Germany), except for NaCl, 
which was obtained from VWR (Leuven, Belgium), uric acid from Alfa Aesar (Karlsruhe, 
Germany), glucosaminehydrochloride from Calbiochem (Darmstadt, Germany), mucin 
from Roth (Karlsruhe, Germany) and lipase, bile, MgCl2∙6H2O, glucuronic acid and amylase 
from Sigma (Steinbach, Germany). The constituents and concentrations of the digestive 
juices were as described before [10].  
NP characterization
PS-NP morphology, size and surface charge were characterized with scanning electron 
microscopy (SEM), dynamic light scattering (DLS) and zeta-potential measurements. 
In addition, the adsorbed protein corona was analysed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) following its desorption from the PS-NPs, 
performed as described hereafter.
SEM analysis was performed using a high resolution field emission gun (FEG)SEM 
(Tescan MIRA-LMH FEG-SEM; Tescan, Brno, Czech Republic). Samples were prepared by 
depositing 20 μl of a 20 µg/ml NP suspension in water onto a nickel-coated polycarbonate 
filter which was left to dry completely and then coated with a 5 nm layer of chromium. Size 
distributions were determined using Scandium SIS image analysis software (Olympus Soft 
Imaging Solutions GmbH, Germany). Th e mean diameter ± SD of 80-600 particles is given.
DLS measurements were performed as previously described [10]. The zeta-potential 
was measured using a Malvern Zetasizer 2000 (Malvern Instruments, UK). Each sample 
was measured in 5 runs, 1.5 minutes each. For DLS and zeta-potential measurements, 
100 µg/ml NP suspensions in water or cell culture medium were used. All samples were 
analysed in triplicate and the results are presented as the mean ± SD.
Digestion of PS-NPs
Four types of 50 nm PS-NPs with different surface modifications were subjected to the in 
vitro human gastrointestinal digestion model. Deionized water, not containing any NPs, was 
used as a negative control. Briefly, all digestive juices were prepared as described before [10] 
and heated to 37°C. The digestion started by adding 0.25 ml of deionized water or 25 mg/ml 
PS-NPs to 1 ml of saliva (pH=6.8 ± 0.1). The mixture was incubated for 5 min at 37 ± 2°C, 
rotating head-over-heels at 55 rpm, simulating peristaltic movements. Subsequently, 2 ml 
of gastric juice (pH=1.3) was added to the mixture and the pH of the sample was checked 
and, if necessary, adjusted to 2.5 ± 0.5 with NaOH (1M) or HCl (37%). The sample was 
further incubated rotating at 37°C for 2 h. Subsequently, 2 ml of duodenal juice (pH=8.1) 
and 1 ml of bile (pH=8.2) were added. This complete mixture of digestive juices is referred 
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to as chyme hereafter. The pH of this mixture was set at 6.5 ± 0.5 with NaOH (1M) or HCl 
(37%) and it was rotated head-over-heels for another 2 h. 
Absence of detectable leakage of the fluorescent dye from the used PS-NPs was shown 
upon digestion. For this, PS-NPs were incubated in the gastric juice for 2 hrs at 37°C, after 
which the suspensions were brought to neutral pH. Subsequently, suspensions at 250 µg/ml 
were centrifuged (30 min, 3000 g, 20°C) in filter tubes (Amicon Ultra-4 3kDa Ultracel-
PL memb 24/Pk; Millipore BV, Netherlands) to remove the PS-NPs and the filtrates were 
measured for fluorescence. 
Cell model
The human colonic adenocarcinoma (Caco-2) cell line was obtained from the American 
Type Culture Collection and was used in all experiments at passage numbers 29-38. The 
HT29-MTX (human colon adenocarcinoma mucus secreting) cell line was obtained from 
the European Collection of Cell Cultures and was used at passages 20-29. Cells were cultured 
in Dulbecco’s Modified Eagle Medium (DMEM) (Lonza) without phenol red, supplemented 
with 10% heat-inactivated fetal bovine serum (FBS) (Gibco), 1% penicillin-streptomycin 
(Sigma), 1% MEM non-essential amino acids (Gibco) and 1% GlutaMAX (Gibco). The 
complete medium is further referred to as DMEM+. The medium was changed every 
2-3 days and cells were subcultured upon reaching 80% confluence. 
For the translocation experiments, cells were seeded at a density of 40 000 cells per cm2 in 
Transwell polyester inserts (3 µm pore size, 1.12 cm2 surface area, Corning, Amsterdam, The 
Netherlands), at ratio 3:1 Caco-2/HT29-MTX. Cells were used for experiments on day 21. 
Cytotoxicity of PS-NPs
For the cytotoxicity test, Caco-2 and HT29-MTX cells in ratio 3:1 were seeded in 96-well 
plate at the concentration of 105 cells/ml in DMEM+ (100 µl/well) and were incubated at 
37°C for 24 h. Then, PS-NPs were added to the wells (100 µl/well) to achieve the desired 
concentrations at the total volume of 200 µl/well. PS-NPs in pristine form were suspended 
in DMEM+, and PS-NPs in digested form in chyme, as appearing after digestion, were 
diluted 4 x with DMEM+ to keep the chyme concentration at the non-cytotoxic level (based 
on previous experiments done in our group, data not shown). After 24 h of exposure at 37°C, 
10 µl WST-1 reagent (Roche Diagnostics GmbH, Germany) was added to each well and the 
plates were shaken for 1 min. After subsequent 2 h incubation at 37°C, the absorbance was 
measured at 440 nm with a plate reader and the background absorbance at 690 nm was 
subtracted. Viability for each concentration of PS-NPs was expressed as a percentage of the 
control. DMEM+ was used as a negative control for pristine PS-NPs, and chyme/DMEM+ 
(1:3) was used as a negative control for digested PS-NPs. Triton-X100 (0.25%) (Sigma) was 
used as a positive control and decreased the viability to 7.1 ± 0.5 %. 
Assessment of cell barrier integrity upon exposure to PS-NPs 
The integrity of the cell barrier in the in vitro cell model was assessed before and after 
exposure to PS-NPs by measuring the TEER (transepithelial electrical resistance) values 
with a chopstick-like STX01 electrode connected to a Millicell ERS-2 Epithelial Volt- Ohm 
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Meter (Millipore, Bedford, MA). After each cell culture medium refreshment, cells were 
allowed to equilibrate for 30 min at 37°C before TEER measurements were performed. Only 
the inserts with initial TEER values above 200 Ω*cm2 were used in experiments. Cell layer 
integrity directly after exposure to PS-NPs was additionally evaluated with Lucifer Yellow. 
To this end, Lucifer Yellow at a concentration of 1 mg/ml in DMEM+ was added apically 
to the cells (500 µl/insert) and after 1 h incubation at 37°C, the basolateral medium was 
collected and analysed for fluorescence at 485/530 nm.
Assessment of the protein corona of PS-NPs
The 50 nm PS-NPs at a concentration of 1.66 mg/ml were incubated in cell culture medium 
for 24 h at 37°C [22]. Subsequently, to remove non-firmly bound proteins, the samples were 
washed three times by centrifugation (18000 g, 15°C, 40 min), re-suspension of the pellet 
in 1 ml PBS (Gibco; Bleiswijk, The Netherlands) and each time transferring to a new tube. 
The final pellet was re-suspended in a loading buffer (Laemmli Sample Buffer, BIO-RAD; 
Veenendaal, The Netherlands) containing β-mercaptoethanol (Sigma). The samples were 
boiled for 5 min and the centrifugation step was repeated once more to separate the PS-NPs 
from proteins desorbed from their surface. The total protein content in the samples was 
measured with RC DC Protein Assay (BIO-RAD). Briefly, 62.5 µl reagent I was added 
to 12.5 μl sample and incubated for 1 min at room temperature. Subsequently, 62.5 µl of 
reagent II was added and tubes were centrifuged at 15000 x g for 4 min. Supernatant was 
discarded, liquid drained from the tubes, and 63.5 µl reagent A was added and incubated for 
5 min, followed by adding 500 µl reagent B, vortexing and incubation for 15 min at room 
temperature before measurement of absorbance at 750 nm. The absorbance was converted 
into protein concentration based on a standard curve of BSA that was included in each 
experiment. All experiments were conducted in triplicate for each treatment and repeated 
at least twice. As controls, DMEM+ and chyme/DMEM+ (nonincubated) were used. The 
reported amounts of protein in the coronas are obtained after subtraction of the values 
obtained for washed controls: DMEM+ washed (cell culture medium) for pristine PS-NPs 
and chyme/DMEM+ washed (chyme diluted with the cell culture medium) for digested 
PS-NPs. The amounts of protein are presented as an average ± standard error of the mean.
Protein containing supernatant was then loaded onto an SDS-PAGE gel. Each lane 
with NP samples, both pristine and digested, contained an equal amount of protein. One-
dimensional polyacrylamide gel electrophoresis was performed at 90 V for about 80 min 
on 12% polyacrylamide gels of 1 mm thickness (Mini-PROTEAN TGX Gels, BIO-RAD). 
A protein ladder of 10-250 kDa was included in each gel (Precision Plus Protein Dual 
Color Standards, BIO-RAD). The gels were washed in 40% methanol in water containing 
10% acetic acid for 15 min and were subsequently stained with Bio-Safe Coomassie Stain 
G-250 (BIO-RAD) for 1.5 hrs. Afterwards, the gels were destained by extensive washing in 
distilled water.
The experiments were repeated three times with comparable results. The gels were 
scanned (Odyssey, Li-cor ISO 9001) and gel densitometry was performed using the Odyssey 
software (Li-cor Biosciences).  
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PS-NP in vitro translocation experiments
For the translocation studies, pristine and digested PS-NPs were used. Pristine (stock) 
PS-NPs were suspended in DMEM+ at a concentration of 250 µg/ml. The NPs-chyme 
suspensions directly after the in vitro digestion were suspended in DMEM+ in a 1:3 ratio 
(at 250 µg/ml). These suspensions were directly applied apically on cells (500 µl/insert), 
at day 21 of culture. After 24 h of exposure, the basolateral medium was collected and 
fluorescence was measured with a Synergy HT Multi-Detection Microplate Reader (Biotek 
Instruments Inc., Winooski, VT, USA) at excitation/emission wavelengths of 530/590 nm 
and 485/530 nm, for red and yellow-green PS-NPs, respectively. The obtained values were 
converted into NP concentrations, based on a concentration standard calibration curve 
included in each experiment. 
All experiments were conducted in triplicate for each treatment and repeated twice. 
The reported percentages of translocation are the NP amounts in basolateral samples 
divided by the NP amounts to which cells were exposed in the apical chamber. The results 
of translocation are presented as an average ± standard error of the mean.
Statistics
Data were analysed with Prism software (v5.02; GraphPad Software, Inc., La Jolla, USA). A 
one-way analysis of variance ANOVA test and post hoc Tukey test were used to determine 
significant differences between the groups. Groups were considered significantly different 
when p<0.05. 
RESULTS
NP characterization
PS-NPs with different surface modifications were characterized in water using SEM. The 
spherical shape of the PS-NPs was confirmed (Figure 1). All types of 50 nm PS-NPs had 
similar size distributions with an average size of 31.6 - 35.0 nm, except for the 50 nm (+) 
NPs, which had a larger average size of 50.6 nm (Figure 1 and Table 1). 
The hydrodynamic diameters of the PS-NPs were characterized in water and DMEM+ using 
DLS. In water the PS-NPs were monodispersed as indicated by their polydispersity indices (Table 
1) and their hydrodynamic diameters ranged from 52.4 to 56.2 nm. In DMEM+ at t=0 h (each 
measurement takes 5 minutes) hydrodynamic diameters were in all cases significantly larger 
than in water, ranging from 114.9 to 187.6 nm (Table 1). Incubation of the PS-NPs for 24 h in 
DMEM+ did not significantly affect the hydrodynamic sizes compared to t=0 h (Table 1).
The zeta-potential measurements of the 50 nm (+) and 50 nm (-) NPs in water 
confirmed their positive and negative charges (Table 1). The two types of negatively charged 
50 nm PS-NPs (-M and –P) had the same zeta-potential (i.e. -27.7 and -27.8mV), while the 
zeta-potential of the positively charged PS-NPs was 26.6 mV. The “neutral” PS-NPs had a 
negative charge of -26.0 mV in water. The initially different charges of PS-NPs in water all 
converted into rather equal negative charges after suspension in DMEM+ (ranging from 
-9.4 mV to -13.3 mV) and did not significantly change after 24 h (Table 1).
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Cytotoxicity of PS-NPs
To determine if in vitro digestion affects PS-NP toxicity, a WST-1 viability assay was used on 
a proliferating co-cultured Caco-2 and HT29-MTX cells. “neutral” PS-NPs, in both pristine 
and digested form, did not affect the cell viability up to a concentration of 250 µg/ml (Fig. 2). 
Negatively charged PS-NPs (both –M and –P) in pristine form did not affect the cell viability 
up to a concentration of 125 µg/ml, while at 250 µg/ml the viability decreased to 86 ± 5% (–M) 
and 81 ± 5% (-P). In digested form the negatively charged NPs did not affect the cell viability 
up to 250 µg/ml. Positively charged PS-NPs, both pristine and digested, showed significant 
cytotoxicity, starting at a concentration of 25 µg/ml and 50 µg/ml, respectively. Both pristine 
and digested positively charged NPs reduced the cell viability to 7% at 250 µg/ml. 
Assessment of cell barrier integrity upon exposure to PS-NPs 
In this study we used a co-culture cell model (Caco-2 and HT29-MTX cells) in a transwell 
design. In this model cells are covered with mucus, as shown in our previous study [7]. The 
TEER value was measured during culture to monitor confluency and cell layer integrity. 
TEER values increased over the first days after seeding and then remained at a constant 
level (>200 Ω*cm2) until day 21, as reported previously [27]. Additionally, the TEER values 
were measured after exposure of the cell layers to 250 μg/ml of PS-NPs for 24 h. As shown in 
Figure 3, the TEER value of exposed cell layers was not significantly affected compared to the 
non-exposed controls (DMEM+ and chyme/DMEM+) with exception of digested 50 nm (+) 
NPs that significantly decreased the TEER to 71.2% of that of the non-exposed cell control. 
54 
 
Figure 1. Scanning electron micrographs of PS-NPs in water: A) 50 nm (“0”), B) 50 nm (+), C) 50 nm 
(-M), D) 50 nm (-P). Magnification 100.000 x. The bar indicates 500 nm.  
Cytotoxicity of PS-NPs 
To determine if in vitro digestion affects PS-NP toxicity, a WST-1 viability assay was used on 
a proliferating co-cultured Caco-2 and HT29-MTX cells. “neutral” PS-NPs, in both pristine 
and digested form, did not affect the cell viability up to a concentration of 250 µg/ml (Fig. 2). 
Negatively charged PS-NPs (both –M and –P) in pristine form did not affect the cell viability 
up to a concentration of 125 µg/ml, while at 250 µg/ml the viability decreased to 86 ± 5% (–
M) and 81 ± 5% (-P). In digested form the negatively charged NPs did not affect the cell 
viability up to 250 µg/ml. Positively charged PS-NPs, both pristine and digested, showed 
significant cytotoxicity, starting at a concentration of 25 µg/ml and 50 µg/ml, respectively. 
Both pristine and digested positively charged NPs reduced the cell viability to 7% at 250 
µg/ml. 
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Figure 1. Scanning electron micrographs of PS-NPs in water: A) 50 nm (“0”), B) 50 nm (+), C) 50 nm 
(-M), D) 50 nm (-P). Magnification 100.000 x. The bar indicates 500 nm. 
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Figure 2. Effect on cell viability of a co-culture of Caco-2 and HT29-MTX cells upon exposure to 50 
nm PS-NPs for 24 h. Abbreviations: (“0”): “neutral”  PS-NPs, (+): positively charged PS-NPs, (-M
and -P): negatively charged PS-NPs, dig: digested samples. Error bars show the standard error of mean 
(n=3). *: significant difference between the pristine and digested form of the same PS-NPs; #: 
significant difference with all other pristine PS-NPs; &: significant difference with all other digested 
PS-NPs. n=3.  
Assessment of cell barrier integrity upon exposure to PS-NPs  
In this study we used a co-culture cell model (Caco-2 and HT29-MTX cells) in a transwell 
design. In this model cells are covered with mucus, as shown in our previous study [7]. The 
TEER value was measured during culture to monitor confluency and cell layer integrity. 
TEER values increased over the first days after seeding and then remained at a constant level 
(>200 Ω*cm2) until day 21, as reported previously [27]. Additionally, the TEER values were 
measured after exposure of the cell layers to 250 μg/ml of PS-NPs for 24 h. As shown in 
Figure 3, the TEER value of exposed cell layers was not significantly affected compared to 
the non-exposed controls (DMEM+ and chyme/DMEM+) with exception of digested 50 nm 
(+) NPs that significantly decreased the TEER to 71.2% of that of the non-exposed cell 
control. 
* # 
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* # 
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Figure 2. Effect on cell viability of a co-culture of Caco-2 and HT29-MTX cells upon exposure to 
50 nm PS-NPs for 24 h. Abbreviations: (“0”): “neutral”  PS-NPs, (+): positively charged PS-NPs, (-M 
and -P): negatively charged PS-NPs, dig: digested samples. Error bars show the standard error of 
mean (n=3). *: significant difference between the pristine and digested form of the same PS-NPs; #: 
significant differe ce with all other pristin  PS-NPs; &: significant difference with all other digested 
PS-NPs. n=3. 
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Figure 3. TEER values in a co-culture of Caco-2 and HT29-MTX cells upon exposure to pristine and 
digested 50 nm PS-NPs at 250 μg/ml for 24 h, as a percentage of the negative control (DMEM+). 
Abbreviations: (“0”): “neutral”  PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively 
charged PS-NPs; dig: digested samples. *Significantly different from the chyme/DMEM+ control 
(n=3). 
Cell barrier integrity after exposure to PS-NPs was additionally assessed by 
translocation studies using Lucifer Yellow. As shown in Figure 4, Lucifer Yellow 
permeability, after exposure to pristine and digested PS-NPs at 250 μg/ml for 24 h, was not 
significantly affected compared to the DMEM+ and chyme/DMEM+ controls (3.3% and 
2.5% permeability, respectively) and stayed in the range of 2.8 to 6.3% for all PS-NPs except 
for the digested 50 nm (+) NPs, for which the permeability reached 11.7%, which was 
significantly higher than the controls and than the other digested NP samples (p<0.001), but 
not significantly higher than the non-digested 50 nm (+) NPs (p=0.06).    
Figure 3. TEER values in a co-c lture of Caco-2 and HT29-MTX cells upon exposure to pristine 
and digested 50 nm PS-NPs at 250 μg/ml for 24 h, as a percentage of the negative control (DMEM+). 
Abbreviations: (“0”): “neutral”  PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively 
charged PS-NPs; dig: digested samples. *Significantly different from the chyme/DMEM+ control 
(n=3).
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Cell barrier integrity after exposure to PS-NPs was additionally assessed by translocation 
studies using Lucifer Yellow. As shown in Figure 4, Lucifer Yellow permeability, after 
exposure to pristine and digested PS-NPs at 250 μg/ml for 24 h, was not significantly affected 
compared to the DMEM+ and chyme/DMEM+ controls (3.3% and 2.5% permeability, 
respectively) and stayed in the range of 2.8 to 6.3% for all PS-NPs except for the digested 
50 nm (+) NPs, for which the permeability reached 11.7%, which was significantly higher 
than the controls and than the other digested NP samples (p<0.001), but not significantly 
higher than the non-digested 50 nm (+) NPs (p=0.06).   
Assessment of the protein corona of PS-NPs
To assess the proteins adsorbed onto the PS-NPs, we extracted the protein corona from all 
4 types of PS-NPs, both pristine and digested, which were incubated in DMEM+ for 24 h 
at 37°C. A control DMEM+ sample treated similarly as the PS-NP samples contained only 
very low amount of total protein (0.03 µg/µl; data not shown), confirming that the proteins 
shown for pristine PS-NPs are only the proteins of the NP protein corona. A control chyme/
DMEM+ sample treated similarly as the PS-NP samples contained an average total protein 
amount of 0.3 µg/µl (data not shown), indicating that some of the proteins in the digested 
samples did not originate from the protein coronas of the PS-NPs. In order to correct 
for this, the amount of protein in this control sample was subtracted from the measured 
amounts of protein in the digested NP samples, which is presented in Figure 5. 
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Figure 4. Translocation of Lucifer Yellow across a co-culture of Caco-2 and HT29-MTX cells upon 
exposure to pristine and digested 50 nm PS-NPs at 250 μg/ml for 24 h. Abbreviations: (“0”): “neutral”  
PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested 
samples. *Significantly different from the chyme/DMEM+ control (n=3); #Significantly different 
from 50 nm (+) dig. NPs.  
 
Assessment of the protein corona of PS-NPs 
To assess the proteins adsorbed onto the PS-NPs, we extracted the protein corona from all 4 
types of PS-NPs, both pristine and digested, which were incubated in DMEM+ for 24 h at 
37°C. A control DMEM+ sample treated similarly as the PS-NP samples contained only very 
low amount of total protein (0.03 µg/µl; data not shown), confirming that the proteins shown 
for pristine PS-NPs are only the proteins of the NP protein corona. A control chyme/DMEM+ 
sample treated similarly as the PS-NP samples contained an average total protein amount of 
0.3 µg/µl (data not shown), indicating that some of the proteins in the digested samples did 
not originate from the protein coronas of the PS-NPs. In order to correct for this, the amount 
of protein in this control sample was subtracted from the measured amounts of protein in the 
digested NP samples, which is presented in Figure 5.  
Figure 4. Translocation of Lucifer Yellow across a co-culture of Caco-2 and HT29-MTX cells upon 
exposure to pristine and digested 50 nm PS-NPs at 250 μg/ml for 24 h. Abbreviations: (“0”): “neutral” 
PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested 
samples. *Significantly different from the chyme/DMEM+ control (n=3); #Significantly different from 
50 nm (+) dig. NPs. 
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As shown in Figure 5, differences in surface chemistry resulted in different amounts 
of proteins in the protein corona of pristine PS-NPs in the following order: 2.3 µg/µl (-P) 
> 1.9 µg/µl (“0”) > 1.4 µg/µl (-M) > 0.7 µg/µl (+). Also the coronas of different digested 
PS-NPs contained different amounts of protein: 1.3 µg/µl (-P) > 1.0 µg/µl (-M) > 0.4 µg/µl 
(“0”) > 0.2 µg/µl (+). All digested PS-NPs had less adsorbed protein than their pristine 
equivalents, which reached significance for (“0”) (p=0.01), (+) (p<0.02) and (-P) (p=0.02) 
NPs. The corona of the (-P) NPs contained more protein than that of (–M) NPs, both in 
pristine (1.6 x more) and digested (1.3 x more) form. 
Figure 6A shows the SDS-PAGE gel loaded with samples normalized on the total 
protein content and it reveals minor differences in the types of adsorbed proteins between 
different pristine PS-NPs. However, the protein patterns between the pristine PS-NPs and 
their digested equivalents are very different. The band at 50-70 kDa, which is very thick 
and dominating in the pristine PS-NP samples, is much weaker and less dominant in the 
digested PS-NP samples. Figure 6B shows the comparison of the band intensity profiles 
between pristine and digested form of equivalent PS-NPs. It clearly demonstrates a strong 
decrease of the protein band at 50-70 kDa in all digested PS-NPs compared to their pristine 
equivalents and the appearance of a thick band at ~12 kDa, which is absent in pristine 
PS-NP samples. Proteins of ~12 kDa were also found in the chyme/DMEM+ control 
sample, though the band was weaker than in the NP samples. Compared to the chyme/
DMEM+ washed control sample, digested NP samples contained the same bands, however 
their intensity was stronger, and all NP samples also contained additional bands, of which 
the band at ~18 kDa (in -M and -P NPs) and the band at ~45 kDa (in -M, -P and “0” NPs) 
were most pronounced. The band at ~45 kDa was the only band which made the chyme/
Figure 5. Total protein content [µg/µl] in samples of the protein corona desorbed from the surface of 
pristine and digested 50 nm PS-NPs incubated in DMEM+ for 24 h. Abbreviations: (“0”): “neutral” 
PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested 
samples. *Significant difference between the pristine and digested form of the same PS-NPs (n=3).
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Figure 5. Total protein content [µg/µl] in samples of the protein corona desorbed from the surface of 
pristine and digested 50 nm PS-NPs incubated in DMEM+ for 24 h. Abbreviations: (“0”): “neutral”  
PS-NPs, (+): positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested 
samples. *Significant difference between the pristine and digested form of the same PS-NPs (n=3). 
As shown in Figure 5, differences in surface chemistry resulted in different amounts of 
proteins in the protein corona of pristine PS-NPs in the following order: 2.3 µg/µl (-P) > 1.9 
µg/µl (“0”) > 1.4 µg/µl (-M) > 0.7 µg/µl (+). Also the coronas of different digested PS-NPs 
contained different amounts of protein: 1.3 µg/µl (-P) > 1.0 µg/µl (-M) > 0.4 µg/µl (“0”) > 0.2 
µg/µl (+). All digested PS-NPs had less adsorbed protein than their pristine equivalents, 
which reached significance for (“0”) (p=0.01), (+) (p<0.02) and (-P) (p=0.02) NPs. The 
corona of the (-P) NPs contained more protein than that of (–M) NPs, both in pristine (1.6 x
more) and digested (1.3 x more) form.
Figur  6A shows the SDS-PAGE gel loaded ith samples normalized on the total 
protein content and it reveals minor differences in the types of adsorbed proteins between 
different pristine PS-NPs. However, the protein patterns between the pristine PS-NPs and 
their digested equivalents are very different. The band at 50-70 kDa, which is very thick and 
dominating i  the pris ine PS-NP samples, is much weaker a d less dominant in the digested
PS-NP samples. Figure 6B shows the comparison of the band intensity profiles between 
pristine and digested form of equivalent PS-NPs. It clearly demonstrates a strong decrease of 
the protein band at 50-70 kDa in all digested PS-NPs compared to their pristine equivalents 
and the appe rance of a thick band t ~12 kDa, which is absent in pristine PS-NP samples.
* 
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Figure 6. A) SDS-PAGE showing the protein pattern of the corona of pristine and digested 50 nm 
PS-NPs. NP samples were normalized on the total protein amount (11 µg). The molecular weights of the 
proteins in the standard ladder are given on the left side. The sample order is indicated above the lanes. 
Abbreviations: DMEM+: medium control (11 µg protein); Chyme/DMEM+: chyme/medium control 
(11 µg protein); DMEM+ washed (0.9 µg protein) and Chyme+DMEM+ washed (7 µg protein): samples 
processed in the same way as NP samples. Arrows indicate bands typical for digested NPs (as explained 
in the text). B) Profiles of band intensities of PS-NPs: pristine (green) and digested (red). 
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DMEM+ sample different from the DMEM+ sample, indicating that the protein of this 
molecular weight was typical for the chyme. High molecular weight proteins (>250 kDa), 
present in pristine (+) and (-M) NPs, were absent after digestion. Digested samples resulted 
in more smeary lanes than pristine samples. While there was a substantial difference 
between samples of pristine PS-NPs and digested PS-NPs, all digested PS-NP samples were 
not much different between one another regarding the types of adsorbed proteins, and they 
differed only regarding the ratios of these component proteins. 
PS-NP in vitro translocation experiments
The co-culture model of Caco-2 and HT29-MTX cells was exposed to four types of 50 nm 
PS-NPs at 250 μg/ml for 24 h, each NP in pristine and digested form. As shown in Figure 7, 
without digestion the (“0”) and (-P) NPs had the highest translocation rate (7.4 and 7.2% of 
the applied dose, respectively), while the translocation rate of the (+) NPs (1.2%; p<0.001) 
and (-M) NPs (0.02%; p<0.001) was much lower. Digestion increased the translocation 
of all PS-NPs, from 7.4 to 9.1% for the (“0”) PS-NPs (not significant), and significantly 
from 1.2 to 4.8% (p=0.02), 0.02 to 1.6% (p<0.001) and 7.2 to 12.3% (p=0.03), for the (+), 
(-M) and (-P) PS-NPs, respectively. Translocation between different types of digested 
PS-NPs was significantly (p<0.05) different for all PS-NPs, with the exception of (“0” dig.) 
and (-P dig.) PS-NPs (p=0.06). Remarkably, the two types of negatively charged PS-NPs 
showed a completely different translocation behaviour in both pristine and digested form, 
where translocation of the pristine and digested 50 nm (-P) NPs was 360x and 7.7x higher 
respectively  than that of the (-M) NPs.
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Figure 7. Translocation of pristine and digested 50 nm PS-NPs across a co-culture of Caco-2 and 
HT29-MTX cells upon exposure at 250 μg/ml for 24 h. Abbreviations: (“0”): “neutral”  PS-NPs, (+): 
positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested PS-NPs; n.d.: not 
detectable. *Significant difference between the pristine and digested form of the same PS-NPs (n=3). 
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The aim of this study was to assess the impact of in vitro gastrointestinal digestion on in vitro
intestinal translocation of iffer ntly charged 50 nm PS-NPs. To this end, PS-NPs with four 
different surface modifications were studied in an in vitro gastrointestinal digestion model 
coupled to an in vitro intestinal barrier model consisting of Caco-2 and HT29-MTX cells. In
vitro digestion significantly increased translocation of  (+), (-M) and (-P) NPs 4-, 80- and 1.7-
fold, respectively. One type of negatively charged PS-NPs (-P) translocated significantly 
more than the other type of negatively charged (-M) PS-NPs in both pristine (as also 
previously reported [7]) (360x), and digested form (7.7x). Interestingly, (-M) NPs, which 
almost did not translocate at all in pristine form (0.02% of the applied amount), translocated 
at 1.6% of applied amount in digested form.  
 We determined the translocation of differently charged pristine and digested PS-NPs 
after 24 h of exposure. The integrity of the co-culture cell layer following exposure was 
evaluated to ensure the validity of presented results. “Neutral” and negatively charged NPs, 
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* 
Figure 7. Translocation of p istine nd digested 50 nm PS-NPs across a co-culture of Caco-2 and 
HT29-MTX cells upon exposure at 250 μg/ml for 24 h. Abbreviations: (“0”): “neutral”  PS-NPs, (+): 
positively charged PS-NPs, (-M and -P): negatively charged PS-NPs; dig: digested PS-NPs; n.d.: not 
detectable. *Significant difference between the pristine and di ested form of the same PS-NPs (n=3).
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DISCUSSION
The aim of this study was to assess the impact of in vitro gastrointestinal digestion on in 
vitro intestinal translocation of differently charged 50 nm PS-NPs. To this end, PS-NPs with 
four different surface modifications were studied in an in vitro gastrointestinal digestion 
model coupled to an in vitro intestinal barrier model consisting of Caco-2 and HT29-MTX 
cells. In vitro digestion significantly increased translocation of  (+), (-M) and (-P) NPs 4-, 
80- and 1.7-fold, respectively. One type of negatively charged PS-NPs (-P) translocated 
significantly more than the other type of negatively charged (-M) PS-NPs in both pristine 
(as also previously reported [7]) (360x), and digested form (7.7x). Interestingly, (-M) NPs, 
which almost did not translocate at all in pristine form (0.02% of the applied amount), 
translocated at 1.6% of applied amount in digested form. 
We determined the translocation of differently charged pristine and digested PS-NPs 
after 24 h of exposure. The integrity of the co-culture cell layer following exposure was 
evaluated to ensure the validity of presented results. “Neutral” and negatively charged NPs, 
up to an exposure concentration of 250 µg/ml, did not affect the cell layer integrity, as shown 
by TEER values and Lucifer Yellow permeability. Responsiveness of TEER measurements in 
our systems was shown in our previous experiments, where opening of the tight junctions 
by exposure to EGTA resulted in significantly increased leakage of Lucifer Yellow [7]. 
Other studies looked at TEER values and translocation at earlier time points, and report 
that directly at the onset of polymer NP exposure the integrity of Caco-2 and co-culture 
monolayers was not affected [28] and a gradual cumulative translocation was observed 
[28-30]. Thus translocation due to initial loss of monolayer integrity can be excluded 
for the “neutral” and negatively charged PS-NPs. Positively charged PS-NPs significantly 
decreased TEER values (which has been seen before in the same cell model by [4]) and 
significantly increased Lucifer Yellow permeability, but only in the digested form. The dose 
of 250 µg/ml was selected to be able to detect the rather low expected translocation rates, 
which was based on previous results [7]. To further explore potential cytotoxicity of the 
NPs, we exposed proliferating cells to PS-NPs and measured the cell viability. As reported 
before for polymeric NPs [17, 31] and silicon NPs [32], only pristine and digested forms 
of positively charged PS-NPs decreased the viability of the proliferating cells. Proliferating 
Caco-2 cells are more sensitive to toxicity of NPs than differentiated cells as used in the 
translocation experiment, as has been shown using AgNPs [33, 34]. As for the digested 
PS-NP effects on TEER values and Lucifer Yellow permeability were observed on the 21 day 
old co-culture of Caco-2 and HT29-MTX, cytotoxic effects of these PS-NPS at the dose 
used cannot be excluded. 
Not only did in vitro digestion increase the translocation but it also affected the protein 
corona of PS-NPs. Digested NPs contained less protein in their corona compared to their 
pristine equivalents: 4.8 x for (“0”), 3.5 x for (+), 1.4 x for (-M) and 1.8 x for (-P), and 
in the case of (“0”), (+) and (-P) NPs this difference was significant (p<0.03) even after 
incubation of the digested NPs for 24h in cell culture medium. The effect of gastrointestinal 
conditions on the protein corona of NPs has not been reported before. However, proteolytic 
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enzyme phospholipase A2 (from macrophage phagolysosomes) has been shown to decrease 
the amount of proteins in the corona of polymeric NPs after overnight incubation [35]. 
Furthermore, it has been shown that the NP surface chemistry plays an important role 
in determining the NP protein corona [7, 21, 22]. In line with this, we show that different 
surface chemistries of PS-NPs adsorbed different amounts of proteins, both in pristine and 
digested forms. Digested PS-NPs had less adsorbed protein and they translocated more 
than pristine PS-NPs, which suggests a direct correlation between these two parameters. 
On the other hand, the difference in translocation between different pristine PS-NPs did 
not correlate directly with the difference in the amount of adsorbed protein. The same holds 
for the different digested PS-NPs. In literature, there is also no clear consensus as a negative 
correlation between the amount of adsorbed protein on NPs and their cellular interaction 
and uptake has been reported [36-38], as well as the opposite [37, 39-41]. Further detailed 
studies are required to elucidate the influence of the composition of the corona on cellular 
interactions and uptake mechanisms.
Digestion also affected the composition of the protein corona of NPs, which was 
demonstrated by differences in protein band patterns between pristine and digested 
PS-NPs. The main composition of the protein corona of pristine PS-NPs was independent 
of functionalization, as shown before for PS-NPs [7, 25, 35] and resulted in similar protein 
band pattern, with only minor differences in the ratios of component proteins, for all 
pristine PS-NPs. The major components of the corona of pristine NPs were proteins most 
abundantly present in cell culture medium (see DMEM+ control). The most prominent 
protein band on the gel had a mass of around 50-70 kDa, and comprised likely the 
fibrinogen gamma chain (50 kDa), fibrinogen beta chain (60 kDa), fibrinogen alpha chain 
(72 kDa) and albumin (72 kDa) as previously reported to be present in the protein corona 
of 50 nm PS-NPs [42]. Previous studies also showed that albumin and fibrinogen were the 
main components of the corona of differently functionalized 50, 100 and 200 nm PS-NPs 
[42, 43] incubated in plasma. 
The pattern of protein bands in digested NPs, regarding protein types and their relative 
amounts, was clearly different from that of pristine NPs. Compared to pristine NPs, coronas 
of digested PS-NPs contained less proteins of high molecular weight and of 50-70 kDa 
and more low molecular weight proteins. The lanes with digested samples were smeary, 
suggesting partially broken down proteins. The intensity of the band at ~26 kDa, being 
most likely apolipoprotein A-1 [42], was clearly decreased in digested (“0”) and digested 
(+) NPs compared to their equivalent pristine PS-NPs. In (–P) and (–M) NPs this band was 
hardly visible. Strikingly, digested PS-NP samples contained additional bands at ~18 kDa 
(in -M and -P NPs) and at ~45 kDa (in -M, -P and 0 NPs) that were not present in the 
washed control nor in the coronas of the pristine PS-NPs. As shown before for pristine 
PS-NPs [7], the composition of the protein corona of digested NPs was independent of the 
functionalization. All together, these results clearly indicate that in vitro digestion affects 
the protein corona by enzymatic breakdown of the proteins. The breakdown occurs either 
directly on the NP surface to already adsorbed proteins, or in suspension, which results in 
subsequent adsorption of the digested protein fragments onto the NPs. 
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CONCLUSION
In our study we demonstrated that digestion of differently charged 50 nm PS-NPs 
influenced both their translocation behaviour and their protein corona. The latter being 
affected in two aspects, regarding its amount and composition of proteins. Translocation 
of all digested PS-NPs was clearly increased compared to the translocation of their pristine 
equivalent PS-NPs, significantly for (+), (-M) and (-P) PS-NPs. Digested PS-NPs contained 
less protein in their corona than their equivalent pristine PS-NPs, significantly for (“0”), (+) 
and (-P) PS-NPs. Furthermore, digestion had a remarkable effect on the composition of the 
protein corona of PS-NPs in a way that it resulted in a shift from larger proteins (present in 
coronas of pristine NPs) towards low molecular weight proteins.
This study clearly illustrates that gastrointestinal digestion affects in vitro translocation 
behaviour of different types of PS-NPs. The implications are at least twofold, i) polymer NPs 
are increasingly explored to enhance the bioavailability of loaded drugs or poorly soluble 
compounds [44]- manipulating their surface modification will greatly enhance the uptake 
potency and ii) integration of in vitro digestion and in vitro intestinal translocation models 
is crucial to obtain relevant information from screening studies for risk assessment.       
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ABSTRACT
The likelihood of oral exposure to nanoparticles (NPs) is increasing and it is necessary 
to evaluate the oral bioavailability of NPs. In vitro approaches could help reducing 
animal studies. Previously, we assessed the translocation of 50 nm polystyrene NPs 
of different charges (neutral, positive, and negative) using a Caco-2/HT29-MTX in 
vitro intestinal translocation model. The present study aimed to validate this model 
by an in vivo study. For this, Fischer rats were orally exposed to a single dose of 
the same types of polystyrene NPs and uptake in organs was determined. One type 
of negatively charged NP was taken up more than the other NPs, with the highest 
amounts in kidney (37.4 µg/g tissue), heart (52.8 µg/g tissue), stomach wall (98.3 µg/g 
tissue), and small intestinal wall (94.4 µg/g tissue). This partly confirms our in vitro 
findings, where the same NPs translocated to the highest extent as well. However, 
the relative order of uptake for the other NPs differed from the in vitro findings. The 
estimated bioavailability ranged from 0.2% to 1.7% in vivo, which was much lower 
than that in vitro (1.6% to 12.3%). In conclusion, our results show that the uptake of 
the NPs, as predicted from our in vitro Caco-2/HT29-MTX model, overestimates the 
translocation across the rat intestine in vivo. Therefore, the integrated in vitro model 
cannot be used for a direct prediction of the bioavailability of orally administered 
NPs. However, the model can be used for prioritizing NPs before further in vivo 
testing for risk assessment.
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INTRODUCTION
The number and range of consumer products containing nanoparticles (NPs) is constantly 
growing, examples range from e.g. lipsticks, toothpaste, food additives, health supplements, 
juice clarifiers to food packaging materials (Chaudhry et al. 2008; PEN 2013, Bouwmeester 
et al., 2014). Therefore, the likelihood of oral exposure to NPs is still increasing. Thus, there 
is a need to develop methods to assess the oral bioavailability of NPs. For scientific, ethical 
and economical reasons, in vitro models are desired.
To assess the performance of in vitro models, NPs need to be selected that differ in 
translocation efficiency. In several studies polystyrene NPs (PS-NPs) have been shown to 
translocate across in vitro intestinal barrier models (Walczak et al., 2014; Kulkarni and Feng 
2013; Martinez-Argudo et al. 2007) and this translocation depended on NP characteristics 
like size, charge and surface chemistry. In addition, in vivo studies have demonstrated 
the bioavailability of PS-NPs after oral exposure as well (Jani et al., 1989; Jani et al., 1990; 
Hussain et al. 1997). However, no data is available from studies that used the same PS-NPs 
in vitro and in vivo. For these reasons we previously selected PS-NPs to perform in vitro 
gut translocation studies (Walczak et al., 2014). With the present study we aim to evaluate 
the validity of our in vitro model by comparison of previously obtained in vitro data with in 
vivo data. In order to do this we used the same range of PS-NPs that were previously used 
in vitro in an in vivo study. 
In these previous in vitro studies we developed an integrated in vitro gastrointestinal 
digestion and in vitro intestinal epithelium model as a screening tool for assessing the 
translocation efficiency of orally administered PS-NPs. The translocation of these PS-NPs 
ranged from 1.6 to 12.3% (Walczak et al., in press). Furthermore, these results indicated 
that the translocation rate of the PS-NPs was affected by at least three factors: (i) the 
physicochemical properties of the PS-NPs (i.e. size and surface chemistry) (Walczak et al., 
2014), (ii) the environmental conditions that the PS-NPs were exposed to (i.e. incubation 
in an in vitro gastrointestinal digestion model) (Walczak et al., in press), and (iii) the 
properties of the in vitro monolayer simulating the intestinal epithelium (i.e. presence of 
mucus) (Walczak et al., 2014). Effects of size, surface chemistry, and the properties of the in 
vitro monolayer on PS-NP translocation have also been reported by others (Hussain et al. 
2001; Szentkuti 1997; des Rieux et al. 2005; Fazlollahi et al. 2011; Mahler et al. 2012). 
In order to reduce the undesirable use of animals in the toxicological evaluation of 
NPs (Hartung et al., 2013), alternative in vitro intestinal translocation models need to be 
developed. However, before such in vitro models can be used in risk assessment of NPs, 
they need to be validated (Kandarova and Letasiova 2011; Worth and Balls 2004) using in 
vivo data (Genschow et al. 2002). As mentioned earlier, the aim of this study was to assess 
to which extend our in vitro model (combination of a gastrointestinal digestion model 
and an intestinal epithelium translocation model) predicts the translocation efficiency 
occurring in vivo. To that end, rats were orally exposed to a single dose of the same PS-NPs 
as used in previous in vitro studies (i.e. neutral, positive, and negative, the latter from two 
different suppliers with different surface modifications (Walczak et al., 2014)) and PS-NP 
bioavailability in organs was determined. 
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MATERIALS AND METHODS
Nanoparticles 
Neutral, amine- and carboxyl-modified 50 nm PS-NPs (referred to as 50 (0), 50 (+), 50 (-M)) 
with a red fluorophore core (Ex/Em: 530/590) were purchased from Magsphere (Pasadena, 
CA, USA). Carboxyl-modified 50 nm PS-NPs (referred to as 50 (-P)) with a yellow-green 
fluorophore core (Ex/Em: 485/530) were purchased from Polysciences (Warrington, 
Pennsylvania, USA). PS-NPs were washed prior to administration by centrifugation for 5 h 
at 18 000 g, 15°C and re-suspension in deionised water, in order to remove preservatives 
and surfactants present in the suspension solution. The final mass concentration of all stock 
suspensions was 2.5 %. 
NP characterization  
The nanoparticles, as purchased, were characterized previously (Walczak et al., 2014) using 
Scanning Electron Microscopy (SEM), Dynamic Light Scattering (DLS), and zeta-potential 
measurements. To confirm the size of the PS-NPs as administered to animals (i.e. following 
washing and re-suspension in deionised water), hydrodynamic sizes were again determined 
using DLS. The measurements were performed as previously described (Walczak et al. 
2012). Suspensions of 100 µg/ml were analysed in triplicate and the results are presented as 
the mean ± SD.
Stability of the fluorescent dye in PS-NPs during exposure
No detectable leakage of the fluorescent dye from the used PS-NPs was shown upon 
incubation under simulated gastric digestion conditions. For this, PS-NPs were incubated 
in simulated gastric juice for 2 hrs at 37°C, after which the suspensions were brought to 
neutral pH and suspensions at 250 µg/ml were centrifuged (30 min, 3 000 g, 20°C) in filter 
tubes (Amicon Ultra-4 3kDa Ultracel-PL memb 24/Pk; Millipore BV, Netherlands). The 
filtrates were then analysed for fluorescence. 
Animal experiment
Five weeks old male Fischer 344 rats with a body weight of 107 ± 8 g (upon arrival) were 
obtained from Harlan (Horst, The Netherlands). Upon arrival, rats were left to acclimatise 
for three weeks in groups of two under standard conditions of humidity (55-65%), 
temperature (22 ± 3 °C), and light (12 h light/ 12 h dark cycles), with ad libitum access to 
feed pellets (Abdiets, Woerden, The Netherlands) and tap water. After three weeks, 25 rats 
were divided into five groups (n=5) for the experiment, based on their weight to have a 
similar weight distribution in each group (201 ± 13 g). Before treatment, rats were fasted 
for 2 h. A single dose of 1 ml PS-NP suspension per 200 g bw was administered through 
oral gavage at a concentration of 25 mg/ml (resulting in a dose of 125 mg/kg bw). Rats 
in the control group received the same volume of vehicle solution (i.e. deionised water) 
only. After administration, rats were housed separately until the end of the experiment. All 
animal experiments were approved by the ethical committee on animal experimentation of 
Wageningen University & Research centre, The Netherlands. 
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Blood samples (around 100 µl) were withdrawn from the tail vein at time points: 
0, 0.5, 1, 2 and 4 h and collected in heparinized tubes. At t=6 h, rats were sacrificed 
under anaesthesia, blood was collected from the aorta, after which liver, kidneys, spleen, 
lungs, heart, testis, brain, stomach, small intestine and large intestine were collected. 
Food remainders and faecal contents were gently removed from the stomach, small- 
and large intestines with a spoon and the tissues were subsequently rinsed in PBS, to 
remove any unabsorbed PS-NPs. The organs were weighed and divided into two pieces 
for fluorescent and histopathological evaluation. The pieces meant for fluorescence 
measurements were preserved on ice, and the pieces meant for histopathology/
microscopic observations were preserved in Bouin solution (testis) or in 10% neutral 
buffered formalin (all other organs).
Fluorescence measurements of blood and organs
Harvested tissue samples were digested using an aqueous enzyme solution containing 1g/l 
proteinase K (Sigma-Aldrich,St. Louis, MP, USA) in 50 mM NH4HCO3 buffer (to maintain 
a constant pH value of 7.4 during enzymatic digestion) and 5g/l SDS to improve activity 
of the enzyme (Loeschner et al., 2013). Organs were carefully weighed, cut in pieces and 
digested in digestion buffer at a weight ratio of 1:5. The samples were thoroughly vortexed 
and incubated at 37°C under continuous stirring on a magnetic stirrer for 4 h. This 
resulted in slightly turbid but homogenous suspensions. Fluorescence of the samples was 
measured using a SpectraMax M2 microplate reader (Molecular Devices, Berkshire, UK) 
at excitation/emission wavelengths of 530/590 nm and 470/520 nm, for red and yellow-
green PS-NPs, respectively. The PS-NP concentration was determined based on previously 
prepared standard calibration curves in each organ separately, obtained by spiking blank 
organ homogenates (prepared as described above) with serial dilutions of PS-NPs ranging 
from 0 to 20 µg/ml. The PS-NP bioavailability was estimated by summing up the amounts 
of NPs measured in all tested organs except for the brain, stomach wall and small- and large 
intestinal walls. For this, the amounts of NPs per gram tissue were multiplied by the weights 
of the organs.     
Histopathology
Samples for histopathology, fixed in 10% formalin or Bouin solution, were dehydrated 
in a series of ethanol and embedded in paraffin. Approximately 5 μm thick sections 
were cut, mounted on glass slides and stained with hematoxylin and eosin (H&E). The 
sections were observed under an optical microscope (Zeiss, Cambridge, UK) at different 
magnifications.
Fluorescence imaging
Intact livers, kidneys, spleens, lungs, testes, small intestinal wall and large intestinal wall were 
scanned for fluorescence with a fluorescence imager (Cellavista V3.1, SynenTec Bio Services 
GmbH, Münster, Germany) using illumination at wavelengths Ex/Em= 470nm/520nm or 
530nm/590nm, for yellow-green (-P) PS-NPs and red (0, +, -M) PS-NPs, respectively. 
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Statistics
Data were analysed with SPSS (IBM, Version 21) and the charts were generated with Prism 
software (v5.02; GraphPad Software, Inc., La Jolla, USA). A one-way analysis of variance 
ANOVA test and post-hoc Tukey test were used to determine significant differences between 
the groups. T-test was used to compare the estimated bioavailability between the groups. 
RESULTS
NP characterization  
The PS-NPs with different surface modifications were characterized in water using SEM 
and zeta-potential measurements as reported previously (Walczak et al., 2014). Briefly, 
all types of 50 nm PS-NPs had similar size distributions (as measured with SEM in stock 
suspensions) with an average size of 31.6 - 35.0 nm, except for the 50 nm (+) PS-NPs, 
which had a larger average size of 50.6 nm (Table 1). The zeta-potential measurements in 
stock suspensions of the 50 nm (+) and 50 nm (-) PS-NPs in water confirmed their positive 
and negative charges (Table 1). The two types of negatively charged 50 nm PS-NPs (-M 
and –P) had the same zeta-potential (i.e. -27.7 and -27.8mV), while the zeta-potential of 
the positively charged PS-NPs was 26.6 mV. The neutral PS-NPs had a negative charge of 
-26.0 mV in water. The size of PS-NPs re-suspended in deionised water, as administered to 
animals, was measured with DLS. The PS-NPs were monodispersed and their hydrodynamic 
diameters ranged from 50.0 ± 0 nm to 54.3 ± 0.1 nm (Table 1).
Fluorescence measurements of blood and organs 
Fluorescence of the collected blood and organs was determined. The concentration of the 
50 nm (-P) PS-NPs was high enough for detection in the kidney and small- and large intestinal 
walls at the appropriate wavelength using fluorescent microscopy, and the concentrations 
of the 50 nm (0), (+), and (-M) PS-NPs were high enough for detection in the small- and 
large intestinal walls only (Fig. 1 a, b, c). The fluorescence intensity could not be quantified 
reliably using whole organs. Therefore, fluorescence intensity was quantified using organ 
Table 1. Physicochemical characterization of 50 nm PS-NPs
PS-NPs SEM (nm)a DLS (nm)b Zeta-potential (mV)c
50 nm (0) 33.4 ± 12.7 50.0 ± 0.0 -26.0 ± 16.2
50 nm (+) 50.6 ± 9.3 50.3 ± 0.4 26.6 ± 13.9
50 nm (-M) 35.0 ± 15.3 52.7 ± 2.4 -27.7 ± 19.3
50 nm (-P) 31.6 ± 13.6 54.3 ± 0.1 -27.8 ± 17.4
aDiameters [nm] of PS-NPs in water, as measured with SEM in stock suspensions (n=80-380). bHydrodynamic 
diameters [nm] of PS-NPs in water, as determined by DLS at t=0 h, after re-suspending the PS-NPs in 
deionised water. cZeta-potential [mV] of PS-NPs in water, as determined by a zeta-sizer in stock suspensions 
at t=0 h. Abbreviations: (0): neutral PS-NPs, (+): positively charged PS-NPs, (-M) and (-P): negatively 
charged PS-NPs from Magsphere and Polysciences, respectively. Data in a and c from Walczak et al., 2014.
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homogenates and PS-NP organ concentrations were determined based on standard 
calibration curves made in each organ. The PS-NP concentrations in the different organs 
are shown in Figure 2. Each of the four types of PS-NPs induced a significant increase of 
fluorescence in at least one of the tested organs, indicating passage of these PS-NPs through 
Figure 1. Whole organ fluorescence following a single oral administration of 125 mg/kg bw PS-NPs. 
Pictures of kidney (A), small (B) and large intestinal wall (C) at t=6h showing fluorescence under 
the illumination with wavelengths Ex/Em= 470nm/520nm or 530nm/590nm, for yellow-green (-P) 
PS-NPs and red (0, +, -M) PS-NPs, respectively. Control organs were collected from animals treated 
with only water. Abbreviations: (0): neutral PS-NPs, (+): positively charged PS-NPs, (-M) and (-P): 
negatively charged PS-NPs from Magsphere and Polysciences, respectively.   
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Figure 2. Organ distribution of 50 nm PS-NPs after 6 h from a single oral exposure (125 mg/kg bw),
expressed as µg PS-NPs/ g tissue, detected in organs from exposed animals. Abbreviations: n.d.: not 
detectable, 0: neutral PS-NPs, +: positively charged PS-NPs, -M and -P: negatively charged PS-NPs 
from Magsphere and Polysciences, respectively. Error bars show the standard error of mean (n=5). 
Significant difference between the blank and exposed organs is illustrated as: * (p<0.1), ** (p<0.05) 
and *** (p<0.01). Significant difference between different types of PS-NPs is illustrated as: # (p<0.1), 
## (p<0.05) and ### (p<0.01).  
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Figure 2. Organ distribution of 50 nm PS-NPs after 6 h from a single oral exposure (125 mg/kg bw), 
expressed as µg PS-NPs/ g tissue, detected in organs from exposed animals. Abbreviations: n.d.: not 
detectable, 0: neutral PS-NPs, +: positively charged PS-NPs, -M and -P: negatively charged PS-NPs 
from Magsphere and Polysciences, respectively. Error bars show the standard error of mean (n=5). 
Significant difference between the blank and exposed organs is illustrated as: * (p<0.1), ** (p<0.05) 
and *** (p<0.01). Significant difference between different types of PS-NPs is illustrated as: # (p<0.1), 
## (p<0.05) and ### (p<0.01). 
Table 2. Comparison of results from in vitro and in vivo experiments measuring intestinal translocation 
in Caco-2/HT29-MTX cells and systemic uptake in rats, respectively.    
PS-NPs
In vitro translocation
(% of administered dose)*
In vivo estimated bioavailability  
(% of administered dose)
50 nm (0) 9.1 ± 0.8 % 0.3 ± 0.1 %
50 nm (+) 4.8 ± 0.7 % 0.2 ± 0.0 %
50 nm (-M) 1.6 ± 0.2 % 1.5 ± 0.9 %
50 nm (-P) 12.3 ± 1.1 % 1.7 ± 0.7 %
*Data from (Walczak et al., in press). Abbreviations: (0): neutral PS-NPs, (+): positively charged PS-NPs, 
(-M) and (-P): negatively charged PS-NPs from Magsphere and Polysciences, respectively.
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Figure 3. Estimated bioavailability of 50 nm PS-NPs, expressed as a percentage of the administered 
dose (125 mg/kg bw), calculated by summing up the amounts of PS-NPs detected in all analysed 
organs, except the stomach- and intestinal walls, and brain. Abbreviations: (0): neutral PS-NPs, (+): 
positively charged PS-NPs, (-M) and (-P): negatively charged PS-NPs from Magsphere and 
Polysciences, respectively. Error bars show the standard error of mean (n=5). *: Significant difference
(p<0.1).
Table 2. Comparison of results from in vitro and in vivo experiments measuring intestinal 
translocation in Caco-2/HT29-MTX cells and systemic uptake in rats, respectively.     
*Data from (Walczak et al., submitted). Abbreviations: (0): neutral PS-NPs, (+): positively charged 
PS-NPs, (-M) and (-P): negatively charged PS-NPs from Magsphere and Polysciences, respectively.  
Table 3. Overview of oral studies performed with PS-NPs in rats. 
NP type Detection 
method
Experimental
conditions
Dose Size Uptake (% of the
administered dose)
Ref.
PS-NPs
In vitro translocation
(% of administered dose)*
In vivo estimated bioavailability 
(% of administered dose)
50 nm (0) 9.1 ± 0.8 % 0.3 ± 0.1 %
50 nm (+) 4.8 ± 0.7 % 0.2 ± 0.0 %
50 nm (-M) 1.6 ± 0.2 % 1.5 ± 0.9 %
50 nm (-P) 12.3 ± 1.1 % 1.7 ± 0.7 %
* 
* 
Figure 3. Estimated bioavailability of 50 nm PS-NPs, expressed as a percentage of the administered 
dose (125 mg/kg bw), calculated by summing up the amounts of PS-NPs detected in all analysed 
organs, except the stomach- and intestinal walls, and brain. Abbreviations: (0): neutral PS-NPs, 
(+): positively charged PS-NPs, (-M) and (-P): egatively ch rged PS-NPs from Magsphere and 
Polysciences, respectively. Error bars show the standard error of mean (n=5). *: Significant difference 
(p<0.1). 
the intestinal wall. In animals exposed to 50 nm (-P) PS-NPs, the concentration of these 
PS-NPs was significantly increased in kidney (p<0.05), spleen (p<0.05), testis (p<0.01), 
heart (p<0.05), stomach wall (p<0.000), small intestinal wall (p<0.01) and large intestinal 
wall (p<0.05). In animals exposed to 50 nm (+) PS-NPs, the concentration of these PS-NPs 
was significantly increased in kidney (p<0.1), spleen (p<0.01), testis (p<0.01), lung (p<0.1), 
heart (p<0.1), stomach wall (p<0.1), small intestinal wall (p<0.01) and large intestinal wall 
(p<0.01). The concentrations of 50 nm (0) and (-M) PS-NPs in the organs were considerably 
lower than those of 50 nm (-P) and (+) PS-NPs, and they reached significance only in few 
organs. In the animals exposed to 50 nm (0) PS-NPs, the concentration of these PS-NPs was 
significantly increased in spleen (p<0.05), lung (p<0.1), small intestinal wall (p<0.05) and 
large intestinal wall (p<0.01). The concentration of 50 nm (-M) PS-NPs was significantly 
increased in kidney (p<0.05), stomach wall (p<0.05), small intestinal wall (p<0.05) and large 
intestinal wall (p<0.05). No PS-NPs were detected in blood samples from any time point.
In some organs, the PS-NP concentration was significantly different between the 
different types of PS-NPs, depending on their surface modifications. In kidney, the 
concentration of 50 nm (-P) PS-NPs was significantly higher than that of the 50 nm (+) 
(p<0.05) and 50 nm (0) PS-NPs (p<0.05). Also in heart, the concentration of 50 nm (-P) 
PS-NPs was significantly higher than that of 50 nm (+) (p<0.05), 50 nm (0) (p<0.05) and 
50 nm (-M) PS-NPs (p<0.01). In the stomach wall, the concentration of 50 nm (-P) PS-NPs 
was significantly higher than that of 50 nm (+) (p<0.1), and in the small intestinal wall 
the concentration of 50 nm (-P) PS-NPs was significantly higher than that of 50 nm (+) 
(p<0.05), 50 nm (0) (p<0.1) and 50 nm (-M) PS-NPs (p<0.1).
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The overall bioavailability of PS-NPs was estimated by summing up the amounts of 
PS-NPs in all measured organs, except the stomach wall and intestinal walls, as PS-NPs 
present in these organs were most likely the result of direct absorption rather than from 
uptake from the blood, and except the brain, due to the selectivity of the blood-brain barrier. 
As shown in Figure 3, the resulting amount of PS-NPs as a percentage of the administered 
dose was as low as 0.3 % and 0.2 % for 50 nm (0) and (+) PS-NPs, respectively, while the 
(-M) and (-P) PS-NPs reached bioavailable levels of 1.5 % and 1.7 %, respectively. The 
estimated bioavailability of 50 nm (-P) PS-NPs was significantly (p<0.1) higher than that of 
50 nm (0) and 50 nm (+) PS-NPs.  
Microscopic observations of tissue slides did not reveal any histopathological changes.
DISCUSSION
In the present study we evaluated the biodistribution of differently charged PS-NPs in rats 
after a single oral administration. Our results show the bioavailability and biodistribution 
of PS-NPs from the gastrointestinal tract to different organs within 6 hours. The highest 
amounts of PS-NPs were measured in the stomach- and intestinal walls. PS-NPs were 
detected also in lung, testis, spleen, kidney and heart, meaning that the PS-NPs were 
systemically available. However, the overall estimated bioavailability was low, ranging from 
0.2% to 1.7% of the administered dose. All types of PS-NPs used in our study had the same 
size, yet the organ uptake and distribution pattern was different. This shows that surface 
charge and chemistry of PS-NPs affected their bioavailability to the organs, as reported 
before for PS-NPs (Hillery and Florence 1996; Hussain et al. 1997; Jani et al. 1989) and 
other types of NPs (El-Shabouri 2002; Xiao et al. 2011). 
Irrespective of surface charge, all types of PS-NPs were measured in significant amounts 
in the small- and large intestinal walls, as shown by fluorescence measurements and organ 
imaging. The intestinal wall has been shown before to be the main site of biodistribution 
for PS-NPs after oral administration (Hussain et al. 1997; Jani et al. 1992). High levels of 
PS-NPs measured in intestinal walls in our study could be related with the uptake of PS-NPs 
in lymphoid tissue associated with these organs, as shown before (Florence et al. 1995; 
Hillery et al. 1994; Seifert et al. 1996). Also testis, spleen, kidney and heart had considerably 
high concentrations of PS-NPs, irrespective of the type of administered PS-NPs. These 
organs, and additionally also liver, have been shown before to be the main organs where 
PS-NPs (Hussain et al. 1997; Jani et al. 1990) and other types of NPs (Baek et al. 2012; Cho 
et al. 2013; van der Zande et al. 2012) were distributed after being taken up into systemic 
circulation after an oral exposure. In addition, oral exposure of mice to zinc oxide NPs has 
been shown to induce histopathological changes in the testis (Talebi et al. 2013). Strikingly, 
the liver showed no significant increase in fluorescence above background levels, for any 
of the used NP types. This could be related to the size of the PS-NP. It has been shown that 
while liposome NPs smaller than 70 nm accumulated in liver, liposome NPs larger than 
200 nm accumulated in spleen (Liu et al. 1992). The PS-NPs used in the present study could 
possibly agglomerate during the passage through the gastrointestinal tract and as a result 
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become larger than 70 nm. Also another study performed with 50 nm PS-NPs has shown 
the absence of the NPs in liver after 6 h from a single oral exposure (Jani et al. 1992). Neither 
were PS-NPs detected in blood at any time point, even with the intervals of half an hour, 
possibly due to a rapid transport of PS-NPs from the blood circulation to the organs, like 
shown before (Geraets et al. 2014).  
Several in vivo oral studies have been performed before with different types of PS-NPs. 
Table 3 summarizes oral studies performed in rats with differently sized and coated PS-NPs. 
The results from these studies highlight the dependence of uptake and accumulation of 
PS-NPs on several factors, including the size, surface charge and type of coating material 
(Araujo et al. 1999; Hillery et al. 1994; Hillyer and Albrecht 2001; Hussain and Florence 
1998; Hussain et al. 1997; Jani et al. 1989). In general, smaller PS-NPs were taken up to 
a higher extent than the larger ones (Jani et al. 1990), the non-ionized more than the 
carboxylated ones (Jani et al. 1989) and  407 poloxamer-coated more than 188 poloxamer-
coated across the GI tract (Hillery and Florence 1996; Hussain et al. 1997).
The estimated oral bioavailability that we report here (i.e. 0.2 - 1.7%) is lower than in a 
previous oral study using 50 nm PS-NPs, where 6.6% estimated total uptake was reported 
(Jani et al. 1990) (Table 3). Also the amounts of PS-NPs associated with intestinal tissues 
that we detected (ranging between 0.38 and 0.74% depending on the type of PS-NPs, 
calculated as a sum of the small- and large intestinal walls, data not shown) were lower 
than the ones reported by others for 60 nm PS-NPs, which varied between 1.5 and 10%, 
depending on the type of PS-NPs used ((Hillery and Florence 1996; Hillery et al. 1994). The 
difference between data from the present study and those of other in vivo studies might be 
due to the use of different exposure conditions, as we exposed the rats for 6 h while in the 
previous studies rats were exposed for 5 or 10 days. Furthermore, the bioavailability values 
given here were estimated from the amounts of PS-NPs that were measured in a selection of 
organs, and therefore can be underestimated. The differences in the described amounts of 
NPs that pass the intestinal walls could be further caused by differences in tissue sampling 
methods and methods of quantifying the concentration of PS-NPs in tissues, and by large 
interindividual differences as shown before after intraduodenal administration of PS-NPs, 
where the numbers of particles subsequently found in lymph ducts varied considerably 
between the different animals (Seifert et al. 1996). However, the amount of 50 nm (-P) 
PS-NPs that was detected in kidney (0.3%) was similar to the 0.2% reported by others for 
50  nm PS-NPs (Jani et al. 1990). Comparison of our results from 50 nm (-P) PS-NP to 
300 nm PS-NPs in another study shows that the amount of the 50 nm (-P) PS-NPs that 
we detected in the liver (1.3%), spleen (0.07%), and stomach wall (0.54%) was similar to 
the 1.4%, 0.2% and 0.5% reported for the liver, spleen and stomach wall of 300 nm PS-NP 
treated animals respectively (Jani et al. 1990). Furthermore, the amount of PS-NPs we 
detected in the heart (0.17%) was largely similar to the 0.3% detected for 500 nm PS-NPs 
(Hussain et al. 1997)). However, our bioavailability values are lower than the extrapolated 
23% that was reported for much larger 500 nm PS-NPs (Hussain et al. 1997). Even larger 
PS-NPs of 1 µm had a lower uptake than what we report here (2x10-6% of 1 µm PS-NPs 
detected in lymph fluid (Seifert et al. 1996)).  
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Comparison of the bioavailability values ranging between 0.2% and 1.7% that we report 
here, with the translocation values of the same 50 nm PS-NPs in our integrated in vitro 
digestion and in vitro intestinal model, which ranged from 1.6% to 12.3% (Walczak et al., in 
press), shows lower uptake values in the in vivo model. (Table 2). Therefore, our integrated 
in vitro model appears to overestimate the translocation through the rat intestinal wall. 
Also the relative order of translocation in vitro (Walczak et al. 2014; Walczak et al., in press) 
differed from the order of uptake of PS-NPs in vivo. However, the 50 nm (-P) PS-NPs, 
which translocated to the largest extent in vitro, were also taken up to the largest extent in 
the present in vivo study, as shown in organs where the PS-NPs concentrations were highest 
(i.e. in kidney and heart). 
CONCLUSIONS
In conclusion, our results show that the predicted uptake of PS-NPs from our integrated 
in vitro model appears to overestimate the actual uptake occurring in the rat in vivo. 
Therefore, the in vitro model cannot be used for a direct prediction of bioavailability of 
orally administered PS-NPs in a rat model. However, our model can be used for screening 
and prioritizing NPs before further in vivo testing for risk assessment. Similar to in vitro 
results, the surface charge and surface chemistry affected the uptake and biodistribution of 
50 nm PS-NPs after oral exposure in rats. The negatively charged PS-NPs were present in 
almost all organs to a much higher extent than the neutral and positively charged PS-NPs, 
which is in line with the in vitro translocation data of these PS-NPs. 
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GENERAL DISCUSSION
After some decades of development, the interest in nanotechnology continues to attract 
much attention. A special domain within nanotechnology is the synthesis and use of 
nanoparticles (NPs). NPs are commonly defined as particles having a size smaller than 
100 nm. Due to their small size, NPs gain unique physical and chemical properties that 
differ from their bulk counterparts. Because of these properties, NPs find applications in 
many types of industry, including electronics, clothing, textiles, health care, medicine, 
cosmetics and food. A great variety of food and food-related products containing NPs are 
currently being produced. Silver, silica and titanium dioxide are the NPs that are used most 
commonly in the food sector. These products are used for food processing and packaging, 
but also as storage life sensors, food additives, and juice clarifiers (Wijnhoven et al. 2010; 
Chaudhry et al. 2008; Weir et al. 2012; Nanoparticle Products Inventory, PEN). Due to 
these types of application of NPs, there is a high likelihood of oral exposure of consumers 
to NPs, both intentionally and unintentionally. 
There are many specific benefits of using NPs in products. However, due to the same 
unique characteristic, NPs also give rise to safety concerns for human health (Oberdorster 
et al. 2005; Drake & Hazelwood 2005; Navarro et al. 2008; Sung et al. 2009). Several in vivo 
studies with oral administration of different types of NPs showed that oral consumption of 
NPs results in systemic uptake, toxic effects and bioaccumulation of NPs in various organs 
(Jani et al. 1990; Hussain et al. 1997; Hillery and Florence 1996; Hillery et al. 1994; Seifert 
et al. 1996; van der Zande et al. 2012, van der Zande et al. 2014; Kim et al. 2008; Kim et 
al. 2010). Given the number of products containing NPs that are already on the market, 
a risk assessment of NPs is urgently needed. Only a few risk assessment studies for NPs 
have been published in the scientific literature (Dekkers et al. 2013; van Kesteren et al. 
2014; Wijnhoven et al. 2009). The current  risk assessment of NPs (and chemicals) relies 
mainly on in vivo studies (EFSA and Committee, 2011). However, given the great number 
of different NPs and their variability (ageing) to test, immense amounts of animals would be 
needed for such an approach. For several reasons, scientific, ethical and economical, efficient 
alternative approaches need to be developed. Lately the development of in vitro methods for 
prediction of toxicity and bioavailability of NPs gets much attention (Hartung et al. 2013). 
At the start of this project, there were some in vitro models simulating gastrointestinal 
digestion and intestinal exposure, but they had not been used for NP testing. Several studies 
have shown an adverse effect of NPs on human intestinal cells (Abbott Chalew and Schwab 
2013; Kang et al. 2013; Wang et al. 2008) and demonstrated translocation of NPs through 
the intestinal epithelium (Kulkarni and Feng 2013; Martinez-Argudo et al. 2007; Hussain 
et al. 2001; Szentkuti 1997; des Rieux et al. 2005; Fazlollahi et al. 2011; Mahler et al. 2012; 
Oh et al. 2011; Elbakry et al. 2012; Varela et al. 2012; Schubbe et al. 2012). However, no in 
vitro approach has been taken to link different elements of oral exposure in one exposure 
scenario and predict the NP bioavailability in the human body after oral exposure. Therefore, 
the aim of the present thesis was to develop an integrated in vitro approach to evaluate 
the uptake of NPs in the human body following ingestion for the prediction of their oral 
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bioavailability in the human body. To this end, an in vitro gastrointestinal digestion model 
was used, to test the fate of NPs upon digestion in the human digestion tract. Further, in 
vitro intestinal epithelial models were used to evaluate the potential translocation of NPs 
across the intestinal barrier to predict their potential systemic absorption. Next, the in vitro 
gastrointestinal digestion model was combined with the intestinal barrier model in order 
to assess the translocation of digested NPs across the intestinal model. Lastly, an in vivo 
experiment was performed to pre-validate the integrated in vitro model.
In the present thesis, two types of NPs were used: silver NPs (AgNPs) and polystyrene 
NPs (PS-NPs). AgNPs were selected due to their common application in food and food-
related products, and PS-NPs were selected because they are excellent model NPs, suitable 
for model development studies, due to their commercial availability with a wide variety of 
physicochemical properties like charge and fluorescent labelling. 
In order to study the fate of NPs in the human body after ingestion, the first step is to 
assess what happens with NPs during passage through the human gastrointestinal tract. 
Chapter 2 of this thesis describes the effect of digestion on the behaviour and physicochemical 
properties of AgNPs. AgNPs of 60 nm were studied together with silver ions (in the form 
of AgNO₃) as a control. Samples were digested in an in vitro human digestion model 
composed of oral, gastric and intestinal digestion phases, and digestion was carried out in 
two variants: with and without digestive enzymes and proteins. Samples after each step of 
the digestion (saliva, gastric and intestinal) were analysed with several analytical techniques 
(SP-ICPMS, DLS and scanning electron microscopy with energy dispersive X-ray analysis 
(SEM-EDX)). In the absence of proteins, the number of AgNPs dropped significantly after 
gastric digestion and stayed at the same level after intestinal digestion. This reduction 
in number of AgNPs was accompanied with a decrease of their size. In the presence of 
proteins, after gastric digestion the number of AgNPs dropped significantly and SEM-EDX 
revealed that reduction in number of particles was caused by their clustering and that these 
clusters were composed of AgNPs and chlorine. This effect of gastric digestion on AgNPs 
was demonstrated later in other studies as well (Mwilu et al. 2013; Rogers et al. 2012). It 
was also shown that these agglomerates were coated with insoluble silver chloride formed 
from re-precipitated Ag+ ions, prior released from NP surface (Mwilu et al. 2013). In salt 
solutions of increased chloride concentrations AgNPs aggregated with AgCl bridging in 
between (Chambers et al. 2014). After the gastric incubation, samples were incubated in the 
intestinal juice. Upon this incubation, the NP clusters disintegrated back into the free 60 nm 
AgNPs, same amounts of NPs were measured compared to the mouth phase. This suggests 
that AgNPs as used in this study, digested under physiologically relevant conditions, can 
reach the intestinal wall in their initial size and elemental composition. The phenomenon 
of cluster formation and disintegration was also observed for silica NPs (Peters et al. 2012). 
Strikingly, after intestinal digestion in the presence of physiological enzymes Ag+ ions 
formed 20-30 nm silver salt particles that were composed of silver, sulphur and chlorine. In 
another in vitro study silver chloride agglomerates were formed as a result of gastric digestion 
of pure Ag+ ions (Mwilu et al. 2013). Interestingly, an oral feeding study using rats revealed 
silver salt particles (containing sulphur and selenium) in the intestinal wall following 
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exposure to AgNPs and Ag+ ions (Loeschner et al. 2011). The authors suggested that these 
complex silver particles were derived from Ag+ ions, which was confirmed by another study 
(van der Zande et al. 2012). The fact that Ag+ ions transformed during digestion into silver 
salts has a great importance for toxicity assessment of ingestion of Ag+ ions. The conclusion 
from this study was that the gastrointestinal digestion can impact AgNPs in both size and 
composition, therefore NPs tested for in vitro intestinal translocation should be digested 
prior to exposure. 
In order to reach the systemic circulation, NPs need to pass the gut wall. Therefore, 
in order to assess the potential bioavailability of nanoparticles (NPs), a proper model for 
intestinal translocation is essential. Currently, several in vitro models of human intestinal 
epithelium exist, using cells grown on a semi-permeable membrane, separating apical and 
basolateral chambers (Lefebvre et al. 2014). An increasing number of studies report the 
use of models with different degrees of complexity for testing NPs. The simplest and most 
commonly used is a mono-culture of Caco-2 cells. More complex models also incorporate 
mucus producing cells and M cells grown in co-cultures with Caco-2 cells (Mahler et al. 
2012; des Rieux et al. 2005; Bouwmeester et al. 2011b). All these models have not been 
compared with each other in one study to evaluate their applicability for NP testing. 
Therefore, in Chapter 3, we compared the translocation of NPs in a mono-culture (Caco-2 
cells), a co-culture with mucus secreting HT29-MTX cells and a tri-culture with M-cells. 
For this study on the definition of an adequate in vitro model, it was best to choose NPs that 
fulfilled several criteria. PS-NPs were selected because they: 1) have been already shown 
to translocate across in vitro intestinal models (Kulkarni and Feng 2013; Martinez-Argudo 
et al. 2007), 2) appeared to translocate differently depending on NP characteristics like 
size, charge and surface chemistry (Mahler et al. 2012; Bhattacharjee et al. 2013b), and 
3) have been demonstrated to be bioavailable in in vivo studies after oral exposure (Jani 
et al. 1989; Jani et al. 1990; Hussain et al. 1997). To test if size or charge of NPs influence 
the translocation in the models, differently sized (50 and 100 nm) and charged (neutral, 
positively and negatively) polystyrene NPs were used. Our findings clearly show that 
ingested PS-NPs, depending on their size and physicochemical properties, translocate 
across intestinal barrier in vitro. Not only NP size and charge were shown to strongly affect 
the translocation of NPs. Additionally, surface chemistry was also shown to be important, 
as the two types of negatively charged NPs (with the same size and zeta potential) with 
different surface modifications had an over 30-fold difference in translocation. Clearly, 
the chemical composition at the surface seems more important than the zeta potential. 
Compared with the Caco-2 mono-culture, presence of mucus significantly reduced the 
translocation of neutral 50 nm NPs in the co-culture. In the tri-culture, incorporation of 
M-cells shifted the translocation rate for these NPs closer to this in the mono-culture model. 
In another study, a similar reduction of translocation in the co-culture, comparing to the 
mono- and tri-culture, was reported for plain 50 nm PS-NPs (Schimpel et al. 2014). The 
relative pattern of NP translocation in all three used intestinal models was similar, however 
the absolute amounts of translocated NPs differed per model with no coherence that one 
specific model had more efficient translocation than others. Therefore, for comparing the 
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relative translocation of different NPs, using one intestinal model would be sufficient. 
However, when absolute translocation values are needed, it should be kept in mind that 
depending on the chosen model, the outcomes will differ. It was concluded from this study 
that in vivo experiments were needed in order to assess which of the three models is most 
closely reflecting the in vivo translocation. 
In Chapter 4, an integrated in vitro oral model was developed by integrating the 
previously described digestive and intestinal models. The combination of in vitro 
gastrointestinal digestion with in vitro intestinal translocation was expected to give a 
prediction of bioavailability of orally administered NPs, which was the aim of this thesis. 
The PS-NPs, as used in the previous study, were first digested and in this form applied 
on the intestinal cell model. Because in the previous study mucus was shown to play a 
crucial role in influencing the translocation of PS-NPs and because it has the advantage 
of reducing chyme toxicity to cells, a co-culture of intestinal Caco-2 and HT29-MTX cells 
was selected for this study. In vitro digestion significantly increased the translocation of 
all, except the neutral, PS-NPs. Upon in vitro digestion, translocation was 4-fold higher for 
positively charged NPs and 80- and 1.7-fold higher for two types of negatively charged NPs. 
The effect of digestion on the protein corona of NPs was also studied, as it was expected 
that the enzymes of digestive juices affect the proteins adsorbed onto the NPs. It was shown 
that digestion affected both the amount and composition of the protein corona. The amount 
of protein after digestion was significantly reduced in the corona of three out of four types 
of NPs: 4.8-fold for neutral, 3.5-fold for positively charged and 1.8-fold for one type of 
negatively charged PS-NPs. The digestion changed the composition of the protein corona by 
decreasing the amount of higher molecular weight proteins and shifting the protein content 
of the corona to low molecular weight proteins. From the results obtained in Chapter 2 
it was already known that digestion changes the physicochemical properties of NPs, and 
this study demonstrated that digestion influences the protein corona of NPs and further 
impacts the interactions with cells, leading to different translocation rates. This study 
clearly illustrated that gastrointestinal digestion affects in vitro translocation behaviour of 
different types of PS-NPs. In case of our non-degradable PS-NPs the digestion increased 
the intestinal translocation, while the opposite has been shown by others for degradable 
chitosan NPs (Lee et al. 2011). These findings stress the importance of including in vitro 
digestion in future in vitro intestinal translocation screening studies for risk assessment of 
orally taken NPs.  
After developing the integrated in vitro digestion-translocation model and measuring 
the NP translocation in this model, it was necessary to validate the findings by an in vivo 
study (Kandarova and Letasiova 2011; Worth and Balls 2004). For this, we orally exposed 
Fischer rats to a single dose of the same PS-NPs as used in the in vitro studies and uptake 
in organs was determined. The estimated bioavailability in vivo ranged from 0.2% to 1.7% 
(depending on the type of NP), which was much lower than that in vitro (1.6% to 12.3%). 
One type of negatively charged NPs which translocated to the largest extent in vitro, were 
also taken up to the largest extent in the in vivo study, as shown in organs where the PS-NPs 
concentrations were highest (i.e. in kidney and heart). However, the relative order of uptake 
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for the other NPs differed from the in vitro findings. In conclusion, our results show that 
the translocation of the NPs, as predicted from our in vitro Caco-2/HT29-MTX model, 
overestimates the translocation across the rat intestine in vivo. Therefore, the integrated in 
vitro model cannot be directly used for a quantitative prediction of the bioavailability of 
orally administered NPs. However, the model can be used for screening and prioritizing 
NPs before further in vivo testing for risk assessment.
FUTURE PERSPECTIVES AND CONCLUSIONS
After obtaining the results summarised and discussed above, it is also of interest to consider 
what aspects are of importance and need special attention to further develop the concepts 
of the present thesis and add to the development of adequate in vitro models for testing of 
NPs. Some of these aspects are discussed in some more detail in the next sections.
1. Characterization of NPs 
Characterization of NPs is a basic need in any experiment, still too often research studies 
are not accompanied by proper characterization data. It has been argued before that in 
any experiment with NPs, at least their pristine physicochemical properties should 
be characterized. The minimal set of these properties encompasses size, shape, core 
composition, surface charge, composition of capping functional groups, etc (Oberdorster 
et al. 2005; Bouwmeester et al. 2009; Bouwmeester et al. 2011a). While nowadays a lot of 
attention is focused on the minimal set of characterization of pristine NPs (shape, size, 
charge), there are more important parameters. Studies show the importance of also other 
surface properties, like hydrophobicity (shown to influence the cell membrane binding 
of NPs (Li et al. 2008)), and charge density (shown to affect the protein adsorption on 
NPs (Gessner et al. 2002)). It has been shown that steric shielding of the charge and steric 
interaction of chemical groups on the surface of NPs, as well as molecular weight and 
density of the coating (Gref et al. 2000) can affect the protein corona of NPs (Jedlovszky-
Hajdu et al. 2012) and their biological responses (Bhattacharjee et al. 2013a; Bhattacharjee 
et al. 2013c; Yoncheva et al. 2005). Characterization of these parameters is often lacking. 
This is mainly due to technical limitations, because for measuring hydrophobicity or exact 
composition of functional groups on NPs routine analytical instrumentation is not available. 
As concluded from this thesis, more efforts should now be devoted to relate the chemical 
surface properties of NPs with the same surface charge but different surface modification to 
their different biological behaviour. 
Perhaps, characterization of the pristine material is not the most important aspect 
of characterization of NPs. The physicochemical properties of NPs- due to their unique 
properties resulting from their small size- are extremely dynamic and matrix-depended. 
Thus, introduction of NPs in any medium (e.g. cell culture medium, fluids of a high ionic 
strength, of low pH or containing proteins, food) affects their properties to a high extent. 
Therefore, not only the properties of pristine NPs should be characterized, but also- and 
perhaps more importantly- the properties of NPs as present in medium, as this is the 
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form in which they actually come in contact with biological systems (Walczyk et al. 2010). 
The outcomes of this thesis show clearly that incubation of NPs in media (e.g. chyme) 
can change their biological activity. In order to understand the relationship between the 
physicochemical properties of NPs and their biological activity the exposure-relevant 
characterization should be performed. 
1a. Detection and characterization of NPs in complex matrices
Characterization of NPs in a matrix is even more challenging than characterization 
of the pristine NPs. There are clear analytical limitations here and the availability of 
techniques suitable for characterizing NPs in media depends on the complexity of these 
media (Loeschner et al. 2011; Peters et al. 2014a). While in cell culture media NPs can 
be measured relatively easily, this is more difficult in complex media, e.g. in chyme or 
even separate digestive juices. The nowadays routinely used DLS, zeta-sizer or electron 
microscopy techniques are difficult to apply in these media due to disturbance of proteins 
and other organic matter. The work in this thesis shows that characterization of NPs in 
digestive juices is only possible in certain combinations of NPs and techniques. Therefore, it 
is clear that the methods for detection and characterization of NPs in complex matrices still 
need to be improved. The outcomes of this thesis clearly show that without sufficient data 
on the physicochemical properties of NPs in the relevant (complex) media, it is difficult 
to fully understand the observed biological effects. For example, it would be helpful to 
know the exact size and zeta-potential of PS-NPs as they come out of the digestion model, 
so in the form in which they are applied on cells, however these measurements were not 
possible. Characterizing these digested NPs with available techniques was only possible 
after extensive sample clean-up preparations (like centrifugation, washing, re-suspending 
in water or other simple medium or filtration), which however can be expected to influence 
the physiocochemical properties of NPs in a new way. Therefore, there is a need of analytical 
methods that require less destructive or transformative sampling techniques (Szakal et al. 
2014), of which some examples are presented hereafter.
1b. Detection and characterization of NPs in animal tissues 
Detection and reliable quantification of NPs in tissues from animal studies (e.g. after oral 
exposure) is even more challenging, mainly because of the typically low amounts of NPs in 
these tissues. Clearly, different detection techniques have to be used for NPs with different 
chemical properties (i.e. metal or organic).
For NPs like polystyrene (used in Chapter 5) SP-ICPMS is not suitable, as it cannot 
distinguish ionized polystyrene from the other organic material in the samples. Not 
too many alternatives are available: polystyrene cannot be observed with electron 
microscopy techniques in matrices as complex as tissue samples. Fluorescent PS-NPs can 
be used, but detection of fluorescent PS-NPs in tissues can be done only above certain 
threshold, because of the autofluorescence of the tissues, giving a background signal. A 
recommendation in this case, in order to further improve the sensitivity, would be to 
use fluorescence probes in sensitive wavelengths, outside the spectrum encountered in 
tissues and (especially) blood. 
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For metal and metal oxide NPs different and very sensitive techniques are available. 
For example SP-ICPMS as used in Chapter 2 of this thesis, which is a relatively new 
technique and was being developed at the start of this thesis. It allows measurement of 
NPs even in very complex matrices by using plasma destruction (Peters et al. 2014a). 
SP-ICPMS allows measurement of the size and number of NPs in biological samples, even 
at extremely low concentrations. Additionally, it has a very good performance regarding 
trueness, repeatability, and reproducibility (Peters et al. 2014b). However, for SP-ICPMS 
improvement is needed to enable the detection and quantification of small-sized (< 20 nm) 
NPs (Peters et al. 2014c). Field Flow Fractionation coupled to SP-ICPMS is a promising 
approach and, alternatively, by using exchanging columns (like IES) the background 
signal can be removed to improve the small size NP detection (Hadioui et al. 2014). Also 
problematic is the characterization of metal NPs that are prone to dissolution. For risk 
assessment it is crucial to be able to differentiate between the NPs and their ionic forms, and 
this still cannot be reliably done with SP-ICPMS. Several studies have shown accumulation 
of silver in organs of orally exposed animals (van der Zande et al. 2012), where it was not 
possible to assess whether these were AgNPs or silver containing salt particles formed from 
Ag+ ions. This problem arises from using ICPMS or AAS, which cannot indicate the form of 
silver in samples. On the other hand, it is possible to visualize the AgNPs in tissue samples 
with TEM and perform their elemental analysis with TEM-EDX. This technique, however, 
lacks a high resolution, and therefore in practice it is often only applicable for studying 
agglomerates, but not single NPs.    
2. Regulations, safety assessment  
Another aspect that needs further attention is the safety assessment and regulation of 
NPs. While we are nowadays likely exposed to a great number and diversity of products 
containing NPs, investigations on the possible toxic effects of these NPs are lagging behind. 
In addition, no accurate data on the potential current level of oral exposure are available 
and only a few case studies can be found in literature (i.e. Weir et al. 2012 and Peters et 
al. 2014c on TiO2, and Dekkers et al. 2011 on silica). So, even after years of research on 
nanotoxicology not much is known about the potential risks of nanomaterials (Dekkers et 
al. 2013; Szakal et al. 2014). For safety evaluation of NPs, two aspects should be taken into 
consideration: exposure assessment and hazard assessment. For both, adequate and reliable 
detection and characterization data of the NPs in products are necessary (see section on 
characterization). The products containing nanomaterials should be properly labelled 
in order to inform consumers of the presence of nanomaterials in food. Currently, the 
regulation about labelling products containing nanomaterials (Article 18(3) of Regulation 
(EU) No 1169/2011) says that “all ingredients present in the form of engineered nanomaterials 
must be clearly indicated in the list of ingredients and the names of such ingredients must be 
followed by the word ‘nano’ in brackets” (European Commission, 2011a). However, currently 
use of this regulation is problematic due to the lack of a clear definition of what should be 
regarded as nanomaterial. Currently, there are two definitions used in EU. (Engineered) NM 
in food products (European Commission, 2011a) are defined as “any intentionally produced 
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material that has one or more dimensions of the order of 100 nm or less or that is composed of 
discrete functional parts, either internally or at the surface, many of which have one or more 
dimensions of the order of 100 nm or less, including structures, agglomerates or aggregates, 
which may have a size above the order of 100 nm but retain properties that are characteristic 
of the nanoscale”. Meanwhile, the EU Definition Recommendation (2011/696/EU), which is 
broadly applicable across different regulatory sectors, defines NMs regardless of their origin 
and thereby includes also natural and incidental NM (European Commission, 2011b). The 
main difference between these two is that one defines NPs as “any intentionally produced 
material”, while the other defines them regardless of their origin, so includes both the 
natural and incidental NM. This obviously creates problems with interpretation. Therefore, 
the starting point should be clarifying the definition and based on this identifying products 
which should be subject to regulation. Subsequently, the next step should be to define 
priorities within this large number of NP types and products containing them. To this end, 
the use of adequate in vitro models seems essential. This could be the point for the further 
application of our integrated in vitro model. The products labelled as “nano” would be an 
interesting target for application in our model to reveal the fate of the NPs from these 
products in the digestion model and their subsequent translocation rate and help to set 
priorities for subsequent in vivo testing.
3. Alternative models for animal studies in hazard identification of NPs
As mentioned in the previous chapters of this thesis, for the hazard identification of NPs 
(like any other chemicals), the classical approach relies heavily on animal studies (EFSA and 
Committee, 2011). For several reasons, scientific, ethical and economical, efficient alternative 
approaches need to be developed. Lately, the development of in vitro methods for prediction 
of toxicity and bioavailability of NPs gets much attention (Hartung et al. 2013). Except for 
reducing the animal studies, in vitro methods for testing NPs have many more advantages. In 
vitro approaches provide possibilities for faster and more high-throughput testing. They also 
allow to obtain more mechanistic insight of the tested processes. Reliable in vitro models to 
assess the potential bioavailability of NPs can be used in a tiered safety assessment approach 
(EFSA and Committee, 2011). To approximate human conditions, it is necessary to mimic 
the complexity of human gut, with its physiology and anatomy. Currently such alternative 
methods are being developed and one of such attempts is presented in this thesis (chapter 
2, 3, and 4). Using integrated models with elements of human origin (e.g.  human cells, 
digestion models based on human parameters) can give eventually a closer insight in effects 
of exposure of humans than using inbred young rats. The integrated in vitro model presented 
in this thesis is a step in the direction of this development. The model can serve for screening 
and prioritizing NPs for further animal studies and in this way it can help refining and 
reducing the animal studies. However, the values for NP translocation obtained in the model 
gave an overestimation of the bioavailability obtained in vivo. A similar overestimation of NP 
translocation compared to in vivo results has been recently demonstrated in another study 
using a model of Caco-2 and THP-1 cells grown in a 3-D matrix (Huang et al. 2014). While 
with the results of this thesis we get closer to developing an integrated in vitro model for 
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predicting in vivo fate and bioavailability of NPs, there are still some points for improvement. 
They are listed and described in detail below.    
3a. Inclusion of extracellular matrix 
A change to our model could be including extracellular matrix (e.g. collagen) lining on the 
insert membrane in the cell models, which might make the in vitro model and exposure 
more realistic. Collagen matrix has been used in studies with Caco-2 cells seeded in inserts 
(Maznah 1999; Leonard et al. 2010; Esch et al. 2014). Human cells can be grown on collagen 
hydrogel scaffolds, which are made to replicate the shape and size of human small intestinal 
villi. These 3-D hydrogel scaffolds seem to mimic in vivo cellular differentiation and 
absorption better than conventional culture systems (Yu et al. 2012). Instead of collagen, 
also more permeable synthetic membranes can be utilized for in vitro cell models (Giovino 
et al. 2013). Yet another alternative for collagen is using a Matrigel solution to create a 3-D 
matrix where  cells can be grown (Huang et al. 2014).
Our model did not include a collagen layer because in the control experiments it was 
shown to limit the free passage of NPs through the pores of inserts. Keeping in mind that 
the in vitro model in the current form overestimated the in vivo absorption, a factor limiting 
translocation, like collagen, could shift the results towards more in vivo-like values. In 
addition, inclusion of an extracellular matrix would render the in vitro model more similar 
to the in vivo anatomy, where a connective tissue layer is present under the epithelial cells 
and certainly might limit the absorption of NPs from the intestinal lumen. 
3b. Inclusion of other cell types
Macrophages present in the human intestinal mucosa play a crucial role in taking up NPs 
(Lomer et al. 2001; Lomer et al. 2002). Including macrophages in our co-culture model of 
Caco-2 and HT29-MTX cells could possibly make the in vitro translocation more similar to 
the in vivo bioavailability. THP-1 cells grown to mimic macrophages have been already co-
cultured with Caco-2 cells  (Satsu et al. 2006; Huang et al. 2014). Especially interesting is the 
model where macrophages are grown in a collagen matrix layer on the insert membrane, on 
top of which Caco-2 cells are cultured (Leonard et al. 2010). In such a model, macrophages 
could potentially take up the NPs as they translocate across the collagen layer, limiting their 
translocation to the basolateral compartment.
3c. Exposure condition improvement 
A limitation of experiments performed with intestinal cells in vitro is the fact that standard 
cell culture media do not contain gastrointestinal lumen factors. These  lumen factors 
may be relevant for the intestinal cells grown in vitro to express their full physiological 
potential and could be included in media (Patel et al. 2006). An additional reason to include 
the gastrointestinal lumen factors is that these factors likely affect the physicochemical 
properties of NPs, of which the importance has been shown in this thesis. It would be 
interesting to study the protein corona of NPs formed during incubation in physiologically 
relevant media. In line with this, an interesting point to study could be exposure of cells to 
NPs in the absence of serum (not present in the intestinal lumen in vivo), which has been 
done before, also in Caco-2 cells (Nowak et al. 2014). 
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3d. Kinetic modelling to extrapolate the outcomes of in vitro translocation to in vivo 
bioavailability
Using an in vitro approach, translocation kinetics can be studied in a fast and high-
throughput manner. In many experiments relatively long exposure durations are used, 
which not necessarily correspond to in vivo exposure situation. The actual contact of NPs 
with the rat small intestinal wall would last approximately only 1 or 2 h (Durmus-Altun 
et al. 2011). An exposure to NPs in our model shorter than 24 h would likely lead to a 
lower translocation level, as shown by Schimpel et al. in different intestinal cell models 
(2014). Kinetic studies in vitro with more time points could be used for kinetic modelling 
to extrapolate the translocation to earlier time points, especially in cases where detection 
limits would not allow detection of translocated NPs at earlier time points. In addition, 
kinetic modeling of the data can be used to study the consequences of the in vitro kinetics 
(i.e. linear, Michaelis Menten) for the in vivo situation. In this modeling the obtained in vitro 
translocation information can be extrapolated to the in vivo situation. For these in silico 
approaches using physiologically based pharmacokinetic modeling (PBPK) modeling and 
physiologically based toxico-kinetics programs can be used. While these models are readily 
available for conventional chemicals, less has been done for NPs. One of the few attempts 
is on AgNPs and Ag+ ions (Bachler et al. 2013). In case of our integrated in vitro model (i.e. 
combining the digestion and translocation), it is possible to collect NPs at each step of the 
digestion and translocation and assess the physicochemical changes in NPs. This can be 
used for more advanced nano (quantitative) structure bioavailability relationship studies. 
3e. Gut-on-a-Chip technologies
Current advances in bioengineering and microchip development can further improve 
intestinal in vitro models as developed in this thesis. Moving from static conditions to 
dynamic conditions, with i.e. flow on both the apical and basolateral side of a cell model could 
be very important. When growing cells on flexible membranes that can mimic physiological 
peristaltic motions, the shear forces resulting from the flow have been shown to induce 
Caco-2 cells differentiation into a polarized columnar epithelium that spontaneously grows 
into folds resembling the structure of intestinal villi (Kim et al. 2012). Additionally, these 
structures have been demonstrated to be covered with mucus (Kim and Ingber 2013). 
This does not happen with Caco-2 cells grown in static conditions in transwell systems. It 
allows studying the translocation efficiency of NPs in fully formed human small intestine. 
At the same time, this is a highly controlled microfluidic environment, which allows more 
detailed, accurate and real-time analysis of toxicity, uptake and translocation (Vergeres et 
al. 2012). In such fluidics systems, the basolateral flow can be used linking the GI system to 
another cell model, e.g. endothelial or hepatocyte culture (Huh et al. 2013).
OVERALL CONCLUSION
Overall, the present thesis presents the development of an integrated in vitro strategy for 
studying the fate and bioavailability of NPs after ingestion. The developed integrated in 
vitro model combines an in vitro gastrointestinal digestion model with an in vitro intestinal 
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model. The translocation of the NPs, as predicted from the integrated in vitro model, 
overestimated the translocation across the rat intestine in vivo. Therefore, the integrated 
in vitro model cannot be directly used for a quantitative prediction of the bioavailability 
of orally administered NPs. However, the model can be used for screening and prioritizing 
NPs before further in vivo testing for risk assessment.
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Nanotechnology developed in the past decades and resulted in many innovative products. 
A branch of nanotechnology focuses on the manufacturing and use of nanoparticles (NPs). 
Currently, we find many products containing NPs on the market (Wijnhoven et al. 2010; 
Chaudhry et al. 2008; Woodrow Wilson institute). Because many of these products are food 
or food-related products (Bouwmeester et al. 2014), human oral exposure to NPs is very 
likely. Before entering the EU market, a risk assessment of NPs applied in these products 
is required. Many of the products are also available via internet. At the moment, the risk 
assessment of chemicals and NPs relies heavily on animal studies. For scientific, ethical 
and economical reasons, there is a demand to refine, reduce and replace animal testing by 
developing in vitro alternatives for hazard characterization. In vitro methods are ideally 
incorporated in a tiered testing approach and for oral exposure the focus is on the effect 
of passing the gastrointestinal tract on the physicochemical properties of the NPs and on 
the subsequent passage of the gut wall. This can be followed by in vitro effect screening, if 
indications of systemic bioavailability is obtained. Thus, the aim of the present thesis was 
to develop an integrated in vitro approach based on in vitro models (i.e. in vitro digestion 
model and in vitro gut epithelium model) to evaluate the uptake of NPs following ingestion 
for the prediction of their oral bioavailability in the human body. 
Chapter 1 of the thesis gives an introduction to the topic, highlights the importance of 
careful characterization of NPs tested in the various assays and presents existing in vitro 
models of gastrointestinal digestion and human intestinal epithelium used for toxicity 
testing of NPs. Some of these in vitro models were selected and evaluated for testing NPs in 
the next (experimental) chapters. 
In order to study the fate of NPs after ingestion, the first step was to study the suitability 
of an in vitro digestion model to assess what happens with NPs during the passage 
through the human gastrointestinal tract. For this, in chapter 2 of this thesis the effects 
of the digestion on the fate and physicochemical properties of 60 nm silver nanoparticles 
(AgNPs) and Ag+ ions were studied. Samples were incubated in a static in vitro human 
digestion model composed of subsequent oral, gastric and intestinal digestion phases. It 
was demonstrated that gastrointestinal digestion impacted AgNPs and Ag+ ions in such a 
way that they changed during gastrointestinal digestion. As measured with (single particle) 
inductively coupled plasma-mass spectroscopy (SP-ICPMS), AgNPs agglomerated to a high 
extent during gastric passage, a process facilitated by chlorine interparticle bridges as shown 
by scanning electron microscopy with energy dispersive X-ray (SEM-EDX) analysis. These 
clusters were shown to break down during subsequent intestinal incubation, releasing the 
original AgNPs from the clusters. Strikingly, the NPs retained their original size in the 
intestinal juice. Thus, it was concluded that orally ingested 60 nm AgNPs, digested under 
physiologically relevant conditions, ultimately can reach the intestinal wall in their initial 
size and composition. Interestingly, the results of this study also revealed that intestinal 
digestion of Ag+ ions resulted in formation of 20-30 nm particles composed of silver, 
sulphur and chlorine. Therefore, we concluded also that ingestion of Ag+ ions ultimately 
leads to intestinal exposure to NPs, albeit with a complex chemical composition. 
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In order to reach the systemic circulation, NPs need to pass the gut wall. Therefore, in 
order to assess the potential bioavailability of NPs, measuring their intestinal translocation 
is essential. Given the aim to select and validate in vitro alternative testing strategies, 
selection of an in vitro model was undertaken in Chapter 3 of the thesis. Chapter 3 presents 
a comparison of three cell culture models: a mono-culture (Caco-2 cells), a co-culture 
with mucus secreting HT29-MTX cells, and a tri-culture with M-cells. Differently sized 
(50 and 100 nm) and charged (neutral, positively and negatively) polystyrene nanoparticles 
(PS-NPs) were used to challenge these models. PS-NPs were shown to translocate across the 
in vitro intestinal barriers, depending on their physicochemical properties. Size and charge 
were shown to strongly affect the translocation of NPs, but also surface chemistry was shown 
to be important, because the two types of negatively charged NPs with different surface 
modifications had an over 30-fold difference in translocation. This result indicates that the 
chemical composition at the surface of the NPs is more important than the zeta potential. 
The relative pattern of NP translocation in all three used intestinal models was similar, but 
the absolute amounts of translocated NPs differed per model. Therefore, we concluded that 
for comparing the relative translocation of different NPs, using one intestinal model would 
be sufficient. Preferably, a model with mucus should be chosen, as mucus creates more 
realistic exposure conditions, also protecting cells from toxic effect of chyme. However, for 
screening studies in a tiered risk assessment approach, when absolute translocation values 
are needed, it should be kept in mind that depending on the chosen model, the outcomes 
will differ. 
In chapter 2 in vitro digestion was shown to influence the physicochemical properties 
of AgNPs. To test if this would affect the translocation efficiency of PS-NPs, we integrated 
the in vitro digestion model with the in vitro intestinal co-culture model to test the 
translocation of digested PS-NPs. In chapter 4 the translocation results from this integrated 
in vitro model are presented. It demonstrates that in vitro digestion of differently charged 
50 nm PS-NPs influenced both their translocation behaviour and their protein corona. 
Translocation of all digested PS-NPs was clearly increased compared to the translocation 
of their pristine equivalent PS-NPs and was ranging from 1.6% to 12.3%, depending on NP 
type. One type of negatively charged NP was the NP translocating to the highest extent. The 
protein corona was affected in both the amount of proteins and their composition. Digested 
PS-NPs contained less protein in their corona than their equivalent pristine PS-NPs. The 
composition of the protein corona of PS-NPs was changed, which resulted in a shift from 
larger proteins (present in coronas of pristine NPs) towards low molecular weight proteins. 
This study clearly illustrated that gastrointestinal digestion affects in vitro translocation 
behaviour of different types of PS-NPs. These findings stress the importance of including 
the in vitro digestion in future in vitro intestinal translocation screening studies for risk 
assessment of orally taken NPs.    
To assess the utility of the developed integrated in vitro model for assessing the 
bioavailability, it required validation by an in vivo study. Chapter 5 presents the estimated 
bioavailability resulting from an oral exposure of rats to a single dose of the same PS-NPs 
as tested in the integrated in vitro model. Similar to the in vitro results, the surface charge 
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and surface chemistry affected the uptake and biodistribution of PS-NPs in rats after 
oral exposure. Also in line with the in vitro results it appeared that one type of negatively 
charged NP was taken up to a larger extent than the other NPs. The highest amounts of 
NPs were detected in kidney, heart, stomach wall, and small intestinal wall. This partly 
confirmed our in vitro findings, where the same NPs translocated to the highest extent 
among all tested NPs. However, the relative order of uptake for the other NPs differed from 
the in vitro findings. The estimated bioavailability ranged from 0.2% to 1.7% in vivo, which 
was much lower than that in vitro (1.6% to 12.3%). These results show that the predicted 
uptake of PS-NPs from our integrated in vitro model appears to overestimate the actual 
uptake occurring in the rat in vivo. In conclusion, the integrated in vitro model cannot be 
directly used for a quantitative prediction of the bioavailability of orally administered NPs. 
However, the integrated in vitro model can be used for prioritizing NPs, based on their 
translocation rate, for further in vivo testing for risk assessment.
Chapter 6 presents a discussion on the in vitro and in vivo findings of the present thesis 
and some future perspectives for research on issues raised in this thesis.
Overall, the present thesis presents the development of an integrated in vitro strategy for 
studying the fate and bioavailability of NPs after ingestion. The developed integrated in 
vitro model combines an in vitro gastrointestinal digestion model with an in vitro intestinal 
model. The translocation of the NPs, as predicted from the integrated in vitro model, 
overestimated the translocation across the rat intestine in vivo. Therefore, the integrated 
in vitro model cannot be directly used for a quantitative prediction of the bioavailability 
of orally administered NPs. However, the model can be used for screening and prioritizing 
NPs before further in vivo testing for risk assessment.
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In de afgelopen decennia heeft de nanotechnologie zich verder ontwikkeld en dat heeft 
geresulteerd in veel innovatieve producten. Een van de branches van de nanotechnologie 
richt zich op het fabriceren en het gebruik van nanodeeltjes (NPs). Tegenwoordig zijn er veel 
producten in de handel die NPs bevatten (Wijnhoven et al. 2010; Chaudry et al. 2008; Woodrow 
Wilson institute). Omdat veel van deze producten voedingsmiddelen of voedselgerelateerd zijn 
(Bouwmeester et al. 2014), is orale blootstelling van mensen aan NPs waarschijnlijk. Voordat 
dergelijke producten in de EU op de markt mogen verschijnen, is een risicobeoordeling 
vereist van NPs die in deze producten zijn verwerkt. Veel van deze producten zijn echter 
beschikbaar via internet. De risicobeoordeling van chemicaliën en NPs is momenteel vooral 
gebaseerd op dierstudies. Er zijn wetenschappelijke, ethische en economische redenen die 
vragen om dierproeven te verfijnen, te reduceren en te vervangen door in vitro alternatieven. 
In vitro methodes zijn idealiter opgenomen in een trapsgewijze testbenadering en voor 
orale blootstelling ligt de nadruk in eerste instantie op het effect van de fysisch-chemische 
eigenschappen van de NPs en de invloed daarvan op het passeren van het gastro-intestinale 
kanaal en daaropvolgend de darmwand. Als aanwijzingen van systemische biobeschikbaarheid 
verkregen zijn, kan dit worden gevolgd door een in vitro effectscreening. Het doel van dit 
proefschrift was om een geïntegreerde in vitro benadering te ontwikkelen die is gebaseerd op in 
vitro modellen (bijv. het in vitro verteringsmodel en het in vitro darmwandepitheel-model) om 
zo de opname van NPs in het menselijk lichaam via orale biobeschikbaarheid te voorspellen.
Hoofdstuk 1 van dit proefschrift geeft een inleiding op het onderwerp, belicht het 
belang van zorgvuldige karakterisering van NPs die zijn getest in verschillende assays en 
presenteert bestaande in vitro modellen voor gastro-intestinale vertering en voor humaan 
darmwand epitheel die zijn gebruikt voor het testen van de biobeschikbaarheid van NPs. 
Enkele van deze in vitro-modellen zijn in de volgende (experimentele) hoofstukken 
geselecteerd en geëvalueerd voor het testen van NPs.
Om het lot van NPs na orale opname te bestuderen, was de eerste stap het bestuderen 
van de geschiktheid van een in vitro model om te bepalen wat met NPs gebeurt gedurende 
de passage door het humaan maag-darm kanaal. Daarom werden in hoofdstuk 2 van dit 
proefschrift de effecten van de condities in het maag-darm kanaal bestudeerd op enkele 
fysisch-chemische eigenschappen van 60 nm zilvernanodeeltjes (AgNPs) en Ag+ ionen. 
Monsters werden geïncubeerd in een statisch in vitro humaan spijsverteringsmodel dat 
was samengesteld uit orale, maag en dunne darm verteringsfases. De gastro-intestinale 
spijsvertering bleek de eigenschappen van zowel AgNPs en Ag+ ionen te beïnvloeden. 
Gemeten met (’Single particle’) inductief-gekoppelde plasma-massaspectroscopie (SP-
ICPMS) bleken AgNPs zich om te vormen tot clusters van deeltjes met een grote omvang 
tijdens de  passage door de maag. In deze clusters werden de AgNPs bijeen gehouden 
door chloor bevattende interpartikel bruggen, zoals was te zien tijdens de electronen-
microscopische scanning met energie dispergerende X-straling (SEM-EDX) analyse. 
Dit chloor was afkomstig van de verteringssappen in de maag. Deze clusters verdwenen 
tijdens de opvolgende  dunne darm incubatie, waarbij de originele AgNPs uit de clusters 
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vrijkwamen. Wat opviel was dat de NPs hun oorspronkelijke afmeting behielden in het 
darmvocht. Dit leidde tot de conclusie dat oraal ingenomen 60 nm AgNPs die werden 
verteerd onder fysiologisch relevante condities, uiteindelijk de darmwand kunnen bereiken 
in hun initiële afmeting en samenstelling. Een andere interessante bevinding van deze 
studie is  dat incubatie  van Ag+ ionen onder gesimuleerde maag-darm condities resulteerde 
in de vorming van 20-30 nm partikels samengesteld uit zilver, zwavel en chloor. Daaruit 
concludeerden wij dat opname van Ag+ ionen uiteindelijk leidt tot intestinale blootstelling 
aan NPs, zij het met een complexe chemische samenstelling. 
Om de systemische circulatie te bereiken moeten de NPs de darmwand passeren. Om 
de potentiële biobeschikbaarheid van NPs te beoordelen is het meten van hun intestinale 
translocatie essentieel. Vanwege het doel in vitro alternatieve proefstrategieën te selecteren 
en valideren werd in hoofdstuk 3 van het proefschrift de selectie van een in vitro model 
uitgewerkt. Hoofdstuk 3 laat een vergelijking zien van drie celkweekmodellen: een mono-
cultuur (Caco-2 cellen), een co-cultuur met mucus afscheidende HT29-MTX cellen en 
een tri-cultuur met M-cellen. Verschillende maten (50 en 100 nm) en verschillend geladen 
(neutraal, positief en negatief) polystyrene nanodeeltjes (PS-NPs) werden gebruikt om deze 
modellen te testen. PS-NPs bleken, afhankelijk van hun fysisch-chemische eigenschappen, de 
in vitro intestinale barrieres te passeren. Grootte en oppervlaktelading (de zogenaamde zeta 
potentiaal) bleken de translocatie van NPs sterk te beïnvloeden, maar ook oppervlaktechemie 
van de NPs bleek van belang te zijn. Dit laatste kwam naar voren uit de vergelijking van 
de twee typen van negatief geladen NPs met verschillende oppervlaktekarakteristieken die 
een meer dan 30-voudig verschil in translocatie hadden. Dit resultaat toont aan dat de 
chemische samenstelling aan de oppervlakte van NPs belangrijker is dan de zeta-potentiaal. 
Het relatieve patroon van NP translocatie in alle drie gebruikte intestinale modellen was 
gelijk, maar de absolute aantallen van getransloceerde NPs verschilden per model. Daaruit 
concludeerden we dat, om de relatieve translocatie van verschillende NPs te vergelijken, 
één intestinaal model voldoende zou zijn. Bij voorkeur zou een model met mucus gekozen 
moeten worden omdat mucus meer realistische blootstellingscondities creëert, en ook 
cellen beschermt tegen het toxisch effect van chyme. Echter voor het screenen van studies in 
een trapsgewijze risicoschattingsbenadering, wanneer absolute translocatiewaarden nodig 
zijn, moet eraan gedacht worden dat de uitkomsten zullen verschillen, afhankelijk van het 
gekozen model.
In hoofdstuk 2 bleek de in vitro spijsvertering de fysisch-chemische eigenschappen 
van AgNPs te beïnvloeden. Om te testen of dit de translocatie-efficiëntie van PS-NPs 
zou beïnvloeden, integreerden we in hoofdstuk 4 het in vitro spijsverteringsmodel uit 
hoofdstuk 2 met het in vitro intestinale co-cultuurmodel beschreven in hoofdstuk 3 om de 
translocatie van verteerde PS-NPs te testen. In hoofdstuk 4 worden de translocatieresultaten 
van dit geïntegreerde in vitro model gepresenteerd. De resultaten tonen aan dat in vitro 
spijsvertering van verschillend geladen 50 nm PS-NPs zowel hun translocatiegedrag als hun 
eiwitcorona beïnvloedde. Translocatie van alle verteerde PS-NPs was duidelijk toegenomen 
vergeleken met de translocatie van hun ongerepte equivalent PS-NPs en varieerde van 
1.6% tot 12.3%, afhankelijk van PS-NP-type. Eén van de twee types van negatief geladen 
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NPs vertoonde de hoogste translocatie. De eiwitcorona om de PS-NPs werd zowel qua 
eiwithoeveelheid als qua eiwitsamenstelling beïnvloed. Verteerde PS-NPs bevatten minder 
eiwit in hun corona dan hun equivalent ongerepte PS-NPs. Na de vertering bevatte 
de eiwitcorona van PS-NPs vooral kleinere laag-moleculaire eiwitten. Deze studie liet 
duidelijk zien dat de condities in de maag-darm kanaal het in vitro translocatiegedrag van 
verschillende types PS-NPs beïnvloedt. Deze bevindingen benadrukken het belang om in de 
toekomst in vitro spijsvertering mee te nemen in in vitro intestinale translocatiescreening-
studies voor risicobeoordeling van oraal ingenomen NPs. 
Om de bruikbaarheid van het ontwikkelde geïntegreerde in vitro model voor het 
beoordelen van de biobeschikbaarheid te bepalen, is validatie door middel van een in 
vivo studie noodzakelijk. Hoofdstuk 5 presenteert de geschatte biobeschikbaarheid zoals 
gemeten na een orale blootstelling van ratten aan een enkele dosis van dezelfde PS-NPs 
als die getest werden in het geïntegreerde in vitro model. Net als bij de in vitro resultaten, 
beïnvloedden de oppervlaktelading en de oppervlaktechemie de opname en biodistributie 
van PS-NPs in ratten na orale blootstelling. Evenals bij de in vitro resultaten bleek dat 
één type van negatief geladen PS-NPs in een grotere hoeveelheid werd opgenomen dan 
de andere PS-NPs. De grootste hoeveelheden van NPs werden gevonden in nier, hart, 
maagwand en dunnedarmwand. Dit bevestigde ten dele onze in vitro resultaten, waar 
dezelfde negatief geladen PS-NPs het meest de in vitro darmwand passeerden. De relatieve 
volgorde van opname van de andere PS-NPs verschilde echter van de in vitro resultaten. De 
geschatte biobeschikbaarheid varieerde van 0.2% tot 1.7% in vivo en dat is veel lager dan 
in vitro (1.6% tot 12.3%). Deze resultaten laten zien dat de voorspelde opname van PS-NPs 
uit ons geïntegreerde in vitro model de feitelijke opname die in de rat in vivo voorkomt, 
overschat. Concluderend betekent dit dat het geïntegreerde in vitro model niet zonder meer 
kan worden gebruikt voor een kwantitatieve voorspelling van de biobeschikbaarheid van 
oraal toegediende NPs. Het geïntegreerde in vitro model kan echter wel worden gebruikt 
om NPs te prioriteren, gebaseerd op hun translocatiegraad, voor verdere in vivo proeven 
voor risicoschatting.
Hoofdstuk 6 presenteert een discussie over de in vitro en in vivo resultaten van het 
huidige proefschrift en enkele toekomstperspectieven voor onderzoek naar onderwerpen 
die in dit proefschrift zijn onderzocht.
Dit proefschrift presenteert de ontwikkeling van een geïntegreerde in vitro strategie voor 
het bestuderen van lot en biobeschikbaarheid van NPs na orale inname. Het ontwikkelde 
geïntegreerde in vitro model combineert een in vitro gastro-intestinaal verteringsmodel 
met een in vitro intestinaal model. De translocatie van de NPs, zoals voorspeld door 
het geïntegreerde in vitro model, overschatte de translocatie in de ratten darm in vivo. 
Daarom kan het geïntegreerde in vitro model niet zonder meer worden gebruikt voor een 
kwantitatieve voorspelling van biobeschikbaarheid van oraal toegediende NPs. Het model 
kan echter wel worden gebruikt voor screening en prioritering van NPs, voorafgaand aan 
verder in vivo onderzoek voor risicoschatting.
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